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Chapter 1 
General Introduction 
M. Laura Ferrando 
Chapter 1 
1. Streptococcus suis 
1.1 Ecology and taxonomy 
Streptococcus suis is a major zoonotic swine pathogen capable of causing serious 
infections in pigs and persons in close occupational or accidental contact with infected 
pigs or contaminated pork products. Infections caused by 5. suis cause significant 
economic losses to the swine industry worldwide. The natural habitat of 5. suis is the 
upper respiratory tract of pigs, particularly the tonsils and nasal cavities, as well as the 
alimentary and genital tracts [1,2]. Although S. suis is considered mainly a pathogen of 
swine, it has been isolated increasingly frequently from a wide range of mammals 
(ruminants, cats, dogs, deer and horses) and birds [3,4,5,6] which suggests a capacity to 
persist in a broad range of very different hosts, leading to high diffusion of this pathogen 
[7]. 5. suis can survive for 8 days in faeces and for short periods of exposure to moderate 
heat (i.e. survival after 60°C for 10 min and 50°C for 2h) and desiccation (24 h in dust at 
25°C or 1 month in dust at 0°C) [8]. 
5. suis is a Gram-positive facultative anaerobe belonging belonging to the phylum 
Firmicutes, class Lactobacillales that is a- or ß-hemolytic, catalase negative and with a low 
G+C DNA composition. The capsulated bacteria possess cell wall antigenic determinants 
somewhat related to Lancefield group D [9]. Based on differences in antigenic properties 
of the polysaccharide capsule, 33 serotypes have been distinguished to date (types 1-33 
and 1/2), [10,11]; serotypes 32 and 34 have since been proven to belong to the related 
species Streptococcus orisratti [12]. Phylogenetic analysis of the 5. suis heat-shock 
chaperone 60 gene showed the presence of three basal clusters. The majority of serotypes 
are associated with cluster I; 20, 22 and 26 serotypes with cluster II, and isolates of 
serotype 33 with cluster III. According to this systematic analysis, S. suis was most closely 
related to Streptococcus anginosus, Streptococcus parasanguinis, Streptococcus sanguis, 
Streptococcus oralis and Streptococcus mitis [13]. 
1.2 Metabolism 
The metabolic map of S. suis includes more than 80% of the metabolic maps known for 
other Streptococcus species (Chapter 5). Like other Streptococci, S. suis produces energy 
mainly through metabolism of glucose via homolactic or mixed-acid fermentations 
depending on the availability of external oxygen and carbohydrate. Under conditions of 
excess glucose and in presence of oxygen, glucose is preferentially metabolised by the 
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glycolytic pathway (or Embden-Meyerhof pathway) to pyruvate that is reduced via 
oxidative respiration through the tricarboxylic acid (TCA) cycle. However, in S. suis, as in 
most other lactobacilli, the TCA cycle is incomplete, rendering S. suis incapable of 
oxidative respiration. Instead energy is derived from the metabolism of pyruvate using 
organic compounds as electron acceptors. In homolactic fermentation one molecule of 
glucose is ultimately converted to two molecules of lactic acid whereas heterolactic 
fermentation is the production of lactic acid as well as other acids and alcohols. The 
metabolic map of S. suis suggests that pyruvate can be converted into lactic acid but also 
acetic acid, ethanol and formic acid, but not acetoin (Chapter 5). 5. suis is able to ferment 
alternative sugars including mono- and di-saccharides such as ribose, L-arabinose, 
mannose, sorbitol, lactose and raffinose, but also complex carbohydrates such as 
glycogen, starch and pullulan, to glucose [12]. The metabolism of complex carbohydrates 
requires the presence of specialized transport systems and catabolic enzymes such 
amylase, pullulanase and amylopullulanase that permit the utilization of alternative sugars 
in different environmental niches including those present within the host [14]. These 
enzymes enable S. suis to grow efficiently on complex carbohydrates and colonize the host 
mucosal epithelia that are rich in such carbohydrates (Chapter 3, Chapter 4, Chapter 5). 
1.3 Diagnosis 
S. suis can be cultured from nasal, vaginal and tonsillar swabs, cerebrospinal fluid (CSF) or 
blood samples of infected animals. The solid medium most commonly used to isolate S. 
suis is sheep blood agar on which viridans group streptococci produce an a- hemolysis. 
This type of hemolysis is due to the production of hydrogen peroxide by 5. suis which 
oxidizes hemoglobin to a green colored methemoglobin. However, when cultivated on 
horse blood agar 5. suis produces a clear zone of ß-hemolysis [15]. Usually the 
identification is further verified by checking if colonies are catalase negative, negative for 
the Voges-Proskauer (acetoin) reaction, hydrolysis of esculin, trehalose positive, amylase 
positive, and if growth inhibition occurs in the presence of 6.5% NaCI. The use of 
miniaturized biochemical test like the Rapid Strep System is common in microbiology 
diagnosis. This Analytical Profile Index (API) test is based on the reaction of a panel of 
chemicals (usually 20) to determine the bacterial species. However, cross-reactivity, a 
feature of many standard microbiological techniques, often hampers correct identification 
[16] such that infections may go undiagnosed. It is possible that 5. su/s-positive cultures 
are sometimes misidentified as other Streptococcus species, Aerococcus viridans, 
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Enterococcus faecalis or even 5. sanguinis [17,18]. Misidentification in diagnostic 
laboratories has also been influenced by unawareness of the possibility that 5. suis can 
lead to meningitis; the result being that S. suis colonies have been assumed to be 
enterococci or (group D) streptococci [19]. Therefore, more accurate molecular methods 
have been developed to correctly identify 5. suis from infected tissue samples. 
In Asia, molecular techniques to detect 5. suis in human samples, by real time PCR 
detection of the cps2J gene, improved the rate of pathogen detection over the last few 
years. Recently a sensitive loop-mediated isothermal amplification (LAMP) technique 
targeting the cpn60 gene (encoding chaperonin 60) has been developed that can be used 
to successfully detect all 33 S. suis serotypes [20]. 
Serotyping of bacteria is an important step in routine diagnostic procedures. In most 
laboratories, S. suis serotyping is usually carried out by scoring different types of 
agglutination using a panel of 33 specific sera [21]. However this serotyping method 
presents a low sensitivity due to the fact that some isolates react with more than one 
antiserum (cross-reactions). A serotype-specific polystyrene bead-based immunomagnetic 
separation (IMS) technique has been described that permits an better isolation and 
distinction among the serotypes [16]. 
1.4 Molecular markers to detect S. suis 
Two secreted cell wall located proteins have been proposed as virulence markers, namely 
the muramidase-released protein (MRP) and the extracellular factor (EF) [22,23]. Both 
MRP and EF can be detected by monoclonal antibodies and were frequently (77%) 
produced by strains isolated from pigs with symptoms of meningitis in The Netherlands. 
However, the majority (86%) of isolates from tonsils of healthy pigs did not produce these 
proteins [23]. In field isolates of S. suis different molecular variants MRP and EF have been 
characterized by electrophoretic mobility [24]. The variants have been designated as 
MRP* and EF*. So far several variant types have been described: MRP+EF+, MRP+EF*, 
MRP+EF , and MRP EF . It appears that the EF* strains producing the high-molecular 
weight variant of EF are avirulent or weakly-virulent. Nevertheless, in the USA, a lower 
percentage of strains (56%) isolated from the CNS of diseased pigs were MRP+EF+ [24] 
indicating that globally there is no strict correlation between production of MRP and EF 
and virulence. 
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2. Porcine infections with 5. suis 
2.1 S. suis epidemiology in pigs 
S. suis was first isolated during an outbreak of meningitis among piglets in the Netherlands 
in 1954 [25]. Since then S. suis porcine infection with S. suis has been reported worldwide, 
from North America (United States and Canada) to South America (Brazil), Europe, Asia 
(China, Thailand, Vietnam, and Japan), Australia, and New Zealand [15]. In the USA alone 
the economic losses to the swine industry from 5. suis infection is estimated at over 300 
million dollars in the United States [15] and in the Netherlands 12 million Euro [26]. In 
swine herds, the rates of asymptomatic carriage may be as high as 80%. The incidence of 
disease varies over time and is generally less than 5%, possibly due to the differential use 
of antibiotics. Pig morbidity due to infection with S. suis has been estimated to be in the 
range of <1% to >50% [15]. 
In piglets S. suis can be vertically transferred from the sow to the piglet through nasal 
secretions, during suckling [27,28] or via the vaginal secretions during parturition [29]. In 
addition horizontal transmission can occur in pig herds, mainly via the respiratory route 
[30]. Airborne transmission of 5. suis has been shown over a distance of 40 cm or more, 
without nose-to-nose contact [31]. In fact, it appears that transmission between herds 
occurs usually via healthy carrier pigs [32]. The introduction of carriers into a non-infected 
herd usually results in the subsequent onset of disease in weaning- and/or growing pigs 
(i.e. pigs 3 to 12 wk of age) [33]. Clinical disease may suddenly develop within a herd of 
pigs due to predisposing factors, such as co-infection by other swine pathogens. For 
example, co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) 
or Aujeszky's disease virus exacerbates S. suis infection [34]. PRRSV and Aujeszky's disease 
are typically enzootic in intensive pig production settings [35] and show a stress-induced 
susceptibility in pigs [36], suggesting that the association between S. suis infection and 
high-density pig herds is probably multifactorial [8]. Crowding, poor ventilation, sudden 
weather change, mixing, moving, vaccination, and concurrent disease are all stresses that 
predispose pigs to S. suis infections [15]. In general, 5. suis most often affects pigs in 
intensively managed herds, especially herds with a high population density [37]. 
In pigs all S. suis serotypes can potentially cause disease but their virulence differs among 
and within the serotypes. Serotypes show a different geographical distribution [15]. 
Serotype 2 is the serotype most commonly associated with disease and is most frequently 
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isolated from S. su/s-infected pigs [38,39]. However, not all isolates of type 2 are 
pathogenic and this serotype, comprises pathogenic, weakly pathogenic, and 
nonpathogenic strains [40,41,42]. The closely related serotypes 1 and 14 appear highly 
virulent and have been frequently isolated from piglets or adult pigs [7,15,43]. Lung 
inflammation has been observed in pigs infected with serotypes 1-5, 7, 8 and 1/2 [44]. 
Although 5. suis is widespread, the serotypes seem to have a different geographical 
location among the 5 continents. The serotypes 1, 2, 7, 9, and 14 are most frequently 
isolated from diseased pigs in Europe, and serotype 9 in particular, is being increasingly 
isolated and associated with diseased pigs [45,46]. 
In Northern America, the percentage of 5. suis serotype 2 strains isolated from diseased 
animals decreased from 22% to 15% in the past 10 years [7], while serotypes 3, 5 and 8 
have been frequently isolated from diseased animals [30]. Multiple strains or serotypes 
are often found within a herd during an 5. suis outbreak, although no significant 
differences in clinical signs or lesions occur in pigs infected with multiple versus single 
serotypes [47]. 
2.2 Clinical signs of disease induced by 5. suis 
Although pigs of any age can be affected by S. suis, the disease mainly is observed in 
weaning and growing pigs (with peaks at the age of 6 weeks). The first symptoms of the 
disease include fever, depression, anorexia and lassitude. 
The development of the disease is accompanied by a detectable bacteremia or 
pronounced septicaemia, fluctuating fever (up to 42°C), loss of appetite, depression, and 
shifting lameness [48]. 
In pigs, the most important clinical feature associated with 5. suis is meningitis. Symptoms 
of meningitis and meningoencephalitis are often preceded by early signs of a nervous 
disorder including incoordination, adoption of unusual stances, instability, paddling, 
opisthotonos, convulsions and nystagmus. In case of S. suis infections, other pathologies 
have also been described, such as arthritis, pneumonia, rhinitis, fibrinous polyserositis, 
abortion, endocarditis, and septicaemia with sudden death [49,50]. 
2.3 Pathology 
Histological features from pigs showing S. suis disease symptoms may include lesions with 
fibrino-purulent exudates in the brain, swollen joints, fibrinous inflammation of the linings 
of the lungs, and cardiac valvular vegetations (a mass of platelets, fibrin, 5. suis colonies, 
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and inflammatory cells). Less frequently, lesions associated with septicaemia or 
polyarthritis are seen. S. suis can also cause lesions associated with pneumonia, but these 
are often considered to be secondary to other diseases. 
2.4 Treatment ofS. suis infections 
Antimicrobial therapy is an important disease management tool used to treat and/or 
control streptococcal infections, as current bacterins (vaccines comprising killed 
suspensions of bacterial strains) provide only serotype-specific protection. Penicillin is the 
most common antibiotic used in treatment of S. suis infection. Although S. suis is usually 
sensitive to penicillin, penicillin resistance has been reported in pig carriers [51]. 
Antimicrobial susceptibility of S. suis strains (Minimum Inhibitory Concentration MIC) 
differs from country to country [52,53,54]. Most antibiotic resistance determinants 
identified in 5. suis are located on plasmids or transposons and are disseminated. 
Recently, two genetic elements conferring resistance to erythromycin (erm(B)) and 
tetracycline (tet(W)) were characterized in two human S. suis isolates [55]. 
2.5 Vaccines 
Most vaccines used to protect against S. suis infections have been based on formalin-
killed whole cells. These are called bacterins can confer a good protection only to those 
serotypes present in the vaccine [56]. Commonly used is a commercial vaccine containing 
killed S. suis serotype 2 (Emulsibac-SS®, MVP Laboratories, Inc., Ralston NE) [57] and an 
autogenous 5. suis bacterin (produced by MVP Laboratories, Inc., Ralston NE) [58]. Subunit 
vaccines based on murein-associated protein (MAP) fraction subunit vaccine have also 
been compared to an autogenous bacterin [59]. Immunization with bacterin, but not with 
MAP subunit vaccine, induced opsonizing antibody titres against the serotype 2 strain, and 
these antibody titres were found to correlate with protection. However cross-protection 
against a serotype 9 strain was very low for both vaccines [59]. These results emphasize 
the importance of finding conserved protein antigens for the development of new cross-
protective subunit vaccines [60,61,62,63]. The presence of maternal antibodies in the 
colostrum of sows may present challenges for effective vaccination of young piglets as 
recently demonstrated by Baums et al. [64]. Nevertheless immunization of sows can 
confer passive immunity against S. suis to the young piglets but after weaning those young 
pigs become more susceptible to infection [64,65]. 
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The use of an avirulent strain as vaccine can give protection in piglets [66]. The protective 
efficacy of a live and formalin killed non-encapsulated isogenic mutant has been tested in 
specified pathogen-free (SPF) pigs, housed in boxes at animal facilities [67]. All pigs 
vaccinated with wild type (capsulated) killed bacteria were completely protected against 
challenge with the homologous serotype; the killed non-encapsulated strain conferred a 
partial protection to the pigs [67]. This finding suggested that antigens within the S. suis 
cell wall contribute to induction of an immune response. 5. suis cell wall proteins could 
play a role in vaccine protection, but the role of such cell wall proteins in cross-protection 
is still being actively investigated [60,61,62,63]. 
3. Zoonotic infections with S. suis 
3.1 S. suis epidemiology in humans 
The first documented case of a human infection by S. suis was in Denmark in 1968 [68]. 
The number of human S. suis cases reported in the literature has increased significantly in 
more than 20 countries and with more than 700 cases over the past few years [69]. 
Infections with 5. suis have also caused sporadic human illness in other countries, 
including Thailand [70,71,72], the United Kingdom [73], Portugal [74], Italy [75], Japan 
[76], Australia [77], the Netherlands [78] and the United States [79,80,81]. The majority of 
human cases and outbreaks are reported from Asian countries with intensive pig 
production, i.e. China, Vietnam, and Northern Thailand. At present, 5. suis meningitis is 
considered to be the most common cause of adult human meningitis in some areas of 
southeast Asia (see below). Sporadic cases have also been reported in European countries, 
including the Netherlands (Fig. 1.1). 
16-
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Fig. 1.1 : World map of human S. suis cases with background pig density data. Published with permission from the Infectious 
Diseases Research Foundation (World Atlas of Infectious Diseases Project) [82]. 
In Southern Vietnam, S. suis is the main cause of acute bacterial meningitis in adults (151 
meningitis cases in the last 10 years) [83] and it is the third most common cause of 
meningitis in Hong Kong [84]. In cases of human meningitis in Vietnam, S. suis serotype 2 
infection was more common than infections with Streptococcus sanguis and Neisseria 
meningitidis combined [85]. Most reports of S. suis infection are due to sporadic cases of 
infection but two larger outbreaks of 5. suis infection occurred in China. One large 
outbreak was associated with 25 cases and 14 deaths in Jiangsu in 1998, and a second 
Chinese outbreak involving 204 cases and 38 deaths occurred in the Sichuan province in 
2005, emphasizing the importance of S. suis as an emerging zoonosis [86,87,88]. 5. suis 
serotype 2 is the most common cause of meningitis disease in humans [89] although 
serotypes 1, 4, 14, and 16 have been linked to severe disease in a limited number of 
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persons [90]. The relative high mean patient age (47-55 years) and almost complete 
absence of children in case series, as well as the high male-to-female patient ratio (3.5:1.0 
to 6.5:1.0), support the notion that infection with S. suis is generally an occupational 
disease [18,19,69,70,77,78,81,91]. Persons in close occupational or accidental contact 
with pigs or pork products and those who eat uncooked or undercooked pork may be at 
higher risk than others. 5. suis may become an opportunistic pathogen under particular 
circumstances such as stress or immunodeficiency and the onset of meningitis may 
manifest itself by clinical signs such as loss of coordination [19,75]. Purulent meningitis 
may result in permanent hearing loss, septicaemia, and endocarditis, which are commonly 
fulminant and often fatal [69,70,73,92]. In humans, direct entry of S. suis into the blood 
through skin wounds correlates with a very short incubation phase [87]. 
3.2 Treatments in humans 
Data from Vietnam show that 5. suis is susceptible to penicillin, ceftriaxone, and 
vancomycin [69]. Strains isolated from humans are frequently resistant to tetracycline 
(83.2% of isolates), erythromycin (20% of isolates) and chloramphenicol (3.3%)[69]. 
Penicillin resistance has been reported in a single human case [92]. The principles of 
treatment are the same as those for other causes of bacterial meningitis. For empirical 
treatment, ceftriaxone with or without vancomycin (depending on the local epidemiology 
of bacterial meningitis and drug resistance) is a good choice until the laboratory diagnosis 
is confirmed [69]. Penicillin G (24 million U over 24 h for at least 10 days) has been used 
successfully for the treatment of S. suis meningitis [93]. 
4. Aspects of Pathogenesis 
The progression of disease symptoms caused by 5. suis are characterized by at least four 
sequential processes: (i) adherence to host cells, (ii) invasion and crossing of host 
epithelia, (iii) dispersal and survival in the blood stream, and (iv) infection of downstream 
organs. During any of these steps, bacteria may proliferate and induce damage leading to 
exaggerated inflammation (Fig. 1.2). However, there are several open questions 
concerning the pathogenesis of disease cause by S. suis infection that are discussed below 
and throughout this thesis. These consecutive steps in the pathogenesis of invasive 
disease caused by S. suis will now be discussed in sequence. 
18-
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Fig. 1.2 Hypothetical model of the pathogenesis of S. suis infection (modified from Gottschalk et al 2011) [19]. The description 
of pathogenesis steps from A to J are found in the text. A Adhesion of mucosal epithelium; B Invasion by epithelia disruption due 
to Sly toxin production; C Hypothetical dissemination from the mucosal epithelium through the interaction with DC cells; D, E, F 
S. suis survival strategies in the bloodstream as free capsulated or F, J associated with monocytes (adherent or internalized); G, H, 
I 5. suis crosses the blood-brain barrier (BBB) by adhesion and penetration of endothelial cells. An increased permeability of BBB 
due to cytokines or bacterial toxins production can help the bacteria to penetrate across the BBB and gives local inflammation of 
meninges. 
Sly, suilysin; CPS, capsular polysaccharides; CAMs, cellular adhesion molecules, DC dendritic cells, Mo/M 
Monocytes/Macrophages, BBB brain blood barrier, CFS central nervous system. 
4.1 Mucosal adhesion and colonization 
Swine can become infected by S. suis via both the vertical and horizontal route leading to 
colonization of the oropharyngeal cavity, in particular the tonsils [94]. In humans, it is 
thought that people can also become infected through wounded skin by handling of 
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uncooked pork that is contaminated with 5. suis [69,94]. Inoculation through cuts and 
sores in the skin are assumed to be associated with an acute infection because the 
bacteria may directly multiply in the blood stream. Colonization may lead to asymptomatic 
carriage or invasion of the mucosal tissues and dissemination in the blood to other organs. 
In the mucosal epithelium of upper respiratory/intestinal tract are present high 
concentrations of common forms of a-glucans including dietary starch and glycogen, the 
storage form of a-glucose in the eukaryotic cell. a-Glucan-binding proteins include the 
enzymes capable of hydrolysis and synthesis of the a-glucans including starch and 
cellulose, that can act as substrates for microbial growth [95]. Several adhesins with 
metabolic enzymatic activity, have been identified in vitro and may also contribute to the 
adhesion to host epithelial cells, by binding to unknown glycoconjugates or host receptors 
(Fig. 1.2 step A). An example is amylopullulanase (ApuA), a cell wall-anchored a-glucans 
degrading enzyme, that probably binds different host carbohydrates through the 
conserved carbohydrate binding domains present in the ApuA protein (Chapter 3). 
Moreover 6-phosphogluconate-dehydrogenase (6-PGD) [96] and glutamine synthetase 
(GlnA) [97] are cytoplasmic glycolytic enzymes thought to be involved in the adhesion to 
epithelia. Two different studies showed reduced adherence of S. suis lacking 6-PGD- and 
GlnA-to epithelial HEp-2 cells S. suis suggesting the involvement of these proteins in the 
first steps of the bacterial adhesion to host cells. 
The adhesion SadP (SSU0253) was recently shown to bind to galactosyl-al-4-galactose 
(Galal-4Gal) galabiose-containing glycolipids [98,99]. Galabiose occurs as a terminal or 
internal structure in globo-series glycolipids (GbOs), and in humans they form the blood 
group P antigen system. Chemical studies have shown GbOs to be expressed in many pig 
and human tissues [100,101,102]. The SadP was shown to mediate the agglutination of 
sialidase-treated erythrocytes and binding to glycolipid Gb03 and to participate in the 
binding of S. suis to pig pharyngeal epithelium [99]. 
S. suis strains that recognize sialylated O-linked carbohydrate (NeuNAca2-3Galßl) 
terminal structures in mucin-like glycoproteins have also been identified [103], but they 
appear to be less common than the Galal-4Gal-binding (via SadP) strains. 
Electron microscopy studies on 5. suis revealed the presence of several other external 
structures similar to pili that may be involved in adhesion [105,106]. 
20-
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4.2 Mucosal invasion 
The epithelia provide the first host barrier separating 5. suis from the circulating blood. 
The processes leading to 5. suis invasion of epithelia and from there, translocation through 
the mucosal tissues into the bloodstream are not clear but as indicated above it may 
involve altered expression of the capsule, surface adhesins, invasins and the damaging 
effect of suilysin on the epithelium (Fig. 1.2 step B). Suilysin (Sly) is an extracellular thiol-
activated haemolysin produced by S. suis which belongs to the cholesterol binding-toxin 
family. Sly forms pores in host cells by oligomerization [109] and has been shown to be 
cytotoxic for epithelial [110,111] endothelial [112,113,114] and immune cells in vitro 
[115,116]. Thus production of suilysin is hypothesized to play a role in epithelial 
disruption, enabling 5. suis to invade the mucosal tissues and then disseminate in the 
body, an hypothesis that is tested in Chapter 5. However strains not producing suilysin 
have been associated with invasive disease [114]. 
Once 5. suis has crossed the epithelial barrier it may adhere to components of the 
extracellular matrix (ECM) such as laminin, fibronectin, and plasminogen [117]. The host 
ECM presents an intermediate interface between the host epithelia and the underlying 
mucosal tissues. Insynergy with suilysin, the hyaluronate lyase of 5. suis is thought to 
degrade hyaluronic acid, one of the major components of the ECM in the loose connective 
tissue, thereby contributing to invasion and spread of S. suis [118]. 
Furthermore during the interaction of S. suis with the host, a broad variety of bacterial 
extracellular proteins play important roles in binding host cell surface receptors and other 
possible host adherence sites including ECM molecules and glycoconjugates such as 
glycosphingolipids and glycoproteins. Potential host cell molecules for adhesion by 
streptococcal pathogens include surface-associated fibronectin in the ECM [119] and 
glycosphingolipids and glycoproteins bearing sialic acid, galactose or N-
acetylgalactosamine residues [120,121,122]. As in many Gram positive bacteria 5. suis 
possesses a sortase A enzyme (SrtA) that anchors the extracellular proteins containing an 
LPXTG motif to the cell wall. A S. suis SrtA~ mutant showed less adherence to ECM proteins 
[123,124] indicating that LPXTG-motif-containing adhesins are also important for 
interactions with ECM proteins. 
S. suis fibronectin-binding protein (FBPS) was shown to bind human fibronectin and 
fibrinogen in vitro [125]. However experimental infection of pigs with the fbps mutant 
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strain showed that FBPS is not required for colonization of the tonsils but that it may play 
a role in colonization of specific organs during invasive disease [125]. 
In 5. suis two glycolytic enzymes, typically found in the cytosol, have also been identified 
as anchorless adhesins of ECM, namely, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) [126,127], and enolase [128]. A decreased adhesion of S. suis to plasminogen of 
porcine tracheal rings and HEp-2 cells was observed when the cells were pre-incubated 
with recombinant mutant GAPDH, suggesting its involvement in adhesion [126,127]. The 
GAPDH gene is highly upregulated during in vivo growth in different porcine organs [130] 
but its contribution to virulence of S. suis remains to be demonstrated in vivo [129]. 
Enolase is considered the major plasmin- and plasminogen- binding protein of 
streptococcal pathogens and the extracellular S. suis enolase (Eno) was shown to bind 
both plasminogen and fibronectin (obtained from commercial companies) and to be 
important for adhesion and invasion [128]. Plasminogen can be converted, following 
cleavage by plasminogen activators, to the serine protease plasmin. Plasmin in turn can 
degrade ECM proteins. Thus, surface-associated plasmin has been proposed to facilitate 
bacterial invasion and bacterial dissemination through epithelial barriers. 
The 5. suis di-peptidyl peptidase IV (Dpp IV), which interacts with human fibronectin and is 
required for full virulence in experimental infection studies of pigs [131] and in a similar 
way to enolase, may contribute to the degradation of fibronectin. 
4.3 Avoidance of innate and adaptive immunity in the mucosa 
Once present in the mucosal connective tissues, S. suis bacteria will be perceived by the 
mucosal immune system. S. suis appears to produce several factors that can interfere with 
some of the innate immune molecules. Secretory IgA (slgA) plays an important role in 
mucosal immunity by immune exclusion mechanisms, toxin neutralization and steric 
inhibition of adhesion or invasion by binding to bacterial surface antigens [132]. IgA 
protease-producing bacteria can affect this defence by the cleavage of slgA, releasing Fab 
fragments (the regions on antibodies that bind to antigens) [133]. It has recently been 
reported that S. suis produces an IgAl protease capable of cleaving human IgAl [134]. 
However the amount of recombinant IgAl protein used in the IgA protease activity is very 
high compared to the physiological condition and it is possible that the presumed IgAl 
protease is in fact a metalloprotease family member with a different function to IgA 
protease. Nevertheless an isogenic mutant of the putative IgA protease was reported to 
lead to a significantly decreased lethality of S. suis in pigs [135]. 
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A secreted DNase has been identified in S. suis [136] with an expected role in the 
breakdown of neutrophil entrapments (NETS) [137] but its contribution to the virulence of 
5. suis remains to be verified. 5. suis is also able to inhibit neutrophil recruitment by 
degrading interleukin-8 presumably by the production of a serine protease [138]. 
Dendritic cells (DCs) are important sentinels in the skin and mucosal surfaces and 
recognize pathogen-associated molecular patterns (PAMPs) through the binding to 
specific pathogen recognition receptors (PRRs) like Toll-like receptors (TLRs). Upon 
microbial invasion, immature DCs are recruited from nearly tissue regions and activated in 
order to coordinate the adaptive immune responses. Activated or mature DCs then 
migrate to the adjacent lymphoid organs where they activate T cells producing different 
cytokines that mediate inflammation and other antimicrobial responses [139,140]. DCs 
can also initiate phagocytosis to eliminate invasive pathogens. The S. suis capsular 
polysaccharide (CPS) was shown to interfere with phagocytosis and consequently, the 
level of DC maturation and production of several cytokines was reduced compared to an 
unencapsulated strain [141]. 
In Chapter 1 we reported the effect of different S. suis serotypes including an 
encapsulated mutant on DCs (maturation, cytokines production and phagocytosis) to 
investigate if capsule composition might differentially modulate the mucosal immune 
response. In addition we sought if activated DCs could be involved in S. suis dissemination 
from the mucosal site of infection (Fig. 1.2 step C). 
Suilysin could also be important in avoidance of innate and adaptive immune responses as 
it increases the survival of 5. suis upon phagocytosis by DCs [116]. It has been recently 
demonstrated that 5. suis suilysin was partially involved in cytokine release from DCs and 
also contributed to bacterial escape of phagocytosis [116] and resistance to complement-
dependent killing by neutrophils [142,143]. The toxin might activate complement and 
reduce complement availability for bacterial opsonisation, as has previously shown for 
pneumolysin, an orthologous toxin produced byS. pneumonia [144]. 
4.4 Survival in the blood and dissemination to the organs 
5. suis survival in the blood is thought to largely depend on the production of CPS (Fig. 1.2 
steps D-E-F). It has been widely documented that the CPS protects S. suis from neutrophil 
and monocyte/macrophage-mediated phagocytosis and killing [94]. In Streptococcus 
agalactiae capsule sialic acid has been shown to increase the hydrophilic surface 
properties of the bacteria and to have an inhibitory effect on phagocytosis [145]. Capsular 
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sialic acid has been shown to be important in preventing the deposition of the 
complement protein C3 on the surface of GBS, therefore blocking activation of the 
alternative pathway and allowing for GBS resistance to opsonin-dependent intracellular 
killing [146] (Fig. 1.2 step 2D). Indeed, several different in vitro and in vivo experiments 
using isogenic unencapsulated mutant strains have conclusively shown that the absence of 
CPS correlates with highly increased phagocytosis and/or killing of these strains by 
phagocytic cells, with a rapid clearance from circulation [147,148,149,150]. 
5. suis may travel in the bloodstream to reach the target organs by different means: (i) as 
free encapsulated bacteria (Fig. 1.2 step 2E), (ii) as internalized by or adherent to 
monocytes/macrophages (Mo/M) using a "modified Trojan horse" strategy (Fig. 1.2 step F) 
or (iii) as free bacteria protected by a thick capsule layer, as a high level of bacteremia 
usually precedes the onset of bacterial meningitis [151]. The possibility that S. suis can 
survive inside professional phagocytes (macrophages and neutrophils) and disseminate to 
other organs (Trojan horse theory) seems unlikely based on in vitro studies (Chapter 1) but 
cannot be ruled out. Sialic acid has been implicated in the "modified Trojan horse" 
mechanism of S. suis adherence (without phagocytosis) to Mo/M [34] (Fig. 1.2 steps F-J). 
4.5 Crossing the blood-brain barrier fBBB) 
As for other pathogens causing meningitis, 5. suis must cross the blood-brain barrier (BBB) 
and/or the blood-cerebrospinal fluid (CSF) barrier in order to cause central nervous system 
(CNS) infections (Fig. 1.2 steps G,H,I). The main cellular type of the BBB is brain 
microvascular endothelial cells (BMEC). The BBB is characterised by restricted 
permeability on both sides of the layer due to the presence of tight junctions between 
endothelial cells of cerebral vessels and epithelial cells of the choroid plexus. S. suis can 
adhere to, and invade immortalised porcine BMEC, as demonstrated by antibiotic 
protection assays and electron microscopy [152]. 5. suis invasion of primary porcine BMEC 
was confirmed later by Vanier et al. who also showed that serum components, possibly 
fibronectin, played an important role in adherence [153]. As suggested for epithelial cell 
adhesion, the 5. suis CPS may partially interfere with the abilities of the pathogen to 
adhere and invade the BMEC (Fig. 1.2 steps G-H). Cell wall components such as 
lipoteichoic acid (LTA) have also been implicated in BMEC invasion [153,154]. An S. suis 
mutant impaired in D-alanylation of LTA showed reduced levels of adherence and invasion 
of porcine BMEC compared to the wild type strain [154]. Other cell wall anchored 
extracellular proteins may also be involved in BMEC adhesion as indicated by the reduced 
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adherence capacity of the S. suis SrtA mutant to adhere to BMEC, compared to the wild 
type strain [155]. Suilysin positive strains may also disrupt the BBB through cytotoxic 
effects, increasing the BBB permeability (Fig. 1.2 steps G-H) although production of 
suilysin is not essential for invasion [152]. After adherence to BMEC S. suis might stimulate 
production of cytokines resulting in alteration of BBB permeability. This has been 
suggested because of the high production of cytokines by human BMEC which alter tight 
junction structure [156]. Apart from alteration of BBB permeability, overproduction of 
cytokines can activate different leukocyte subpopulations and up-regulate the expression 
of cell adhesion molecules (CAMs), such as integrins and selectins, that allow trans-
endothelial migration of leukocytes [157]. Very recently, using an experimental transwell 
model, translocation across the blood-CSF barrier of S. su/s-activated neutrophils was 
demonstrated [158]. 
As evidenced by human outbreaks of toxic shock-like syndrome (STLSS) as well as by septic 
shock cases in Europe and Asia caused by 5. suis (characterised by short incubation time, 
rapid disease progression and a high rate of mortality), a substantial release of pro-
inflammatory mediators is thought to take place during 5. suis systemic infections of 
human [159]. High levels of systemic cytokines induced by S. suis in vivo post-infection are 
thought to be responsible for the death of animals [7,160]. 
5. Regulation of virulence gene expression 
Environmental conditions such pH, temperature, oxygen availability, and organic 
metabolites may influence the physiology of 5. suis. The ability of 5. suis to colonize 
diverse host niches such mucosal epithelia, the bloodstream and target organs indicates 
that the bacteria have evolved precise mechanisms to alter, sense and adapt to different 
environmental conditions, including those within the host. 
Like many other bacteria, S. suis possess two major types of transcriptional regulators: 1) 
two-component gene regulatory systems (TCS) and 2) stand-alone regulators. TCS consist 
of a membrane sensor histidine kinase that influences the phosphorylation state of a 
cytoplasmatic cognate regulator, which repress or activate gene expression by DNA 
binding [161]. The TCS regulate the expression of metabolic and virulence genes in 
response to the external environmental signals. Among the presumptive signals that are 
thought to be detected by TCS are chemical and physical parameters such as different 
ions, temperature, pH, oxygen pressure, osmolarity, autoinducer compounds, the redox 
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state of electron carriers, and the contact with host cells [162]. The regulation systems for 
other human pathogens (i.e. Salmonella and Staphylococcus aureus) virulence properties 
are well characterized, and involve a sophisticated interaction of several TCS 
[163,164,165]. In Streptococcus pathogens, many virulence factors such capsule, 
hemolysis, and exotoxin have been regulated by TCS [166,167,168]. In total 12 or 13 TCS, 
depending on strain differences, have been annotated in S. suis genomes to date. Despite 
the importance the two component regulatory systems play in 5. suis pathogenesis, only 
few have been studied so far. Mutants lacking TCS CiaR/H or the orphan transcriptional 
regulators RevSC21 and CovR were impaired in adherence to epithelial cells [169,170,171]. 
A study on the TCS SalK/SaIR has demonstrated that this TCS protects 5. suis against killing 
by phagocytes [172,173,174]. This TCS appears not to be present in the European 
reference strain S. suis Pl/7. A deletion mutant of covR produced a thicker capsule, 
conferring higher survival compared to the wild type in phagocytosis assays with human 
monocytes. Inactivation of covR gene also increased the lethality of S. suis in experimental 
infection of piglets [175]. These examples show that TCS are important mediators of 
bacterial virulence and survival in the host, but the precise mechanisms by which each TCS 
functions are generally unknown and may differ for different bacterial species. In addition 
to TCSs, transcriptional regulators, e.g. from the Lacl/GaIR family are important regulators 
of virulence factor production and of bacterial metabolism such as complex carbohydrate 
utilization (Chapter 4, Chapter 5). 
As mentioned above, starch a-glycans (large polymers of glucose) are found in high 
concentrations in the saliva and oropharyngeal cavity [176,177,178]. Glucose, if consumed 
with the diet may also be present in the oral cavity but concentrations diminish rapidly 
(within 30 min) after ingestion [179]. In S. pyogenes transcript levels of genes involved in 
carbohydrate metabolism, including those involved in maltodextrin and mannose 
catabolism, were maximal during the initial colonization phase of primates [180]. These 
data suggest that in streptococcal pathogens, genes required for a-glucan metabolism 
were either being induced or derepressed during the in vivo growth of the bacteria, 
suggesting a role for these metabolic genes in bacterial proliferation during the initial 
stages of colonization of the oropharynx [180]. 
Generally, host-associated bacteria do not synthesize degradative (catabolic) 
carbohydrates enzymes unless the substrates of these enzymes are present in the 
environment. For this reason, bacteria have evolved elaborate regulatory control 
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mechanisms to utilise the carbon source that allows fastest growth [181]. In the presence 
of glucose, the sugar that cells use as the primary source of energy, a carbon catabolite 
control mechanism represses the expression of degradative enzymes, transporters and 
metabolic pathways for catabolism of other (more complex) sugars. In Firmicutes, the 
catabolite control protein A (CcpA) is well-conserved among different species and can 
repress or activate transcription by binding to cis-acting catabolite response element (ere) 
sites (Fig. 1.3). 
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Fig. 1.3: Transport of extracellular glucose is linked to CcpA mediated Carbon Catabolite Repression (CCR) or Activation (CCA). 
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Consensus ere sequences have been determined in several species [181]. Studies in 
Bacillus spp. have shown that the binding of CcpA to DNA ere sites is enhanced by 
interaction of CcpA with the phosphoprotein HPr-Ser-46-P [182,183]. The HPr 
phosphorylation state is determined by the action of HPr kinase/phosphorylase (HPrK/P), 
which, in turn, is affected by the intracellular concentration of fructose 1,6-bisphosphate 
(FBP) that is produced during the glycolysis, the process of degradation of glucose. 
Orthologues of CcpA, HPr, and HPrK/P from Bacillus species are present in the genome 
sequence of S. suis serotype 2 Pl/7, the pathogenic European reference strain [84] (Fig. 3). 
CcpA has been shown to be important for the virulence of several streptococcal species, 
influencing growth, haemolysin production, biofilm formation and capsule expression 
[184,185]. Recently, the role of CcpA was investigated by microarray analysis of wild-type 
S. suis and an isogenic ccpA mutant grown in THB. Deletion of ccpA altered the expression 
of capsule locus genes encoding surface-associated virulence factors: arcB, sao and eno as 
well as ofs and cps2A [186]. 
In Chapter 4 we studied if CcpA was involved in the regulation of the virulence factor 
ApuA. In Chapter 5 we describe a different approach to study the role of carbohydrate 
metabolism on metabolism and virulence, by comparing the transcriptomes of S. suis 
grown in complex medium plus a-glucan (pullulan) or glucose in both exponential and 
early stationary growth phases. Additionally we investigated whether or not carbohydrate 
composition of the growth medium could influence the virulence of S. suis by altering 
adherence or invasiveness. 
6.5. suis genomics 
Comparative genomics is commonly used in order to study bacterial outbreaks and 
identification of loci encoding virulence factors [187]. Therefore, several genomics project 
aimed at sequencing and identifying S. suis isolates from human and pig origin have been 
initiated. One of the first initiatives, started by the Sanger Institute, resulted in the 
sequencing and annotation of three 5. suis isolates, two from human origin, and one from 
pig origin (5. suis Pl/7, AM946016) [84]. The genome of S. suis S10 used in our study, is 
more than 99% identical to the genome of 5. suis Pl/7. As of January 2012, sixteen 
genome sequencing project are reported, and thirteen genome sequences have been 
completed (NCBI Genome and NCBI BioProject 
http://www.ncbi.nlm.nih.gov/genome/?term=Streprococco5%20suis). 
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S. suis genome sizes are around 2 Mb [84,188], of which 40% is unique for this species in 
comparison to the genomes of other Streptococcus species [84]. Within 5. suis, the 
genome content is highly conserved apart from three ca. 90 kb regions, present in the two 
human sequenced isolates from the Chinese outbreak, that contain insertion sequences 
(IS) including conjugative elements and transposon sequences, in addition to drug 
resistance genes, strongly suggestive of horizontal gene transfer [84]. The isolates 
described by Holden et al. (2009) are of serotype 2, belong to a single lineage and include 
two highly similar (1 single locus difference) multilocus sequence types. Interestingly, 
similar numbers of IS were also found in less related strains belonging to different 
serotypes [188] and horizontal transfer of the 90 kb region between different serotype 2 
isolates was demonstrated [188], suggesting that gene transfer, possibly including genes 
involved in antibiotics resistance, could be a common feature of S. suis serotype 2 isolates. 
For horizontal transfer to occur between serotype 2 isolates, a specific 15 bp sequence 
was found to be necessary for recombination; this 15 bp sequence was also present in 
sequenced strains belonging to other (not serotype 2) serotypes [188]. This intriguing 
observation suggests that genomes of S. suis strains could be very dynamic, irrespective of 
their serotype. Indeed, global comparisons of 13 sequences isolates showed that the 
numbers of gene gains and losses in S. suis genomes was larger compared to other 
Streptococcus genomes [188]. It is clear that further analysis of S. suis genomes, from 
strains isolated from different hosts, different organs, and inducing different symptoms, 
will eventually reveal loci and genes involved in differential host infection, organ 
colonisation, and bacterial survival and virulence. Such knowledge will be instrumental in 
developing therapies against 5. suis infection, for instance by showing which gene 
products are necessary for survival in different hosts (organs) and by yielding novel drug 
targets. One modest example of this is provided in Chapter 2, where we mined the S. suis 
genome sequences to find genes encoding surface-anchored, extracellular and thus, 
exposed proteins that were likely candidates to participate in interactions with the host. 
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7. The purpose and nature of this PhD thesis 
The purpose of this PhD was to characterize a putative surface catabolic enzyme ApuA, in 
the important zoonotic pathogen Streptococcus suis and investigate its role in nutrition 
acquisition during colonization of the upper respiratory tract. This enzyme was found to 
have a dual function in adhesion to porcine epithelium and in the degradation of complex 
dietary or host-derived carbohydrates in the mucosal environment. Studies on the 
molecular mechanisms of regulation of ApuA revealed that its expression was regulated 
by carbon catabolite control and a dedicated regulator that induces transcription in the 
presence of substrates for ApuA. Carbon catabolite control mechanisms were also shown 
to regulate several virulence factors. In summary the work demonstrates a clear link 
between virulence and carbohydrate metabolism whereby the pathogen utilises complex 
carbohydrates as an environmental cue to regulate virulence. In addition the role of 
different capsule types in phagocytosis and immune response of human dendritic cells 
was investigated. The thesis contributes substantially to our understanding of the 
mechanisms of pathogenesis in this major pathogen and has implications for the design of 
novel vaccines and anti-infective strategies. 
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Chapter 2 
Summary 
Streptococcus suis is a major porcine pathogen of significant commercial importance 
worldwide and an emerging zoonotic pathogen of humans. Given the important sentinel 
role of mucosal dendritic cells and their importance in induction of T cell responses we 
investigated the effect of different S. suis serotype strains and an isogenic capsule mutant 
of serotype 2 on the maturation, activation and expression of IL-10, IL-12p70 and TNF-ct in 
human monocyte-derived dendritic cells. Additionally, we compared phagocytosis levels 
and bacterial survival after internalization. The capsule of serotype 2, the most common 
serotype associated with infection in humans and pigs, was highly anti-phagocytic and 
modulated the IL-10/IL-12 and IL-10/TNF-ct cytokine production in favor of a more anti-
inflammatory profile compared to other serotypes. This may have consequences for the 
induction of effective immunity to S. suis serotype 2 in humans. A shielding effect of the 
capsule on innate Toll-like receptor signaling was also demonstrated. Furthermore, we 
showed that 24 h after phagocytosis, significant numbers of viable intracellular 5. suis 
were still present intracellular^. This may contribute to the dissemination of S. suis in the 
body. 
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Introduction 
Streptococcus suis is a major pathogen of swine, causing considerable economic losses and 
animal health care problems for the pig farming industry worldwide [1]. The natural 
habitat of 5. suis is the upper respiratory tract and the intestinal tract [2,3], In adult pigs 
carriage of S. suis is usually asymptomatic but colonized sows can infect their piglets after 
nasal or oral contact [4]. Newborn pigs can also become infected during parturition when 
they contact, swallow or aspirate 5. suis from sow vaginal secretions [5]. In young pigs S. 
suis infection causes a wide variety of diseases, including meningitis, septicemia which are 
the main causes of mortality. S. suis is also emerging as a serious zoonotic pathogen of 
humans particularly in South East and East Asia where it is one of the most common 
causes of human meningitis [6,7]. In 2005 a large outbreak of 215 cases S. suis infections 
occurred in Sichuan, China, resulting in 38 deaths [8]. There are 33 serotypes of S. suis of 
which serotype 2 is most commonly associated with disease in humans and pigs 
worldwide [9,10]. In addition serotypes 1 to 9 and 14 are responsible for infections in pigs 
[11] and serotypes 1, 4, 5, 14, 16 and 24 have caused severe disease in a limited number 
of persons [12,13,14,15]. The capsule is known to be a very important virulence factor in 
S. suis [16] although not all capsulated isolates (including serotype 2) are virulent, 
highlighting the importance of other virulence factors in the pathogenesis of disease [3]. 
Dendritic cells (DCs) are important sentinels in the skin and mucosal surfaces that contact 
the external environment and play a key role in the homoeostatic control tolerance and 
immunity in the mucosal tissues [17]. Stromal factors such as retinoic acid and thymic 
stromal lymphopoietin imprint tolerogenic properties on resident DC. However when 
invading microbes are encountered the homeostatic mechanism are overridden by 
chemotactic recruitment of DC and their activation by pattern recognition receptor (PRR) 
binding to pathogen-associated molecular patterns (PAMPs). Upon activation DCs express 
up to lOOx more MHC than monocytes, macrophages and neutrophils other antigen 
presenting cells (APCs) and migrate to mucosal associated lymphoid tissue to induce 
antigen-specific T cell responses [18,19]. Thus DCs are instrumental in the orchestration of 
adaptive immune responses. Cytokines produced by activated DC have a major influence 
on T cell polarization, differentiation and clonal expansion. Interleukin (IL)-12 and tumor 
necrosis factor (TNF)-a, are pro-inflammatory cytokines that promote T helper (Th) 1 cell 
responses, whereas IL-10 is an anti-inflammatory cytokine that can promote induction of 
Th2 cells or regulatory T cells depending on the expression of other tolerizing factors [20]. 
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DCs recognize different types of PAMPs using pattern recognition receptors (PRRs) of the 
Toll-like receptor (TLR), nucleotide-binding oligomerisation domain receptor (NLR) and C-
type lectin receptor (CLR) protein families, [17,21,22]. PRR signaling is critical to DC 
maturation and in recent years much emphasis has been given to dissecting the innate 
signaling pathways involved in pathogen recognition. Each PRR recognizes variants of a 
specific molecular pattern and can be expressed on the cell surface, in intracellular 
compartments or in the cytosol. TLR1, 2, 4, 5, 6 and 11 recognize mainly microbial 
envelope components and are expressed on the cell surface, TLR3, 7, 8 and 9 recognize 
microbial nucleic acids and are expressed in intracellular compartments such as the 
endoplasmic reticulum, endosome and phagosome. TLR2 can form heterodimers with 
TLR1 or TLR6 to detect different, but related ligands. TLR2/1 recognizes tri-acyl 
lipoproteins found predominantly in Gram-negative bacteria and TLR2/6 the diacyl groups 
on lipoteichoic acid and lipoproteins of Gram-positive bacteria. NODI and NOD2 are 
cytoplasmic receptors that can detect peptidoglycan fragments produced in the 
phagosome or phagolysosome of antigen presenting cells although the nature of the 
transporters involved in translocation to the cytoplasm remains unknown [23]. The CLR 
family is characterized by the presence of one or more C-type lectin-like domains (CTLDs) 
and bind mainly sugars including self-antigens. CLRs trigger distinct signaling pathways 
that induce the expression of specific cytokines which determine T cell polarization fates 
[24]. Recently the interactions of a virulent serotype 2 strain and its unencapsulated 
derivative with porcine DC were studied in vitro. The capsular polysaccharide was shown 
to interfere with phagocytosis and consequently the level of DC maturation and 
production of several cytokines was reduced compared to an unencapsulated strain [25]. 
Given the emergence of 5. suis as a significant cause of meningitis in humans we 
investigated the effect of different serotypes (SSI, SS2, SS4, SS7, SS9 and SS14) and the 
unencapsulated mutant of 5. suis serotype 2 (SS2 J28) on the maturation and expression 
of IL-10, IL-12p70 TNF-a in human monocyte-derived DC. Additionally, we compared the 
efficiency of the different isolates in DC phagocytosis assays and studied the intracellular 
survival of internalized 5. suis serotype 2of internalized S. suis serotype 2 S10 and its 
unencapsulated isogenic mutant . The ability of the different serotype strains to induce 
TLR signaling via human TLR2/6 was also investigated using a TLR2/6 specific luciferase 
reporter cell line. To our knowledge this is the first study concerning the interactions of S. 
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suis with human DC and it provides new knowledge of the role of different capsular 
polysaccharide serotypes in the avoidance of host innate immunity. 
Results 
5. suis capsule serotype differentially affects DC maturation and activation 
Immature monocyte-derived DCs derived from six different human donors were used as in 
vitro model to investigate interactions with S. suis. The DCs were stimulated for 48 hours 
with 6 different S. suis serotypes and SS2J28 at MOI 1 and MOI 10 (Fig. 2.1A-C). Expression 
of the surface expressed co-stimulatory molecule CD86 and maturation marker CD83 were 
measured to determine the activation and maturation status of the DCs respectively (Fig. 
2.1A and B for mean fluorescence intensity and 2.1C for histograms). For all 
encapsulated strains stimulation of DC with S. suis at a MOI 10 resulted in higher 
maturation and activation marker expression than at MOI 1. The induction of the surface 
expression CD86 and CD83 differed markedly among the capsule serotypes tested. 
Significantly higher levels of CD83 and CD86 were observed following DC stimulation with 
serotypes SSI, SS7 and SS9 and the unencapsulated SS2 mutant than with serotype SS2. 
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Fig. 2.1. Mean Fluorescence Intensity (MFI) of dendritic cells normalized with LPS. 
The MFI of stained cell surface markers by monocyte derived dendritic cells with 6 different S. suis strains and SS2J28 mutant, 
with immature DCs as the negative control and LPS as the positive control. A. MFI of CD83 B. MFI of CD86. Bars showing unequal 
letters significantly differ in their surface marker expression (P<0.05). 
Interestingly, serotype SS2 was the least effective at maturating DC although its 
unencapsulated variant, SS2J28 was the most effective indicating the importance of the 
capsule in the avoidance of host innate immunity. 
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Fig. 2.1. Mean Fluorescence Intensity (MFI) of dendritic cells normalized with LPS. 
C. Histograms for expression of surface markers CD83 and CD86. Dotted lines represent the isotype controls and black lines the 
stimulated samples. In case of bacteria a black line represents a MOI 1 and a dashed line a MOI 10. 
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The capsule ofS. suis serotype 2 differentially modulates the 11-10 to IL-12 ratio 
The amounts of IL-10, IL-12 and TNF-a measured in the supernatants of DC co-cultured 
with the different serotypes was highly variable (Fig. 2.2). The amounts of IL-10 ranged 
from 5 pg/mL to 56 pg/mL, IL-12p70 from 7 pg/mL to 6948 pg/mL and TNF-a from 5 
pg/mL to 3744 pg/mL (Fig. 2.2A-C). As expected, stimulation with an MOI 10 resulted in 
higher amounts of secreted cytokine than stimulation with an MOI 1. In keeping with the 
data on maturation markers (Fig. 2.1) serotypes SSI, SS7 and SS9 were the highest 
inducers of cytokines, whereas serotype SS2 induced the lowest amounts of cytokines (all 
cytokine < 10pg/mL). In contrast the unencapsulated derivative SS2J28 stimulated the 
highest amounts of IL-10 and IL-12 and high amounts of TNF-a. The ratio of IL-10 to IL-12 
is often used as an indicator of the potential to polarize T cell responses towards Thl or 
Th2/Treg [17]. Interestingly all of the 5 suis serotypes except SS2 induce low IL-10 to IL12 
ratios (less than 0.08). For SS2 the IL-10 to IL-12 ratio was 0.34 at MOI 10 and almost 1.0 
(0.98) at MOI 1. Strikingly, the unencapsulated derivative of SS2 designated SS2J28 has a 
much lower IL-10 to IL-12 ratio than SS2 (0.03 at MOI 1 and 0.008 at MOI 10) suggesting 
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that the type 2 capsule can down-regulate the host cell-mediated response to S. suis (Fig. 
2D). Similar trend of ratio's were observed for the IL-10 to TNF-a ratio (Fig. 2E). 
Effect of capsular polysaccharide on the capacity of DCs to internalize S. suis 
The percentage of 5. suis phagocytosed by DCs varied considerably among the different 
serotypes tested. After one hour of incubation of the DCs with the bacteria, SS4 and SS9 
were more efficiently taken up by the DCs (respectively 23% and 20% of original inoculum 
(107 bacteria) compared to the other strains (Fig. 2.3). In contrast capsule types SSI and 
SS2 were relatively resistant to phagocytosis by DCs (0.04% and 2.16% respectively of the 
original inoculum). The unencapsulated mutant was internalized at significantly higher 
amounts than its wild type SS2 progenitor (5.29% vs 2.16%; P= 0.0001). Surprisingly 
however, the unencapsulated strain was less efficiently internalized than serotype strains 
SS4andSS9(Fig2.3). 
Phagocytosis assay 
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Fig. 2.3. Phagocytosis assay. Phagocytosis by immature DCs with 6 different 5. suis strains and an unencapsulated mutant at an 
MOI 10. This is a representative figure from 1 donor, out of 5 donors. *P < 0.05. 
Capsular type 2 does not affect intracellular survival of internalized S. suis 
To rule out the possibility that differences in internalization of SS2 and SSJ28 by DC might 
be due to strain variation in intracellular survival we measured the survival of these two 
strains in DC over time. After one hour of incubation with iDC antibiotics were added for 1 
hour to ensure that only internalized bacteria were counted after lysis of the DCs. After a 
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total 2 hours of incubation the number of viable bacteria inside the DCs decreased 
considerably, to 39% of the original inoculum for SS2 and 43% of the inoculum for SS2J28 
(Fig. 2.4A). Over the first 4 hours the number of viable 5. suis decreased at a similar rate 
for both strains indicating that the higher level of internalization measured for SS2 J28 
(Fig. 2.4A) could not be due to less rapid killing. 
Viable S. suis reside within DC 24 hours after phagocytosis 
To examine the survival of the wild type SS2 and its mutant SS2J28 inside the DCs after 24 
hours, the DCs (106 cells) and bacteria (MOI 10) were incubated for 2 and 24 hours (Fig. 
2.4B). After 1 hour of incubation antibiotics were added to the medium kill extracellular 
and adhered bacteria. After 5 hours, the medium was replaced by RPMI without 
antibiotics, to prevent the antibiotics from entering the DCs. After 24 hours around 103 
CFU/mL of live S. suis were recovered from the lysed DC suggesting that a small 
proportion of the bacteria could survive intracellular^. To rule out that these 
phagocytosed bacteria were released from DC after 5 hours of co-incubation and were 
growing in the medium the experiment was repeated using an additional antibiotic 
treatment at 23 hours to kill any extracellular/adherent bacteria that might be present. 
The results (Fig. 2.4B) showed that the CFU/mL counts present after 24 hour could be 
attributed to the presence of intracellular S. suis. 
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Fig. 2.4. Survival of S. suis inside dendritic cells. A. Phagocytosis kinetics. Immature DCs were inoculated with SS2 and SS2 J28 at 
a MOI of 10 bacteria/DC for subsequently 2, 3, 4, 5 and 24 hours of incubation. B. Survival of S. suis inside DCs after 2 and 24 
hours. Immature DCs were inoculated with SS2 and SS2J28 at a MOI10 for 2 and 24 hours of incubation. The last hour the DCs 
were incubated with (24+) or without (24) antibiotics. 
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Involvement of TLR2 and TLR6 in cell activation by S. suis 
TLR2/6-mediated activation of NF-KB could be one of the major pathways for DC 
activation via LTA or lipoproteins in the cell envelope of S. suis. Therefore we tested the 
TLR2/6 signaling capacities of all the serotypes in a reporter assay using HEK293 cells 
expressing human TLR2 and TLR6 heterodimer that recognizes lipoteichoic acid (LTA) and 
lipoprotein lipid anchors in Gram-positive bacteria (Fig. 2.5). HEK293 cells transformed 
with only the pNIFTY, a NF-KB luciferase reporter construct did not respond to Pam2CSK 
demonstrating the dependency of NF-KB activation on co-expression of hTLR2/6 receptor. 
Medium was used as a negative control and Pam2CSK (synthetic agonist of TLR2/6) as a 
positive control. The results shown in Fig. 2.5 demonstrate that indeed all strains are 
capable of triggering NF-KB activation via TLR2/6 signaling but there was no correlation 
between the capacity of the strains to induce TLR2/6 signaling and activate DC (Fig. 2.2). 
Interestingly the unencapsulated mutant of SS2 induced significantly (P<0.05) higher levels 
of NF-KB than SS2 indicating that the capsule has a shielding effect on TLR activation. 
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Fig. 2.5. hTLR2/6 assay. HEK293 cells were incubated with 6 different S. suis strains and an unencapsulated mutant at a MOI10, 
PAM2CSK as a positive control and medium as a negative control. This figure is representative out of three hTLR2/6 assays. 
*P<0.05. 
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Discussion 
Apart from its major economic impact on the mortality and morbidity of young pigs in 
agro-food production S. suis is emerging as a one of the major causes of meningitis in 
South East Asia. To gain further knowledge on the role of 5. suis capsule and capsule 
serotype on the immune response of the human host we compared phagocytosis and 
immune responses of human immature DC to different serotypes of S. suis. DCs are 
professional antigen presenting cells that play a key role in the induction of adaptive 
immune responses. Once activated by contact with invading pathogens CD103+ DC can 
traffic from the sites of mucosal infection to the draining lymph nodes to induce T cell 
responses. Additionally they play a crucial role in induction of adaptive immune responses 
in the Peyer's patches of the nasal mucosa and small intestine. Many pathogens have 
evolved mechanisms to avoid phagocytosis including production of leukotoxins, the 
inhibition of complement activation and masking of binding sites for endocytic receptors 
by polysaccharide capsules [37]. 
The serotypes of 5. suis differed significantly in their ability to activate DCs and induce 
cytokine responses. Serotypes SSI, SS7 and SS9 induced expression of significantly higher 
levels of DC activation and maturation markers than serotypes SS2, SS4 and SS14 (Fig. 2.1). 
Interestingly SS2, the strain that was the least effective at activating and maturating DC 
was serotype 2, which is the serotype most commonly associated with invasive disease in 
pigs and humans [38]. In contrast the unencapsulated variant of SS2 (SS2J28) was the 
most effective strain in maturating and activating DC, indicating the important role of the 
capsule in shielding cell wall components that activate DC and induce cytokine responses 
(Fig. 2.1). The thickness of the capsule may also influence the activation by influencing the 
release of MAMPs such as lipoproteins and LTA. Capsule serotype 1 has been reported to 
have a thinner capsule than other serotypes [51] and interestingly this was the most 
effective of all capsulated strains in activating and maturating DC. The anti-phagocytic 
effects of SS2 capsule were apparent from the significantly higher phagocytosis of the 
unencapsulated mutant SS2J28 (5.29% vs 2.16%; P= 0.0001) (Fig. 2.3). To rule out the 
possibility that differences in internalization of SS2 and SS2J28 by DC might be due to 
strain variation in intracellular survival we measured survival over period of 4 hours after 
phagocytosis. The number of viable 5. suis decreased at a similar rate for both strains 
indicating that the higher level of internalization measured for the unencapsulated mutant 
SS2J28 (Fig. 2.3) was not due to less rapid killing (Fig. 2.4A). Similar results were recently 
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described using porcine DCs and a capsulated and unencapsulated serotype 2 strain [25]. 
As in our own study an unencapsulated mutant of a serotype 2 strain was phagocytosed at 
significantly higher levels and once internalized, both the wild-type strain and its non-
encapsulated mutant were killed at similar rates. 
To investigate the effect of other capsule types on phagocytosis the internalization of 
several other serotypes were compared to serotype 2 and its unencapsulated mutant 
SS2J28 (Fig. 2.3). The serotypes differed considerably in their ability to be phagocytosed 
with around 20% of the inoculum being internalized in the case of SS4 and SS9 but only 2% 
in the case of SS2 (Fig. 2.3). This might be explained by the difference in composition of 
the capsules and their charge which is known to be important in the avoidance of 
phagocytosis. A recent genetic analysis of the capsular polysaccharide synthesis locus of 
15 5. suis serotypes predicted that capsules of serotypes 1, 2, and 14 may contain sialic 
acid [39]. In Streptococcus agalactiae capsule sialic acid has been shown to increase the 
hydrophilic surface properties of the bacteria and have an inhibitory effect on 
phagocytosis [40]. This might be an explanation for the fact that phagocytosis of serotype 
strains 1, 2 and 14 was significantly lower than for serotype strains 4 and 9. The sialylated 
capsule of Streptococcus agalactiae also inhibits C3 deposition on the bacterial cell surface 
[41], probably via recruitment of factor H, an anti-activator of the complement alternative 
pathway [42]. However it is not evident that C3 deposition is inhibited by sialic acid in the 
serotype 2 capsule of S. suis because phagocytosis levels are not significantly different in 
the presence or absence of serum factors [25]. 
Interestingly the unencapsulated SS2J28 strain was less efficiently phagocytosed than 
serotype strains SS4 and SS9 (Fig. 2.3). Thus it is possible that SS2 has other mechanisms 
that inhibit phagocytosis. A two-component regulatory system (TCS) designated SalK/SaIR 
has been shown to have a protective role in the killing of S. suis by granulocytes [16,43,44] 
but this locus is absent in the genome of SS2 strain and thus cannot be responsible for the 
lower levels of phagocytosis observed for SS2 compared to SS4, SS7, SS9 and SS14. 
A shielding effect of SS2 capsule was investigated using a reporter cell line for TLR2/6 
signaling. The TLR2/6 heterodimer is formed by binding of the di-acyl groups present on 
lipoproteins of Gram-positive bacteria and lipoteichoic acids present in the cell wall 
[22,45]. This triggers NF-KB activation via a signal kinase cascade involving the adapter 
protein MyD88 and was detected in our assay by production of luciferase under control of 
an NF-KB promoter. The unencapsulated mutant of SS2 induced significantly (P<0.05) 
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higher levels of NF-KB than SS2 suggesting that the capsule has a shielding effect on the 
exposure of TLR agonists that might can activate cells such as DCs (Fig. 2.5). Notably, the 
level of NF-KB activation obtained with the unencapsulated mutant was significantly lower 
than for SS9(p<0.0001), SS14(p<0.0001) and SS4(p<0.0001). The highest level of TLR2/6 
activation was observed for SS9, something observed in a previous study using the same 
strains SS2 and SS9 (Fig. 2.5) [46]. Interestingly we found that SS9 was phagocytized more 
efficiently than the other strains and was highly effective at activating DC. However 
efficiency of phagocytosis did not correlate with activation of DC as evident for strain SSI 
which was phagocytized at relatively low levels compared to the other serotypes but 
nevertheless strongly activated DC in co-culture. 
The amounts of IL-10 IL-12 and TNF-a measured in the supernatants of DC co-cultured 
with the different serotypes was highly variable (Fig. 2.2). The amounts of IL-10 ranged 
from 5 pg/mL to 56 pg/mL, IL-12p70 from 7 pg/mL to 6948 pg/mL and TNF-a from 5 
pg/mL to 3744 pg/mL (Fig. 2.2A-C). In agreement with the data on maturation and 
activation markers (Fig. 2.1) the serotypes SSI, SS7 and SS9 were the highest inducers of 
cytokines, whereas serotype SS2 induced the lowest amounts of cytokines (all cytokine < 
10pg/mL). Interestingly all of the S suis serotypes except SS2 induce low ratios of IL-10 to 
IL12 ratios (less than 0.08). For SS2 the IL-10 to IL-12 ratio was 0.34 at MOI 1 and almost 
1.0 (0.98) at MOI 10. This qualitative effect on the cytokine response was due to the 
serotype 2 capsule because the unencapsulated mutant of SS2 induced cytokines with a 
low IL-10 to IL-12 ratio (0.03 at MOI 1 and 0.008 at MOI 10) as observed for the other 
serotypes (Fig. 2.2D). A similar trend was seen for the IL-10/TNF-a cytokine ratio (Fig. 
2.2E). It is not known whether the immunomodulatory effect of SS2 capsule is also 
observed with porcine DC as the recent study did not measure IL-10 production by DC 
[25]. A consequence of increased IL-10 production may be the polarization of T helper cell 
responses towards Th2 or Treg [47]. In pathogenic species of Yersinia for example, the 
secreted V antigen protein induces IL-10 in macrophages to evade the host's inflammatory 
response during infection [48]. Pathogens such as Mycobacterium tuberculosis and HIV 
target DC-SIGN on DC to escape immunity. Binding to DC-SIGN cause internalization but 
not subsequent antigen processing and induces IL-10 expression resulting in suppression 
of Thl responses [49]. DC-SIGN binds glycans containing high mannose structures appear 
not to be present in the published structure of the serotype 2 capsular polysaccharide 
[50]. However, it is possible that the involvement of other C -type lectin receptors on DC 
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or other glycan structures may be involved in the immunomodulatory effects of the SS2 
capsule. 
Over a period of 5 hours after internalization in DC the number of viable S. suis were 
reduced about 100 fold. The rate of killing and overall levels of intracellular survival of S. 
suis after 5 hours was higher than that reported previously using porcine DC [25]. This may 
have been due the use of a different serotype 2 strain and/or differences in killing capacity 
of human and pig DCs and warrants further study. Despite the fact that a high proportion 
of phagocytized S. suis were killed by DC in the first 5 hours of incubation we were able to 
recover around 103 CFU/ml of SS2 and the unencapsulated mutant after 24 hours 
incubation (Fig. 2.4B). In these experiments antibiotics were added to the medium for 5 
hours to kill extracellular and adhered bacteria then the medium was replaced by RPMI 
without antibiotics, to prevent the antibiotics from entering the DCs. Prior to lysis 
antibiotics were added a second time to some of the samples to kill any extracellular 
bacteria that might have been released from DC. The results (Fig. 2.4B) showed that the 
CFU counts present after 24 hour could indeed be attributed to the presence of viable 
intracellular S. suis. This has important consequences for pathogenesis because activated 
DCs eventually undergo apoptosis and may release viable S. suis. As DC traffic from the 
mucosa travel via the bloodstream to lymphoid tissue such a mechanism may enable 5. 
suis to rapidly disseminate in the body during invasive disease. 
52-
S. suis interactions with human dendritic cells 
Materials and Methods 
Bacterial strains 
Six different serotypes (SSI, SS2, SS4, SS7, SS9 and SS14) and the unencapsulated mutant of SS2 (SS2 
J28) were obtained from Central Veterinary Institute, Lelystad NL (Table 2.1). The genome of S. suis 
S10 is more than 99% identical to the genome of S. suis Pl/7, a sequenced reference strain of which 
the genome had been annotated previously (Chapter 1). In the table are indicated for each strain 
the expression of three virulence markers: two secreted cell wall located proteins namely the 
muramidase-released protein (MRP) and the extracellular factor (EF) [26,27], and secreted 
hemolytic toxin suilysin (SLY) [28]. MRP and EF variants have been designated as MRPS and EF*. All S. 
suis strains were cultured overnight at 37°C in Todd Hewitt broth (Oxoid). The bacteria were then 
recovered by centrifugation, washed twice in phosphate buffered saline (PBS, pH=7.4), resuspended 
at approximately l x lO 9 colony forming units (CFU)/mL in PBS containing 20% glycerol, and stored in 
aliquots at -80°C prior to use. The exact number of bacterial CFU in a thawed aliquot was 
determined by plating serial dilutions on Columbia blood agar plates (BD) containing 5% sheep blood 
in presence of 5% C02. 
Table 2.1: List of strains used in this study 
Serotype 
SSI 
SS2 
SS2 J28 
SS4 
SS7 
SS9 
SS14 
Strain 
6388 
S10 
lOcpsAEF* 
5213 
8039 
8067 
13730 
Virulence 
in pigs 
HV 
V 
AV 
ND 
ND 
AV 
ND 
MRP 
MRPS 
MRP* 
MRP* 
MRP* 
-
-
-
EF 
EF* 
EF* 
EF* 
-
-
-
EF* 
Suilysin 
SLY* 
SLY* 
SLY* 
ND 
-
SLY* 
ND 
CPS 
Cpsl* 
Cps2* 
Cps2" 
Cps4* 
Cps7* 
Cps9* 
Cpsl4* 
Reference 
[29,30] 
[16] 
[16] 
[31] 
[30,32] 
[30,33] 
-
The isogenic unencapsulated mutant strain lOcpsûEF parts of the cps2E and cps2F gene were replaced by an antibiotic 
resistance gene. HV high virulent, V virulent, AV avirulent. MRP muraminidase-released protein. EF extracellular factor. SLY 
suilysin. CPS capsular polysaccharide synthesis *, higher MW protein expressed; s, smaller MW protein expressed 
Differentiation and maturation of dendritic cells 
The study was approved by the Wageningen University Ethical Committee and was performed 
according to the principles of the Declaration of Helsinki. Buffy coats from four blood donors were 
obtained from the Sanquin Blood bank Nijmegen, Netherlands. A written informed consent was 
obtained before the sample collection. Human monocytes were isolated from blood using a 
combination of Ficoll density centrifugation and cell separation using CD14-specific antibody coated 
magnetic microbeads (Miltenyi Biotec). The purity of isolated CD14+ cell fraction was greater than 
90% and viability >95% in all experiments. To generate immature DC (iDCs), the purified CD14+ cells 
were cultured for 6 days in RPMI 1640 medium (Invitrogen), supplemented with 100 units/ mL 
penicillin G (Invitrogen), 100 u.g/mL streptomycin (Invitrogen), IL-4 (R&D systems) and granulocyte-
macrophage colony-stimulating-factor (GM-CSF) (R&D systems). GM-CSF and IL-4 were added to 
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r ,6 . differentiate the monocytes into myeloid DCs. At day 6 the iDCs (1 x 10 /mL) were stimulated with 
LPS (1 u.g/mL) or the different 5. suis serotypes at multiplicities of infection (MOI) of 1 bacterium per 
DC or 10 bacteria per DC for 48 hours. Unstimulated iDCs were used as a negative control. 
Analysis of cell surface markers and measurement of cell death by flow cytometry 
During the 8 day culture period of the CD14+ cells (6 days of differentiation of monocytes into 
immature dendritic cells and two days of stimulation), cells were stained on days 3, 6 and 8 with 
fluorescence-conjugated monoclonal antibodies specific for CD83, CD86 or their isotype-matched 
controls (BD biosciences, San Diego, USA) and analyzed by flow cytometry (FACSCanto II, BD, San 
Diego, USA) to check the maturation and activation status of the cells. CD86 and CD83 were not 
expressed on immature dendritic cells (d3 and 6) but were highly expressed on DCs after activation 
with known maturation factors (e.g. LPS). The magnitude of the response from different human 
donors can vary considerably so for comparison the data was normalized to the LPS control sample 
data (100%) for each donor. On days 3, 6 and 8 the percentage of viable cells was measured by flow 
cytometry (FACSCanto II, BD, San Diego, USA). Live, apoptotic and necrotic cells were discriminated 
by staining with Annexin V and propidium iodide on days 3, 6 and 8 according to the manufacturer's 
protocol. The cells were analyzed on a flow cytometer (FACSCanto II, BD, San Diego, USA). Cells that 
are negative for both Annexin V and PI are not apoptotic or necrotic as translocation of the 
membrane phospholipid phosphatidylserine has not occurred and the plasma membrane is still 
intact. Therefore, Annexin V and PI double negative cells were considered as viable cells, whereas 
both single and double positive cells were regarded as non-viable [29]. The flow cytometry data was 
analyzed using the BD FACSDiva software. On days 3 to 8 the viability of the cells was between 60 
and 95%. There were no significant differences in cell death between S. suis co-cultures or compared 
to the medium and LPS controls. 
Cytokine assay 
Supernatants from the DC stimulation assays were collected after stimulation for 48 hours, and 
analyzed for the presence of cytokines (IL-10, IL-12p70 and TNF-a) using a cytometric bead-based 
immunoassay that enables multiplex measurements of soluble cytokines in the same sample [30], 
according to the manufacturer's protocol (BD biosciences). The limits of sensitivity for detection 
were as follows: 0.13 pg/mL, 0.6 pg/mL and 0.7 pg/mL. The flow cytometry data were analyzed using 
the BD FCAP software. 
Phagocytosis assay 
The iDCs (106 cells) were inoculated with the different S. suis serotypes (MOI 10) and incubated for 
one hour in antibiotic-free RPMI 1640 at 37°C and the presence of 5% C02. The DCs were further 
incubated for one hour in RPMI 1640 containing 56.2 u.g/mL penicillin G and 100 u.g/mL gentamicin. 
Subsequently the DCs were collected and the centrifuged for 5 minutes at 845 g. The pellet was 
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washed with PBS to remove the antibiotics and the DCs lysed and vigorously vortex in ice-cold milliQ 
water. The cell lysate was then serial plated on Columbia blood agar plates (BD) containing 5% sheep 
blood to enumerate the CFU of S. suis. 
Adhesion and Phagocytosis Assay 
In Fig. 3 the iDCs (106 cells) were inoculated with SS2 and SS2 J28 (MOI10) and incubated for 1 hour 
in antibiotic-free RPMI1640. To count the adherent and phagocytosed bacteria DCs were washed 
after one hour twice with PBS to remove the unbound bacteria, lysed with ice-cold milliQ water and 
plated on Columbia blood agar plates (BD) containing 5% sheep blood. 
Kill Curve 
Phagocytosis of S. suis was performed as described above and then the DCs were incubated in RPMI 
1640 containing 56.2 u.g/ml_ penicillin G and 100 ug/mL gentamicin to kill extracellular bacteria. The 
killing of phagocytosed S. suis was determined after 1, 2, 3 and 4 h by removing the antibiotics with 
PBS washes, lysis in ice-cold milliQ water and serial plating on Columbia blood agar plates (BD) 
containing 5% sheep blood (Fig 4A) 
Survival ofS. suis inside DCs after 2 and 24 hours 
The iDCs (106 cells) were inoculated with SS2 and SS2 J28 (MOI10) and incubated for one hour in 
antibiotic-free RPMI1640. After one hour of incubation antibiotics (100 u.g/mL gentamicin and 56.2 
Ug/mL of penicillin G) were added to kill all the extracellular bacteria. After a further one hour 
incubation in the presence of the antibiotics DCs samples were collected and plated in the same way 
as described in the phagocytosis assay (2h time point). After a further 4 hours, the medium was 
replaced by RPMI lacking antibiotics to prevent the antibiotics from entering the DCs and killing 
intracellular bacteria. After a total of 23 hours incubation the DCs were incubated for one hour in 
RPMI with or without antibiotics washed twice with PBS, lysed with ice-cold milliQ water and plated 
on Columbia blood agar plates (BD) containing 5% sheep blood (24 h time point). 
TLR2/6 assay 
The TLR2/6 signaling assay was performed essentially as previously described [31]. Briefly, HEK293 
cells (Invivogen, Toulouse, France) were transformed with human TLR2/6 and pNIFTY, a NF-KB 
luciferase reporter construct (Invivogen). The cells were plated a concentration of 6 x 10 cells per 
well in DMEM medium. Cells were then stimulated with the different S. suis strains, Pam2CSK as a 
positive control and with medium alone (negative control) and incubated at 37°C and 5% C02 for 24 
hours. After this incubation period the medium was replaced with Bright glow (Promega), the plate 
was vortexed and the luminescence was measured using a Spectramax M5 (Molecular Devices). 
Human embryonic kidney (HEK)293 cells not expressing TLR receptors but harbouring pNIFTY, a NF-
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KB luciferase reporter construct (Invivogen, Toulouse, France) were used as the negative control in 
the NF-KB assays. 
Statistical analysis 
Dixon's Q test was applied for the evaluation of differences in the values of the immune- and 
cytokine assays. Datasets contained values of six different donors. P values of <0.05 were considered 
significant. Independent sample t-test was applied for the evaluation of differences between SS2 
and SS2J28 in the phagocytosis assay and the kill curve. P <0.05 were considered significant. 
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Summary 
We have identified apuA in Streptococcus suis which encodes a bifunctional 
amylopullulanase with conserved a-amylase and pullulanase binding domains and 
catalytic motifs. ApuA exhibited properties typical for a Gram-positive surface protein with 
a putative signal sequence and LPKTGE cell wall anchoring motif. The cc-1,4 glycosidic 
activity has been showed by the production of an recombinant protein of the a-amylase 
domain. The predicted a-(l,6) glycosidic activity of a pullulanase was found in the cell 
surface protein extract of S. suis. ApuA was required for normal growth in complex 
medium containing pullulan as the major carbon source suggesting that in vivo this 
enzyme plays a role in nutrient acquisition via the degradation of glycogen and food-
derived starch in the nasopharyngeal and oral cavities. ApuA was shown to promote 
adhesion to porcine epithelium and mucus in vitro, highlighting a link between 
carbohydrate utilization and the ability of S. suis to colonize and infect the host. 
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Introduction 
Streptococcus suis is a major porcine pathogen of significant commercial importance 
worldwide. In suckling and weaning pigs it is the principal cause of acute meningitis but 
can infect other organs leading to arthritis, serositis, endocarditis, otitis media and 
bronchopneumonia [1,2]. Healthy pigs asymptomatically colonized with S. suis form a 
reservoir for this disease and play a major role in the epidemiology [3]. To date 33 
different capsule serotypes of 5. suis have been identified but serotype 2 is most 
commonly associated with disease worldwide [4,5]. Serotype 2 strains were also 
associated with recent large outbreaks of severe human infections in China and Asia 
[6,7,8]. The recently obtained genome sequences of two Chinese virulent S. suis serotype 
2 (SS2) strains (98HAH12 and 05ZYH33) [9] and Pl/7 the European reference strain [10] 
led to the identification of a large number of potential surface and secreted proteins that 
might play a role in virulence, including a number of putative carbohydrate degrading 
enzymes [11]. Genes encoding carbohydrate degrading enzymes are common in the 
genomes of other streptococcal pathogens and play a role in nutrient acquisition for 
growth and colonization on mucosal surfaces [12,13,14,15]. Dietary sources of highly 
polymerized a-glycans such as starch and glycogen are abundant in the human colon [16], 
oropharynx [17,18,19,20], epithelium of the vagina and lung [21,22,23,24]. Starch and 
glycogen degradation in most organisms proceeds via the action of amylases and pullulan 
degrading enzymes (such pullulanase and amylopullulanase) which cleave a-(l,4) and a-
(1,6) glycosidic linkages. Pullulan is a linear polysaccharide of maltotriose repeating units 
linked via a-(l,6) glycosidic bonds, produced by the ascomycete fungus Aureobasidium 
pullulons [25]. Although pullulan is not found in animals it is commonly used as substrate 
to identify pullulanases with ot-(l,6) glycosidase activity [9,26,27]. 
In Group A streptococci (GAS), Group B streptococci (GBS) and Streptococcus pneumoniae, 
cell wall anchored enzymes that can hydrolyze pullulan, have been characterized 
[23,28,29]. Recent research has shown an additional role for the streptococcal 
pullulanases in virulence. The GAS pullulanase PulA, was shown to function as a 
strepadhesin, binding to several complex carbohydrate substrates including submaxillar 
mucin [28]. Additionally, recombinant PulA and the related pneumococcal SpuA, have 
been shown to bind with high affinity to alveolar type II cell glycogen in the lung [24]. 
Further evidence for the role of SpuA in virulence comes from genome signature-tagged 
mutagenesis screens in 5. pneumoniae using a mouse pneumonia model to identify genes 
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that decreased pathogen fitness in vivo [30]. Recently, it was shown that GAS PulA 
deficient mutants were less able to adhere to human epithelial cells [31]. Furthermore, 
recombinant SAP, a type I pullulanase from GBS, was shown to bind human epithelial cells 
in vitro [21,31]. Here we report on the characterization and mutagenesis of apuA, 
encoding an extracellular bifunctional amylase/pullulanase with C-terminal pullulanase 
activity that was identified in the genome of 5. suis. Its potential role in virulence was 
investigated using binding assays with porcine epithelial cells and mucin. 
Results 
Identification and analysis of 5. suis serotype 2 amylopullulanase-encoding gene 
A gene designated here as apuA (6285 bp and 2094 amino acids (aa)) and predicted to 
encode an amylopullulanase, was identified in the genome sequence of S. suis Pl/7 
(YP003027676.1). Based on the presence of a putative signal peptide sequence and a C-
terminal LPNTG motif (residues 2059-2064) [32] ApuA is predicted to be a 23 kDa mature 
surface protein covalently linked to the cell wall (Fig. 3.1). 
YSIRK G I II III IV 
o - amy 
2 0 9 4 a a 
LPKTGD 
Fig. 3.1 Schematic representation of the apuA locus. ApuA is encoded by a single open reading frame of 6,285 bp, producing a 
bifunctional amylase/pullulanase protein of 2,094 amino acids. Located upstream of the apuA locus is a putative sugar-specific 
permease, component IIC (sgoT) belonging to a sugar phosphotransferase system (PTS). Downstream the apuA locus is a putative 
transcriptional regulator gene with similarity to lacltr. The oc-amylase and pullulanase domains are located in the amino-
terminal and carboxy-terminal regions, respectively. The N-terminal region includes a signal peptide (SP) of 41 amino acids 
containing a YSIRK-G domain. Within the N-terminal a-amylase domain are two tandem repeats designated CBM41, followed by 
an alpha-amylase (a-amy) catalytic domain, belonging to glycosyl hydrolase family 13. In the pullulanase C-terminal domain, two 
tandem CBM41 repeats are followed by a specific pullulanase N-terminal domain (N-pul) associated with an alpha-amylase (a-
amy) catalytic domain. The amylase and pullulanase domains contain a four-motif (I, II, III and IV) region that is highly conserved 
in a-amylase-like proteins. 
The apuA gene is located upstream of genes encoding a putative sugar-specific permease 
(sgal) classified as component IIC that belongs to a sugar phosphotransferase system 
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(PTS) and downstream of a putative transcriptional regulator gene with homology to the 
lad family (Fig. 3.1). 
The ApuA protein was predicted to contain a distinct a-amylase domain (103 to 860 aa) 
and a pullulanase domain (921 to 1962 aa) (Fig. 3.1). Upstream of each functional domain 
lie two tandem repeats belonging to carbohydrate binding motif family 41 (CBM41) which 
binds tightly to a-glucan polysaccharides containing a-(l,4) glycosidic and a-(l,6) 
glycosidic linkages [24]. Within the protein two pairs of four regions highly conserved in a-
amylase like proteins were identified (I, II, III and IV) which form the catalytic triad Asp-
Glu-Asp [33,34]. 
At the protein level ApuA shares 47 % and 60 % identity to the predicted alkaline 
amylopullulanase in Bacillus sp. KSM-1378 [35] and the putative amylopullulanase in 
Streptococcus infantarius respectively (Fig. 3.2A). Additionally, the predicted S. suis ApuA 
pullulanase domain shares 58% and 55% identity with the well characterized pullulanases 
described in pathogenic S. pneumoniae (SpuA), GAS (PulA) and S. agalactiae (Sap) (Fig. 
3.2A). Both functional domains of ApuA contain the four highly conserved regions 
designated I, II, III, and IV that are found in a-amylases, pullulanases and 
amylopullulanases (Fig 1, Fig. 3.2). The two glutamic acid (Glu) residues that are crucial for 
the catalytic activity of these enzymes [33], lie at positions Glu66i and Glu1598 within 
conserved region III of the a-amylase and pullulanase domains respectively (Fig. 3.2B). 
Analogously, the catalytic aspartate residues are found at positions Asp632 (region I) and 
Asp727 (region IV) of the a-amylase domain, and at positions Aspi569 (region I) and Asp1686 
(region IV) within the pullulanase domain. The presence of the LPXTG motif, and the 
distinct a-amylase and pullulanase domains each possessing conserved catalytic and 
substrate binding sites suggested that ApuA is a cell wall anchored bifunctional 
amylopullulanase. 
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Name Enzyme Strain Identity Reference 
ApuA amylopuilutanase
 p' | y i s 
— (?) amylopuilutanase S. infantahus 
APase alkaline amylopullulanase Bacil1^5 $P-
KSM 1378 
(?) pullulanase 
(?) pullulanase 
SpuA pullulanase 
PulA pullulanase 
S. sanguinis 
SK36 
S. equi 
MCCS10565 
S. pneumoniae 
serotype I 3.B 
S. pyogenes 
NZÎ3Î 
Sap Type I pullulanase s- fgf- ' f**30 
pullulanase 
!>••• '• I I. I HSHMI! 
pullulanase 
100% This work 
47% 20 
58% 23 
55% 43 
Fig.3.2A. Structural comparison of pullulan-degrading enzymes and their subdomains in different Gram-positive species 
Amylopullulanase/pullulanase enzymes in S. suis Pl/7, Streptococcus infontarius, Bacillus spp. KSM 1378, Streptococcus sanguinis 
SK36, Streptococcus equi MGCS10565, Streptococcus pneumoniae serotype I 3.B, Streptococcus pyogenes NZ131 and 
Streptococcus agalactiae COH1. 
amy 
pul J 
Consensus 
Pl /7 
KSM-1378 
f P l / 7 
KSM-1378 
SK36 
MGCS10565 
S13.B 
NZ131 
COH1 
Region I 
556 OWLNH 
462 DVVLNH 
1501 DWYNH 
1396 DWFNH 
715 DWYNH 
734 DWYNH 
717 DWYNH 
664 DWYNH 
734 DWYNH 
Region II Region III Region IV 
* 
628 AFRVDTVKH 
546 YFRVDTVKH 
* 
1565 GFRFDMMGD 
1460 GFRFDMMGD 
779 GFRFDMMGD 
798 GFRFDMMGD 
781 GFRFDMMGD 
728 GFRFDMMGD 
798 GFRFDMMGD 
661 
579 
1598 
1493 
812 
831 
814 
761 
831 
* 
ETWG 
EAWG 
* 
EGWR 
EGWV 
EGWK 
EGWV 
EGWR 
EGWR 
EGWR 
722 
640 
1681 
1578 
895 
914 
897 
844 
914 
* 
FLGSHD 
FLGSHD 
* 
YIAAHD 
YIEAHD 
YIAAHD 
YIAAHD 
YIAAHD 
YIAAHD 
YIAAHD 
Fig. 3.2B. Conserved sequences of the regions I, II, III and IV in the a-amylase and pullulanase domains. Two copies of the four 
regions highly conserved among a-amylases, pullulanases and amylopullulanases were identified in ApuA from Bacillus spp. KSM-
1378. The amino acids shown in bold are conserved among all amylolytic enzymes, while the putative catalytic amino acids are 
denoted by (*). 
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The a-amylase recombinant domain contains a-1,4 glycosidic activity 
The DNA fragment encoding the predicted a-amylase domain of ApuA was cloned in the 
IPTG-inducible expression vector pTrcHis to generate pTrc-amy. Induction of expression by 
IPTG for 3 hours at 37°C resulted in high level production of a protein of the expected size 
(Fig. 3.3A). The recombinant amylase was purified by Immobilized Metal Affinity 
Chromatography (IMAC) using an imidazole gradient to obtain a fraction highly enriched 
for the expressed protein (Fig. 3.3A). The purified recombinant protein tested in the Red 
Starch assay comprises of a single band on a Coomassie stained protein gel and was 
compared to an extract from E. coli and 1 mg of the purified a-amylase from Aspargillus 
oryzae as a positive control. The a-amylase activity of 70 ug of the purified recombinant 
protein was 16 fold higher than 130 ug from the E. coli expression strain (Fig. 3.3B). This 
indicates that the activity of the purified recombinant protein is not due to contamination 
with residual amounts of E. coli glycosidases having an a-1,4 glycosidase activity. Thus 
these results confirm that the N-terminal half of ApuA indeed possesses the predicted a-
1,4 glycosidase activity. 
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Fig. 3.3 a-amylase domain purification and activity A. SDS-PAGE (12% get) of Amy purification steps. NI: total E. colt cellular 
protein no inducted; I: cleared cell lysate of £ coli after 3 h at 37 °C of induction; M marker; FT: Ni-NTA flow-through.; rAmy 
elution from an Ni-NTA column containing the recombinant Amy with the expected size. B. Amylase activity measured with Red 
Starch as substrate. 
Disruption ofapuA in S. suis 510 
To study the putative functions and expression of ApuA in 5. suis, an isogenic apuAr.spc 
knockout mutant of strain 10 was constructed using the £ coli- Gram-positive shuttle 
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vector pG+host9 that shows thermosensitive replication in L lactis [36]. Plasmid pG+host9 
is able to replicate and be maintained episomally in S. suis at 30°C but at temperatures 
above 37°C it is segregationally unstable and lost in the absence of antibiotic selection. In 
the presence of antibiotic selection growth at temperatures above 37°C promotes 
recombination between homologous DNA cloned in pG+host9 and the chromosome. PCR 
apuA fragment containing the pullulanase domain (from 3114 bp to 6133 bp) was ligated 
to the EcoRI and Xhol digested pG+host9 and transformed in E. coli VE7108 to generate 
pG9-api/A:spe. A spectinomycin resistance cassette was then inserted into the middle of 
the apuA coding region using an inverse PCR strategy to generate the integration 
construct pG9-apuA:spc. This construct was introduced into 5. suis by electroporation 
resulting in 10 transformants that were recovered at 28°C in the presence of Erm (Fig. 
3.4A 1s t step). Single cross-over events in these transformants were achieved by overnight 
growth in liquid medium containing Spc and Erm at 37 °C, the non-permissive temperature 
for plasmid replication in 5. suis (Fig. 3.4A 2nd step). Integrant strains were then serially 
passaged for 5 days in liquid medium at 28°C without erythromycin selection to facilitate 
plasmid excision by homologous recombination between flanking duplicated regions. 
Dilutions of the serially passaged cultures were plated on agar plates and single colonies 
tested for erythromycin sensitivity (Erms) and spectinomycin resistance (SpcR) to select for 
double crossover events resulting in insertion of spc into the apuA gene (apuAr.spc) (Fig. 
3.4A 3 r , 4* step). Spc integrants were confirmed to have the expected genotype by PCR 
(Fig. 3.4B) and a single integrant designated 5. suis 10 apuAr.spc was used for further 
studies. 
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S. suis s t ra in 10 g e n o m e 
apuA 3' 
4. 
apuX 5' apuA 3' 
X 
apu>4 5' spc apuA 3' 
-> •«-
apuaF apuaR 
1318 bp 
Erm S 
I 1 
apuAr.spc mutant 
B 
wt T apuAr.spc 
Fig. 3.4 ApuA mutant construction A. Strategy for mutagenesis of the apuA gene to generate the knockout mutant apuAr.spc via 
a double cross-over event. 1 s t step: S. suis strain 10 transformed with pG9-apuA::spc. The first recombination event (integration) 
occurs by a single cross-over (SCO) event through sequences homologous to apuA (only one possible SCO indicated); 2nd step: the 
resulting SCO integrants; 3rd step: a shift of the SCO integrants to 28 "C stimulates the second (double) cross over event (DCO) 
and leads to plasmid excision; 4 th step: Genotype of the verified apuAr.spc mutant. B. PCR validation of the expected genotype 
using primers apuaF and apuaR which flank the insertion region of spc. A 264 bp PCR product is detected in S. suis strain 10 (wt) 
and a 1318 bp product in the apuArspc mutant. As expected the SCO transformant (T) contained both PCR products. 
Pullulanase activity of the apuAr.spc insertion mutant 
A red-pullulan plate assay was used first to evaluate the a-(l,6) glycosidic activity of the 
wild type and mutant strains [37]. Hydrolysis of the red dye-conjugated pullulan resulted 
in a clear zone on the plate incubated with the wild type strain but not the apuAr.spc 
mutant indicating that the mutant lacked detectable pullulanase activity (Fig. 3.5A). The a-
amylase activity of the apuAr.spc mutant and wild type strain was not assessed as the S. 
suis genome contains a second predicted a-amylase gene classified as ct-(l,4) glucan 
branching enzyme (GenelD:8152319). As ApuA was predicted to be cell wall anchored in S. 
suis, the pullulanase activity of cell wall, cytoplasmic and secreted proteins was measured 
in a spectrophotometric assay for endo-acting pullulanase activity using a purified 
pullulanase from Klebsiella planticola as a reference. The pullulanase activity of the cell 
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wall fraction from the wild type strain was 55 mil mg -1 protein. Only background levels of 
pullulanase activity were detected for the apuA mutant indicating that ApuA is the sole 
enzyme responsible for breakdown of a-(l,6) glycosidic linkages found in pullulan, starch 
and glycogen. No pullulanase activity was measured above background levels in the cell 
wall and supernatant fractions (data not shown) demonstrating that this enzyme is surface 
located as predicted. 
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Fig. 3.5. Characterization of wild type and apuA::spc mutant phenotype A. Pullulanase activity of apuAr.spc mutant (left) and wt 
strain 10 (right) on Red-Pullulan plate. The light zone indicates pullulan degradation by the wt isolate. B. Pullulanase activity of 
extracted cell wall proteins from wt and apuA::spc mutant as determined by linear regression on a standard curve obtained with 
K. pianticola pullulanase 
Carbohydrate utilization assays 
S. suis wt and the apuAr.spc mutant were analyzed for the ability to grow on glycogen, 
pullulan and maltotriose as the major sources of carbohydrate. In complex medium both 
strains grow to a low density (OD6u0 0.25 - 0.3) after 13 hours incubation (Fig. 3.6A). 
Supplementation of the medium with maltotriose or glycogen supported growth of both 
the wt and apuA mutant strains to a higher density (OD600 0.4 to 0.6) than in complex 
medium alone (Fig. 3.6C and D). However, in the presence of pullulan growth of the 
mutant was decreased compared to the wild type strain and it reached the same optical 
density as for complex media alone (Fig. 3.6A and B). 
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Fig. 3.6. Growth curves of wild type (-Q-) and apuA::spc (- • - ) mutant strains grown in complex medium A. alone, or B. with 
the addition of 1 % of pullulan C. maltotriose and D. glycogen. 
Adhesion to a porcine tracheal cell line 
The newborn porcine tracheal cell line NPTr was chosen to investigate the role of ApuA in 
adhesion to the epithelium [38]. In agreement with previous studies on serotype 2 strains 
of S. suis in porcine and human kidney and lung adenocarcinoma cell lines, we found that 
the wild type was adherent but not invasive within 2 hours of incubation (results not 
shown). In contrast to previous adhesion studies with the same 5. suis strains and a human 
laryngeal carcinoma cell line we found that the wild type strain adhered strongly to the 
porcine epithelium with maximum percentage of adherence of 19% using a multiplicity of 
infection (m.o.i.) of 75 for the wild type (Fig. 3.7A). The adhesion of wt and mutant strains 
were tested over a range of m.o.i.; in all cases, the mutant was significantly (P < 0.05) less 
adherent than the wt strain (Fig. 3.7A). 
Binding to porcine mucin 
The ability of 5. suis strains to adhere to porcine mucin was examined in a solid-phase 
assay using mucin-coated microtiter wells. As shown in Fig. 3.7B, the binding of the wild 
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type strain to porcine mucin was significantly higher than binding of the apuAr.spc mutant 
using inoculums of 108 and 107c.f.u. ml-1. At the higher inoculum dosages, approximately 
2 fold higher numbers of the wild type strain were recovered after 2h of incubation. 
B 
aapuA::spc 
xlO' 1x10' 
inoculum (c.f.u. m l 1 ) 
Fig. 3.7. A. Percentage adhesion of wild type and isogenic mutant apuAr.spc to the epithelial cell line NPTr. Results were 
determined after 2h co-incubation of epithelial cells with wt and mutant strains at 37^C with 4 different multiplicities of infection 
(m.o.i) followed by extensive washing, lysis and viable plate counts. *, P < 0.05 compared to adherence of the apuAr.spc mutant. 
B. Binding of S. suis wt and apuAr.spc mutant bacteria (at doses 108 and 107 c.f.u. ml-1) to microtiter plate wells coated with 
porcine mucin at 37 °C. The mean standard deviation (error bars) was derived from triplicate wells in two independent 
experiments. *, P < 0-05 compared to binding of the mutant strain apuAr.spc. 
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Discussion 
A gene, apuA, encoding a cell wall anchored amylopullulanase was identified in the 
genome sequence of S. suis strain 10. apuA encodes a protein with distinct a-amylase (a-
(1,4) glycosidic) and pullulanase (a-(l,6) glycosidic) domains (Fig. 3.1). Each domain 
contains conserved a-glucan binding domains and four highly conserved regions 
designated I, II, III and IV. These regions are predicted to confer catalytic activity by 
comparison to a wide range of a-amylases, pullulanases and amylopullulanases [24,33] 
(Fig. 3.2B). The pullulanase domain of ApuA shares high identity with a-(l,6) glycosidic 
pullulanases identified in other pathogenic streptococcal species such as 5. infartarius, S. 
sanguinis, Streptococcus equi, S. pneumoniae (pulA) [29], GAS (spuA) [24,28,31] and GBS 
(sap) [23]. The last three proteins have been well characterized and have 58-55 % identity 
with the pullulanase domain of S. suis ApuA (Fig. 3.2A). Pullulanase activity was found 
solely in the cell fraction of S. suis wild type indicating that this enzyme is surface located. 
Furthermore, insertional inactivation of apuA (by generating the interrupted locus 
apuAr.spc) resulted in loss of pullulanase activity. 
Compared to the wild type, growth of the apuAr.spc mutant was significantly impaired in 
complex medium containing pullulan but not glycogen, or maltotriose as major carbon 
sources. The ability of the apuAr.spc mutant to grow efficiently on glycogen may be due to 
the fact that the 5. suis genome contains a second gene encoding a predicted a-amylase 
domain. Hydrolysis of pullulan with an oc-(l,6) pullulanase yields maltotriose as the main 
product. The failure of the mutant to utilize pullulan as a carbon source strongly suggests 
that ApuA is necessary for hydrolysis of pullulan and the release of maltotriose which is 
used as a carbon source for growth. ApuA shows highest protein sequence similarity to a 
putative amylopullulanase STRINF_01787 of Streptococcus infartarius (60 %) and the 
characterized alkaline amylopullulanase (APase) from Bacillus sp. KSM-1378 (47 %; Fig. 
3.2A) which was shown to hydrolyze both a-(l,4) and a-(l,6) glycosidic bonds from two 
distinct domains and catalytic sites within the same protein [35]. 
The evolution of this type of bifunctional enzyme could have resulted from recombination 
between a-amylase and type I pullulanase genes. Similar events are thought to be 
responsible for the origin of genes encoding bifunctional enzymes, such as enzymes with 
endo- and exoglucanase activities from Caldocellum saccharolyticum [39]. 
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The upper respiratory pharyngeal mucosa is the primary site of adherence and 
colonization by S. suis but the factors involved in these key virulence mechanisms have not 
been identified. Given that the type I pullulanase of Group A streptococci mediates 
adherence to eukaryotic carbohydrate residues [28] we investigated the potential role of 
ApuA in adhesion to the porcine epithelial cell line NPTr. Previous studies with human and 
porcine kidney epithelial cell lines showed that S. suis serotype 2 strains are able to 
adhere, but not invade, eukaryotic cells [40,41]. We found, for the first time, that this was 
also the case for the porcine NPTr cell line which has not previously been used for 5. suis 
virulence studies. The adherence to the porcine epithelial cells was substantially (twenty 
fold) stronger than that reported previously for the human laryngeal carcinoma cell line 
HEp-2 using similar assay conditions [41]. Strikingly, in our cell line model, the adherence 
of apuAr.spc mutant was around 2 fold lower than the wt strain over a range of 
multiplicities of infection suggesting that ApuA may play an important role in colonization 
and virulence in vivo. As pullulan is not found in humans and pigs ApuA presumably binds 
to similar carbohydrate structures on porcine epithelium and mucus. 
Colonization of the nasopharyngeal cavity by S. suis is an important risk factor for the 
infection of young pigs [42,43]. Recent evidence suggests that the nasopharynx and 
palatine tonsils may be the routes of entry in invasive disease [2]. Adhesion of S. suis to 
mucus in the oral cavity is likely to be important for colonization as demonstrated for 
other opportunistic pathogens colonizing the nasopharyngeal cavity [44,45,46]. The 
demonstration that the apuA::spc mutant binds less well to porcine gastric mucus is an 
indication that this surface enzyme may also promote adhesion to mucus in vivo. 
In vivo, ApuA is likely to play a role in nutrient acquisition via the degradation of glycogen, 
the major carbohydrate storage protein in animals, as well as in the degradation of food-
derived starch or glycogen in the nasopharyngeal and oral cavity. Our results demonstrate 
an important role for ApuA in adhesion to porcine epithelial cells and to mucus in vitro. 
These results also point at a link between carbohydrate utilization by S. suis and the ability 
to colonize and infect hosts. 
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Materials and Methods 
Bacterial strains, plasmids and culture conditions 
Bacterial strains and plasmids used in this study are listed in Table 3.1. S. suis strains were grown in 
Todd-Hewitt broth (THB) (Difco) or on Columbia agar plates with 6 % sheep blood (Oxoid) at 37°C 
under 5 % C02 for 18 h. The genome of S. suis S10 is more than 99% identical to the genome of S. 
suis Pl /7, a sequenced reference strain of which the genome had been annotated previously 
(Chapter 1). An optical density (OD) of 1.0 at 600 nm with a 1 cm path length corresponds to 
approximately 10 bacterial colony forming units per milliliter (c.f.u. ml-1). Escherichia coli VE7108 
(derived from TGI) was cultured in Luria-Bertani (LB) broth or LB agar (Difco Laboratories) at 37°C 
for 18 h. When necessary, antibiotics were added to culture media at the following concentrations: 
for E. coli, erythromycin (Erm) 150 ug m f ; and spectinomycin (Spc) 50 u.g ml" ; for S. suis, Erm at 2 
ug m f and Spc at 100 u.g m f . The use of pullulan as a sole carbon source for growth was 
demonstrated using red pullulan agar (1% peptone; 0.1% NH4CI; 0.1% Red pullulan (Megazyme) and 
2% agar) as previously described [37]. A complex medium (CM) comprising of 10 g f proteose 
peptone, 5 g I"1 trypticase peptone, 5 g f 1 yeast extract, 2.5 g f 1 KCl, 1 mM Urea, and 1 mM 
Arginine, pH 7-0 was used to assess growth on different carbon sources by supplementation with 
different carbohydrates at a final concentration of 1% (w/v) as previously described [23]. Growth in 
complex medium was determined by measurement of turbidity OD600 using a SpectraMax M5 
reader. 
TABLE 3.1. Bacterial strains and plasmids used in this study 
Strain or plasmid Genetic markers and/or description ' Reference 
E. coli VE7108 
E. coli VE6838 
E. coli TOP 10 
S. suis 2 SIO 
5. suis apuAr.spc 
Plasmids 
pTrcHisTOP02 
pTrc-ApuaR 
PDL282 
pKUN19-spc 
pG*host9 
pG9-opuA 
pG9apuA::spc 
supE hsdü5 thi A(lac-pro AB) F'[traD36 proAB+ laclq lacZÛMIS] repA* [48] 
supE hsdAS thi û(lac-pro AB) F'[traD36 proAB+ laclq lacZAM15] [48] 
VE7108 carrying pG*host9 
F- mcrA A(mrr-hsdRMS-mcrBC) O80/ocZAM15 AtocX74 recAl oroD139 Invitrogen 
A(oro/eu) 7697 galU galK rpsL (StrR) endAl nupG 
Virulent serotype 2 strain [55,56] 
Isogenic apuA::spc mutant of strain SIO This work 
Expression vector containing C-Terminal His-tag Invitrogen 
pTrcHis2 vector containing 936 bp of apuA This work 
Replication functions of pUC19 and pVT736-l, AmprSpcr [57] 
pKUN19 containing Spc' gene of pDL282 [49] 
Erm', a thermosensitive derivative of pGK12 [36] 
pGhost*9 derivative containing 3020 bp of apuA This work 
pG9-opuA:.spc containing a 1.2-kb Spcr fragment from pKUN19-spc This work 
cloned within apuA 
ErrrT, erythromycin resistant; Ampf, ampiciliin resistant; Spcr, spectinomycin resistant. 
73 
Chapter 3 
Nucleotide and protein sequence analyses 
Blast searches with S. suis strain Pl/7 (serotype 2) genome sequences were performed using non-
redundant sequences accessible at the National Centre for Biotechnology Information internet site 
(http://www.ncbi.nlm.nih.gov). Sequence alignments were performed using the ClustalW program 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html). Signal peptide motifs were identified in protein 
sequences using the SignalP VI .1 software (http://www.cbs.dtu.dk/services/SignalP/). 
Expression and purification of recombinant a-amylase domain. 
The nucleotide sequence predicted to encode the mature a-amylase domain of ApuA (amino acids 
51 to 855) was amplified by PCR from S. suis 2 10 genomic DNA using GoTaq (Promega) and primers 
AmyF and AmyR as listed in Table 3.2. 
TABLE 3.2. Oligonucleotide primers used in this study 
Primer 
amyF 
amyR 
pulF-FcoRI 
pulR-X/iol 
pul F-Pvul 
pulR-ßg/// 
Spc-Pvul 
Spc-Bglll 
apuaF 
apuaR 
Sequence3 
CTTTCGGAACAGGATGGC 
GACGATGTCACCTGCTTCTG 
GaATCGAATTCTATACCGATGGCAATTATGAT 
TCGAATCTCGAGATCTTGTCCAGACGCTTGAG 
GCTAGTCCATGGTACTGCCTCCATGAAGTGATAAT 
TCGTCGATCGCGCGTCGTGTCTTAGTTGATTCC 
GCTATACCATGGTAAGGTCGACTCTAGAGGATC 
i L b l A b L A b A l L l L b l l A I A A I I I I I I I A A I U U I A I MA 
TGGGTGTGATTTTGGATGTG 
TAAAGGCCAGCTCAATTGCT 
Purpose 
Cloning of a-amylase 
domain in pTrcHisTopo 
Cloning of amylopullulanase 
fragment in pGhosf9 
Inverse PCR of pG9-opuA 
Insertion of spc gene into 
pG9-opuA 
To check for correct mutant 
clones using colony PCR 
The sequences in bold and underlined correspond to gene sequence and restriction sites respectively. 
The purified PCR products were ligated to the pTrcHis TOPO TA expression vector (Invitrogen) such 
that the expressed recombinant a-amylase would be fused to an N-terminal polypeptide containing 
six histidine residues for affinity purification. After transformation of F. coli TOPO 10, several clones 
were picked and checked for the correct insertion of the a- amylase gene fragment and verified by 
DNA sequencing. Expression of the amylase-protein domain was induced by addition of 1 mM 
Isopropil ß-D-1-tiogalattopiranoside (IPTG) to an exponential culture (OD600 of 0.6) for 3 hours at 
37°C with shaking (250 rpm). The cells were harvested by centrifugation (8 000 g x 10 min at 4°C) 
and the pellet was resuspended in lysis buffer (50 mM Tris-CI; 150 mM NaCI (pH 7.4]) containing a 
cocktail of protease inhibitors; Roche), and then disrupted using a high pressure cell disrupter 
(Constant Systems, U.K.). The soluble poteins extract was recovered after high speed centrifugation 
(14 000 rpm 40 min) and loaded onto a HisTrap affinity chromatography column (Amersham 
Pharmacia Biotech, Freiburg, Germany). Proteins were eluted in a phosphate buffer containing 500 
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mM NaCI and increasing concentrations of imidazole and checked by SDS-PAGE gel electrophoresis. 
Fractions containing purified fusion proteins of the expected size (approx. 110 kDa) were stored at 
4°C in aliquots in the elution buffer. Protein concentration was measured using a BCA Protein Assay 
(Thermo Scientific), according to the supplier's instructions. 
Assay for a-amylase activity 
Alpha amylase activity was measured using Red Starch (Megazyme) according to the manufacturer's 
instructions. Briefly Red-Starch (1% w/v in 0.5 M KCl) was incubated for 10 min at 40°C with 500 nl 
of each protein fractions in 1 ml of buffer B (maleic acid 0-1 M, calcium chloride 2 mM, sodium azide 
0.01% w/v pH 6.5 ). Red-Starch is depolymerized by a-amylase to produce low-molecular weight dye 
compounds that remain in solution on addition of 2.5 ml ethanol. After centrifugation at 1 000 g x 10 
min the released dye was quantified in the supernatant by spectrophotometer (510 nm) 
(SpectraMax M5 reader). 
Insertional inactivation of apuAr.spc 
All the primers used for mutagenesis have been listed in Table 3.2. Chromosomal DNA was isolated 
using the CTAB extraction method after pretreatment of the bacteria with lysozyme (10 mg ml~ ) for 
10 min at 37°C as previously described [47]. An internal EcoRI-Xhol fragment (nucleotide position 
3114 to 6133) of the apuA gene was amplified using primers pulF and puIR and ligated into EcoRI 
and Xhol digested pG+host9, a shuttle vector that is thermosensitive for replication in Gram-positive 
bacteria [36]. The resulting plasmid pG9-apuA::spc was introduced into competent E. coli strain 
VE7108 [48] by electroporation and the transformants selected on LB agar containing erythromycin. 
Plasmid pG9-apuA::spc extracted from the transformants was linearized by inverse PCR using Pfu 
Taq polymerase (Promega) and the internal apuAr.spc primers pulF-Pvu/ and pulR-ßg///. A spc 
cassette, containing the promoter and transcriptional terminator, was amplified from plasmid 
pKUN19-Spc [49] using primers 5'Spc-Pvu/ and 3' Spc-Bglll. Both the inverse PCR product of pG9-
apuAr.spc and the spc cassette were then digested with Pvul and Bglll enzymes and ligated using T4 
DNA ligase (Promega) to generate pG9-apuA::spc which contains a spc cassette inserted between 
nucleotides 4564 and 4624 of apuA. 
Purified plasmid pG9-apuA:spc was then transformed into competent 5. suis strain 10 by 
electroporation as described previously [50]. The transformants were selected on agar plates 
containing 2 ng ml - 1 Erm at 28°C, the permissive temperature for replication of pG+host9. 
Transformants were then grown at 37°C, the non-permissive temperature of replication, on 
Colombia agar containing Erm and Spc to select for chromosomal integration. The integrants were 
serially passaged for 5 days in liquid medium at 28°C without Erm selection to select for loss of the 
plasmid via a double cross-over event, leaving the spc gene insertion in apuAr.spc [51]. Erythromycin 
sensitive colonies with the apuAr.spc phenotype were verified by PCR using primers apuaF and 
apuaR. 
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Pullulanase activity of cell wall, intracellular and secreted proteins 
The cell free supernatant (secreted proteins) and cytoplasmic and cell wall protein fractions of wild 
type (wt) and apuA::spc mutant were assayed for pullulanase activity. To obtain streptococcal 
secreted proteins, 90 ml of overnight culture bacteria grown in THB was pelleted (10 000 g x 10 min 
at 4 °C) and 10 ml of supernatant was collected and concentrated to a final volume of 1 ml using a 
10 kDa filter (Sartorius). To extract the cell wall proteins the resultant bacterial pellet was incubated 
for 1.5 h at 37°C in 1 ml of extraction buffer (30 mM Tris-HCI pH 8.0; 3 mM MgCI2, 25 % sucrose) 
containing protease inhibitors (Roche), 1 mg m f lysozyme and 125 U m f mutanolysin (Sigma). The 
bacterial suspension was then pelleted by centrifugation (10 000 g x 10 min at 4 °C) and the 
supernatant containing cell wall proteins was concentrated using a 10 kDa filter (Sartorius) to a 
volume of approximately 1 ml. The pellet of osmotically fragile protoplasts was lysed by 
resuspension in 10 ml of buffered saline (pH 7-0) containing 5 mM MgCI2. The suspension was 
allowed to stand at room temperature for 15 min and centrifuged at 10 000 x g for 30 min at 4°C 
[52]. The clear supernatant containing the cytoplasmatic proteins was concentrated as described 
above. The concentration of the protein in each fraction was quantified using NanoDrop 
Spectrophotometer (NanoDrop Technologies, USA). 
The pullulanase activity was determined by measuring the enzymatic release of reducing groups 
from a-glucans using red-pullulan as substrate (Megazyme). Briefly, Red-Pullulan (1 % w/v in 0.5 M 
KCl) was incubated for 10 min at 40°C with 1 ml of cell wall protein extracted cells. The red-pullulan 
substrate was depolymerized by an endo-mechanism to produce dyed fragments which remain in 
solution on addition of 2-5 ml absolute ethanol. High-molecular weight material was removed by 
centrifugation, and the soluble dye measured in a spectrophotometer at 510 nm (SpectraMax M5 
reader). The amount of pullulanase activity in the S. suis protein extract was calculated using a 
standard curve generated with purified pullulanase from Klebsiella planticola (Sigma). One unit of 
activity is the amount of enzyme required to split one micromole of ct-(l,6) linkages per minute 
under the defined assay conditions. 
Cell line and culture conditions 
Newborn pig tracheal cells (NPTr) [38] were maintained in Dulbecco's modified eagle medium 
/Ham's F-12 (1:1), 5 mM glutamine (Gibco) supplemented with 10 % fetal calf serum (Gibco), 
without antibiotics at 37°C and 5 % C02. The cells were seeded into new flasks every 4-5 days by 
detachment with 0-25 % w/v trypsin, 1 mM Na-EDTA (trypsin- EDTA, Gibco-lnvitrogen) and 
replacement of the medium [53]. For the adherence assay, approximately 2-3 x 10 cells per well 
were seeded in antibiotic free complete medium on 12 well tissue culture plates (Costar) and 
incubated until they reached confluence. 
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Adherence assays using NPTr cell line 
For the adhesion assay, bacteria were pelleted by centrifugation, washed with PBS and resuspended 
at 10 c.f.u. ml" in fresh cell culture medium without antibiotics. Bacterial suspensions diluted in cell 
culture medium (between 1-15 x 10s and 2-3 x 107 c.f.u. ml-1) were added to wells containing a 
monolayer (2-3 x 10 ) of epithelial cells in 1 ml of medium (multiplicities of infection (m.o.i.) ranged 
from approximately 5 to 100 bacteria per cell). Plates were incubated for 2 h at 37°C with 5 % C02. 
The cell monolayers were washed three times with PBS, and detached by scrapping in 800 u.1 of ice-
cold milli-Q water. To enumerate the viable bacteria, serial dilutions of the cell lysate were plated in 
triplicate on Columbia sheep blood agar plates and incubated at 37°C for 24 h. The number of 
bacteria recovered in this assay was expressed as a percentage of the original inoculum. 
Binding ofS. suis to porcine mucus 
A modified solid-phase mucin binding assay was performed with purified porcine gastric mucin 
(Sigma) as described previously [54]. Briefly, a 96-well microtiter plate (Nunc Inc., Roskilde, 
Denmark) was inoculated with 7-5 u.g of purified porcine gastric mucin in 250 uJ NaHC03 (pH 8-0) 
and incubated overnight at 37°C (mucin-coated wells). Overnight bacterial cultures were pelleted by 
centrifugation (8 000 x g for 5 min), washed in PBS, and adjusted to an OD of 1-0 at 600 nm. 
Triplicate wells in both plates were inoculated with 2-5 x 108 and 2-5 x 107 bacteria in a volume of 
100 uJ in PBS. The microtiter plates were incubated for 2 h at 37°C and 5 % C02. The wells were 
washed 8 to 10 times with sterile PBS. Bound bacteria were desorbed with 250 u.1 of 0-03 % Triton X-
100 in sterile PBS for 1 h at room temperature and enumerated by plating on blood agar for 12 to 14 
h at 37 °C. This concentration of Triton X-100 was shown not to affect the viability of S. suis under 
these conditions (not shown). 
Statistical analysis 
The adherence assays and the binding mucin experiments were performed at least three times using 
triplicate samples. All numerical data presented here are expressed as means ± standard deviation 
(sd). Statistical significance was determined using a two-tailed Student's t test. Differences were 
considered significant at P < 0-05. 
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Summary 
Streptococcus suis is the major pathogen of young pigs and an emerging zoonotic 
pathogen. In humans and pigs it causes a variety of diseases including meningitis, 
septicemia and endocarditis. During colonization, dietary or host sources of a-glucans are 
likely to be a key source of nutrients for S. suis. A cell wall anchored amylopullulanase 
(ApuA) is necessary for the degradation of a-glucans and contributes to the adhesion of S. 
suis to porcine epithelium. ApuA expression was induced in the presence of pullulan and 
maltotriose and repressed in the presence of glucose. The promoter of apuA contains two 
transcription factor binding motifs. The motif located upstream of the -35 box is bound by 
ApuR, a transcriptional activator we propose to be allosterically regulated by maltotriose. 
Additionally CcpA, global carbon catabolite regulator, specifically binds a catabolite 
responsive element (ere) overlapping the -35 box. Based on these findings we propose a 
model for the regulation of a-glucan utilization in S. suis during colonization and invasive 
disease. Here we demonstrate a link between virulence and carbohydrate metabolism 
whereby the degradation products of complex carbohydrates serve as an environmental 
cue to induce ApuA expression. 
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Introduction 
Streptococcus suis is the major pathogen of young pigs causing a variety of diseases 
including meningitis, septicaemia and endocarditis. Additionally S. suis is a zoonotic agent 
which can be transmitted to humans through contact with contaminated swine products 
or infected animals [1]. Recently S. suis emerged as one of the most common causes of 
adult human meningitis in South East and East Asia [2,3]. Pigs colonized by S. suis harbor 
the organism in the nasal-oropharynx [4] which may lead to asymptomatic carriage, 
invasion or dissemination in the bloodstream and eventually, infections of the central 
nervous system (CNS) or meningitis [2,3,5]. 
In the oropharynx dietary a-glucans are likely to be a key nutrient source for S. suis and 
non-pathogenic commensals [6,7]. Alpha-glucans such as starch and glycogen are 
polysaccharides comprising of repeating glucose monomers linked by alpha-glycosidic 
bonds (a-1,4 and a-1,6 linked) and are present at concentrations sufficient to support 
bacterial growth in the saliva and oropharyngeal cavity of pigs and humans [8,9,10,11]. 
Additionally, animal glycogen stores released from damaged or lysed cells may be an 
important substrate for pathogen growth during the early stages of infection. The 
genomes of commensals inhabiting the digestive tract of mammals frequently encode 
amylases and pullulanases to degrade a-glucans via the cleavage of a-1,4 and a-1,6 
glycosidic bonds respectively. The concerted activity of these enzymes primarily generates 
a-1,4 linked polymers of glucose containing two (maltose), three (maltotriose) or four up 
to nineteen glucose units (maltodextrins). In Streptococcus pyogenes (Group A Strep-GAS), 
maltose and maltotriose are transported by a phosphoenolpyruvate-dependent 
phosphotransferase system (PTS) (M5005_Spy_1692) [12], a homologue of which is also 
present in both Streptococcus pneumoniae (SP_0758) [13] and Streptococcus mutans 
(SMU2047) [14]. Additionally, maltodextrins with degrees of glucose polymerization of 3 
to 7 are taken up via a maltodextrin-specific ATP-binding cassette (ABC) transport system 
that is conserved in other streptococci capable of degrading a-glucans [13,15,16]. In GAS, 
mutants affected in maltose and maltodextrin transport are significantly attenuated in 
their growth in human saliva and their ability to colonize the mouse oropharynx compared 
to wild-type [12,17]. 
Recently, a cell wall anchored amylopullulanase (ApuA) was characterized in 5. suis and 
shown to be necessary to support growth on glycogen or pullulan (a-1,6 linked glucose 
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polymer) as a sole carbon source [18]. Additionally, ApuA was shown to promote adhesion 
of S. suis to porcine tracheal cells suggesting that it has a dual role in virulence and 
colonization [18]. Recently, inactivation of pullulanases (SpuA) and S. pneumoniae (PulA) 
were also shown to significantly reduce virulence in mouse models [17,19]. Several other 
recent studies have highlighted a link between a-glucan degrading enzymes and virulence 
in opportunistic pathogens [20,21,22,23]. In S. pneumoniae for example, several signature-
tagged mutagenesis screens identified genes known to be involved in carbohydrate 
metabolism including several enzymes involved in the breakdown of a-glucans 
[24,25,26,27]. 
To date, the mechanism and regulation of a-glucan catabolism in 5. suis is only partly 
understood although this is important in virulence and oropharyngeal colonization. 
Generally, bacteria do not synthesize degradative (catabolic) enzymes unless the 
substrates for these enzymes are present in their environment and have evolved 
elaborate control mechanisms to select the carbon source that allows the fastest growth 
[28]. Bacteria have also developed diverse mechanisms for the control of biosynthetic 
(anabolic) pathways when the end product of the pathway is not needed or is readily 
obtained by uptake from the environment. Control of biosynthetic pathways in microbes 
is often performed at the level of DNA transcription, by transcriptional regulators that 
activate or repress transcription of metabolic genes. 
Catabolite control protein A (CcpA) is a global transcriptional regulator of carbon 
catabolite control (CCC) in Firmicutes and can repress or activate transcription by binding 
to cis-acting catabolite responsive element (ere) sites. Consensus ere sequences have been 
determined in several species [28]. In the model organism Bacillus subtilis, growth on a 
preferred, easily metabolized sugar leads to high concentrations of fructose-1,6-
bisphosphate (FBP) and ATP and phosphorylation of histidine-containing phosphocarrier 
protein (HPr) at Ser46 by HPr kinase/phosphorylase (HPrK). Phosphorylated HPr(Ser-P) 
then binds to the CcpA protein inducing a conformational change that enhances binding to 
ere sites on the DNA. Under conditions of poor nutritional supply HPrK is also responsible 
for dephosphorylation of HPr(Ser-P). Depending on the position of the ere sites in the 
promoter, binding of the HPr-P/CcpA complex can cause carbon catabolite repression 
(CCR) or carbon catabolite activation (CCA). If the ere is located upstream of the -35 
promoter element it may mediate CCA via interaction with the RNA polymerase. In 
contrast ere elements located downstream of the -35 typically lead to CCR by repression 
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of transcription. Apart from CcpA, several other transcriptional repressors or activators 
play a role in the regulation of carbon catabolism and anabolism in Gram-positive 
bacteria. For example in different streptococci, MaIR, a member of the Lacl/GaIR family of 
transcriptional regulators regulates the maltodextrin transport operon and a pullulanase 
in GAS [12]. We hypothesized that in S. suis ApuA was regulated by an upstream 
transcription factor designated here as ApuR. ApuR shares low sequence homology with 
MaIR but high similarity to the maltodextrin regulators Lmo2128 and MdxR in Listeria 
monocytogenes and ß. subtilis respectively. Herein we report on studies designed to 
unravel the role of ApuR in the regulation of ApuA. Our results provide the first detailed 
insights into the control of ct-glucan utilization in S. suis and further expand our 
understanding of the links between metabolic processes and virulence gene regulation. 
- 8 5 -
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Results 
Description of the apuR gene locus and its homology to known transcriptional regulators 
Microbial genes encoding degradative (catabolic) enzymes for carbohydrates are usually 
regulated depending on the availability of the substrates. We hypothesized that this may 
also be the case for the amylopullulanase apuA (SSU1849) and that an upstream gene 
designated here as apuR (SSU1850) was involved in its regulation. The gene encoding 
ApuR was predicted to possess its own promoter with a rho-independent terminator (AG -
10 kcal/mol) downstream of the stop codon (Fig. 4.4.1A). Homology searches indicated 
that ApuR is a member of the Lacl/GaIR family of regulators containing a conserved two 
domain structure. The ApuR N-terminus contains a DNA binding domain which is capable 
of dimerization and DNA binding through a helix-turn-helix motif. The C-terminus contains 
a conserved ligand-binding domain that can be bound by a specific sugar(s), conferring 
specificity to the regulator by modulating its DNA binding activity. 
Comparison of ApuR with protein sequences in the UniProt database revealed similarities 
to several regulators of opérons comprising clusters of carbohydrate catabolic enzymes. 
Highest homologies were to Lactobacillus casei BL23 YvdE (53% identity), B. subtilis 168 
MdxR (49% identity) (also referred to as YvdE) and L. monocytogenes EGD-e Lmo2128 
(47% identity) which are all transcriptional regulators in the maltodextrin utilization 
cluster of genes [29,30,31,32]. Genes in these clusters encode predicted maltogenic 
amylases or neopullulanases as well as ABC transporters and permeases for maltodextrin 
uptake (Fig. 4.4.1B). MdxR of B. subtilis has been proposed to be the cognate 
transcriptional regulator of the maltodextrin-utilization cluster but so far there is no 
experimental evidence to support this hypothesis [29]. However in L monocytogenes, 
YvdE (Lmo2128) was shown to be a transcriptional activator of the maltodextrin gene 
cluster [32]. 
Within the streptococcal species highest homology of ApuR was found to MaIR (25% 
identity-not shown), the negative transcriptional regulator of genes involved in 
maltodextrin uptake and degradation [12,15,16,33,34]. In S. suis the genes downstream of 
apuR include apuA but not the maltodextrin transport gene cluster which is present at a 
different locus in 5. suis (from SSU1914 to SSU1920). Located downstream of apuA are a 
cluster of genes predicted to be involved in uptake and fermentation of ascorbate; sgaT 
(SSU1848, a predicted phosphotransferase system (PTS) IIC component), sgaB (SSU1847, 
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PTS MB component), ptsN (SSU1846, a PTS MA component), sgbH (SSU1845, hexulose-6-
phosphate synthase), sgaU (SSU1844, putative hexulose-6-phosphate isomerase), ulaD 
(SSU1843, L-ribulose-5-phosphate 4-epimerase) (Fig. 4.1A). The size of the intergenic 
region between apuA and sgaT and presence of a predicted terminator (AG -15 kcal/mol) 
suggested that the genes for ascorbate metabolism were transcribed as a separate 
operon. This gene organization is well conserved in the genomes of 5 sequenced strains of 
5. suis genomes (Fig. 4.1B) although in the Chinese strain 05ZYH33 the apuA gene was 
annotated as two genes that encode an amylase and a pullulanase. Homologues of ApuR 
were not found upstream of amylases or pullulanases in other pathogenic streptococci 
indicating that the genetic organization of the apu locus is unique to 5. suis. 
r Y I *~ sgaT sgaByttsN sgbH sgaU araD\ 
pgmA malKl dexB malEl malFl malG 
L. casei BL23 
B. subtilis 168 
L. monocytogenes EGD-e 
S. suis 05ZYH33 
S. suis 98HAH33 
S. suis BM407 
S. suis SC84 
S. suis p i / 7 
^m transcriptional regulator 
^m a-l,4-glucosidase 
^m maltogenic amylase 
mt maltose Phosphorylase 
en glucomutase 
^ sugar ABC transporter 
^m a -1,6-glucosidase 
I maltose/maltodextrin-bindïng lipoprotein 
I permease component 
I permease component 
I permease component 
t Amylopullulanase (a-1,6- 1,4- glucosidase) 
I sugar permease SgaT/UlaA family 
I PTS I IA component 
Fig. 4.1. Organization and homology of apuA locus in S. suis. A. The 6 kb amylopullulanase gene apuA is located downstream of 
apuR which encodes a putative transcriptional regulator of the Lacl/GaIR family. Downstream of apuA are cluster of genes 
predicted to be involved in uptake and fermentation of ascorbate [sgaT, sgaB, ptsN, sgbH, sgbH and ulaD). For each gene, the 
direction of transcription is indicated by an arrow, whose size is proportional to the length of the corresponding open reading 
frame. Putative promoters are represented by arrows and transcription terminators by loops. B. Gene homologues in other Gram 
positive bacteria that share > 45% of protein identity with apuR gene (black arrows). The annotations of the genes downstream 
of apuR are also indicated and colored to show functional relatedness. Gene names are indicated above the arrows. 
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Transcriptional regulation of the apuA gene cluster is induced by pullulan and 
maltotriose 
To investigate the substrate dependent regulation of the apuA gene cluster including 
apuR, its putative transcriptional regulator (Fig. 4.1A), we performed qPCR analysis of 
gene transcripts during growth in different sources of carbohydrate (see below). Addition 
of 1% (w/v) of glucose, lactose, maltotriose or pullulan resulted in high density growth of 
5. suis S10 compared to complex medium alone, demonstrating that these four sugars can 
be metabolized (Fig. 4.2). 
naltotriose • glucose • lactose A pullulan 
Fig. 4.2 S. suis S10 growth curve at 37°C in different media. OD«» readings were taken at indicated times to measure growth in 
complex media (CM) supplemented with 1% (w/vj of maltotriose, glucose, pullulan and lactose. The graph shows the means and 
standard deviations from two independent experiments. 
Compared to growth in glucose or lactose, apuA transcription was strongly induced (up to 
4 fold) by growth in pullulan and maltotriose (Fig. 4.3A). Highest induction of apuA was 
seen after 4 hours in the presence of pullulan while this was at 2.5 hours in maltotriose 
(Fig. 4.3A). This most likely reflects the fact that after 4 hours growth in pullulan the 
bacteria were still in late exponential phase whereas the bacteria had already reached 
stationary phase in the presence of maltotriose (Fig. 4.2). Relative expression levels of 
sgaT and ptsN were significantly induced by growth in pullulan compared to the other 
three sugars (Fig. 4.3B and C). However, fold changes were low (0.1 to 0.06 fold) 
compared to apuA, suggesting these genes were independently regulated (Fig. 4.1). 
Additionally we measured the relative transcript level of apuR to determine if 
transcription was constitutive or induced by different carbohydrate sources. Expression of 
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apuR was significantly induced after 2.5 hrs growth in maltotriose, and after 4 hrs growth 
both in maltotriose and pullulan compared to growth in glucose (Fig. 4.3D). A similar low 
induction was observed for the homologous transcriptional regulator (lmo2128) of the 
maltodextrin gene cluster in L monocytogenes [32]. 
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Fig. 4.3. Relative expression of apu locus in CM containing different sugars. Transcript levels of A. apuA, B. sgaT, C ptsN and D. 
apuR were measured after 2.5 hours and 4 hours of growth in CM containing 1% glucose, lactose, maltotriose or pullulan, relative 
to the reference gene proS which is constitutively expressed at similar levels during growth in different sugars (data not shown). 
The height of the bars represent mean values for the relative expression data ± SEM from two independent experiments (n = 3). 
Statistical significance was calculated using a two-way ANOVA test followed by Bonferroni's post hoc test (*, P < 0.05; *• , P < 
0 . 0 1 ; * * * , P< 0.001). 
Taken together these results show that apuA transcription is induced by maltotriose and 
pullullan. Maltotriose is an end product of the enzymatic degradation of pullulan, starch or 
glycogen by a-glucan degrading enzymes such as pullulanases or amylopullulanases like 
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ApuA [18]. Owing to its proximity to apuA and homology with other regulators of 
amylases/pullulanases and maltodextrin utilization genes in Listeria and Bacillus, we 
hypothesized that ApuR was a regulator of apuA and that its activity was modulated by 
maltotriose and potentially other transported maltodextrins. To investigate the regulation 
of apuA we determined the transcription start site, performed homology searches for 
binding motifs of known regulators, and carried out promoter binding assays with purified 
transcription factors (TFs). 
Transcription start site and bioinformatics analysis of the apuA promoter 
During growth in pullulan the transcriptional start site of the apuA transcript was 
determined experimentally by 5'-RACE to be 31 nt (T nt of 5'-TAC-3' codon) upstream of 
the start codon ATG (described in Materials and Methods) (Fig. 4.4A). 
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Fig. 4.4. Identification of conserved operator binding motifs for ApuR (OM1) and CcpA (OM2) in S. suis Pl /7, B. subtilis 168 and 
L monocytogenes EDG-e. The promoter regions and the relative p-values were determined using the MEME Suite software, 
which calculates the probability of match score with the given sequence. A. The -10 and -35 regions (indicated) were deduced 
based on the transcription start site (Ts arrow) that was determined experimentally by 5'-RACE. B. The OM1 and OM2 putative 
binding sites (black boxes) were identified in the B. subtilis promoter of the mdxE gene (BSU34610) that encodes a maitodextrin-
binding periplasmic protein and in C. the promoter of the L monocytogenes lmo2125 gene that encodes a maltose/maltodextrin 
ABC-transporter. D. and E. Sequence alignment of the DNA binding domains of the ApuR and CcpA proteins of 5. suis, L 
monocytogenes and S. subtilis. Conserved amino acid sequences are indicated in black. 
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The consensus -35 element (5'-TTGCAA-3') and -10 element (5'-TATATA-3') required for 
interaction with the RNA polymerase and transcription initiation were found at the 
expected positions upstream of the transcription start site. 
The -10 element differs at one nucleotide from the consensus for prokaryotic promoters; 
the -35 element is similar to the consensus sequence for RpoD, the main a factor in 
prokaryotes (Fig. 4.4A). 
Visual inspection of the DNA region bound by ApuR for consensus binding motifs of B. 
subtilis mdxR or the Lacl/GaIR family of regulators revealed two potential operator motifs 
(OMs) (RegPrecise database) [35]. Using the MEME informatics tool [36], these same two 
OMs were identified in alignments of the apuA promoter sequence with sequences of 
promoter regions of mdxR and lmo2128 (i.e. PmdxC and Pim02i25 respectively) (Fig. 4.4B and 
C). The first sequence, similar to operator motifs for TFs belonging to the Lacl/GaIR family 
and designated here as OM1 was found at position -50 nt upstream of the apuA start 
codon. OM1 has homology to the predicted binding sites of mdxR and the transcription 
activator lmo2128 and is located 13 bp upstream of the -35 element. The amino acid 
sequences of the helix-turn-helix domains of MdxR and Lmo2128 that are predicted to 
interact with OM1 are highly conserved and are also present in ApuR (Fig. 4.4D), 
suggesting that ApuR might also be a transcriptional activator. 
A second operator motif (designated OM2) was found at position -27 nt overlapping the 
-35 region that is identical to the catabolite responsive element (ere) consensus sequence 
determined in Bacillus species (WTGNAANCGNWNNCWW where W = A or T and N = any 
base). The ere motif is used as a binding site by CcpA [37,38,39]. The amino acid sequence 
of the region of CcpA that was predicted to interact with ere was highly conserved in S. 
suis, Listeria and Bacillus (Fig. 4.4E). The location of OM1 and OM2/cre suggested that 
apuA is subject to dual regulation: i) by a transcriptional activator, ApuR and ii) via carbon 
catabolite repression by CcpA. 
Binding of recombinant ApuR and CcpA to the apuA promoter 
Recombinant ApuR (rApuR) and CcpA (rCcpA) were expressed in E. coli with C terminal-
His-tag using the IPTG inducible trc promoter at 18°C to optimize solubility. Both proteins 
were purified by HPLC affinity chromatography using extensive washing of the column 
bound protein with a buffer containing low concentrations of imidazole to remove weakly 
binding proteins. His-tagged rApuR and rCcpA were eluted using an imidazole gradient and 
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fractions containing the highest purity were obtained using an imidazole concentration of 
around 100 mM (Fig. 4.5A and C). Western blotting with a monoclonal antibody to the His-
tag confirmed that soluble eluted rApuR was of the predicted molecular weight and not 
degraded by proteolysis (Fig. 4.5B). 
To investigate whether rApuR did bind to the promoter of apuA, three overlapping 
fragments of the PapuA promoter region (Pr 1-3; approx. 120 bp in length) were amplified 
using fluorescent dye labeled primers (IRDye 800 nm) and tested in an electrophoresis 
mobility shift assay (EMSA). A single rApuR-DNA complex was observed with promoter 
fragments Pr2 and Pr3 suggesting the binding motif for ApuR lies within the 64 bp 
overlapping region (Fig. 4.6A and B). 
A B C 
^ ^ ^ ^ 40 kDa ^g, 
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Fig. 4.5. SDS Polyacrylamide electrophoresis of purified transcriptional regulators A. A Coomassie stained SDS-PAGE gel (12%), 
showing purified fraction His-ApuR at the expected size of 38 kDa. B. Western Blotting of the gel from A. with a monoclonal His-
tag antibody to the recombinant His-ApuR protein. C. A Coomassie stained SDS-PAGE gel (12%) of purified His-CcpA at expected 
size of 40 kDa. 
The binding of ApuR to Pr2 was shown to be concentration dependent in the range from 
0.5 to 4.0 u.M of rApuR (see Fig. 4.6C). The specificity of rApuR binding to Pr2 was shown 
by the use of non-fluorescent competitor DNA fragments (the fragment Pr2 and a non-
specific DNA fragment not containing the two predicted OM1/OM2 operator binding 
motifs) in a competition EMSA. 
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Fig. 4.6. Binding of recombinant ApuR protein to PapM promoter region A. Schematic representation of the apuA promoter 
(PopU/i) and fluorescently labeled PCR amplified DNA fragments (Pr l , Pr2 and Pr3) used for EMSA. B. to F. Native 5% TBE 
electrophoresis gels of DNA amplicons and DNA/rApuR protein complexes visualized using the Odyssey Imager. In these EMSA 
assays the concentration of each DNA amplicon was around 4-6 ng B. EMSA of 6 uM rApuR binding to Pr l , Pr2 and Pr3. C. 
Increasing DNA/rApuR complex formation in presence of 4 ng Pr2 DNA amplicon and an increasing amount of rApuR (~ 0,5 - 4 p.M 
as indicated) D. Competitive EMSA using increasing concentrations of non-fluorescent non-specific competitor DNA (lacking OM1 
binding motifs). E. Competitive EMSA using increasing concentrations of non-fluorescent Pr2 as a specific competitor. The 
amounts of competitor DNA added are indicated (2 - 14 ng). F. Identification of specific ApuR binding sites in PapM- PR2: native 
promoter region fragment 2. AOM1 and AOM2/cre are synthetic DNA fragments of P„puA that lack the predicted binding sites. + 
rApuR recombinant present - rApuR recombinant absent. 
The non-specific competitor DNA fragment had no effect on Pr2 complex formation 
whereas non-fluorescent Pr2 substantially reduced rApuR binding (Fig. 4.6D and E). To 
investigate whether ApuR binds to OM1 or OM2/cre, promoter fragments lacking these 
motifs were synthesized and tested in the EMSA (AOM1 and AOM2/cre, Table 2). In 
several independent experiments we observed a lower amount of the rApuR-DNA 
complex with fragments lacking AOM2/cre suggesting that ApuR binds strongly to this 
motif. In some experiments complex formation was slightly reduced when AOM1 was 
deleted, possibly due to low affinity binding of ApuA to AOM2/tre at higher 
concentrations (Fig. 4.6F). 
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We hypothesized that CcpA could directly repress apuA expression through binding to the 
PapuA OM2/cre that overlaps with the predicted -35 promoter element. Recombinant 
rCcpA was tested for DNA binding in an EMSA using a fluorescent IRdye-Pr2 fragment 
containing the putative ere element (Fig. 4.7). rCcpA binding was enhanced upon addition 
to the binding reaction mixture of glucose-6-phosphate, a putative cofactor for CcpA 
[40,41,42]. An increasing amount of a rCcpA-DNA complex was observed with an 
increasing concentration of purified rCcpA (1.5 to 5 \iM) (Fig. 4.7A). The complex could be 
outcompeted by addition of unlabeled Pr2 but not with non-specific competitor DNA 
fragment lacking the ere, indicating that CcpA binds specifically to PapUA (Fig- 4.7B and 7C). 
Interestingly, the complex DNA/rCcpA appears to possess residual binding to AOM2/cre 
suggesting that CcpA may also bind OM1 or other sequences in Pr2 (Fig. 4.7D). 
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Fig. 4.7. Binding of CcpA recombinant protein to the apuA promoter. Native 5% TBE electrophoresis gels of DNA and DNA/rCcpA 
protein complexes visualized using the Odyssey Imager. In the EMSA assays the concentration of each Pr2 DNA amplicon was 
around 4-6 ng A. DNA/rCcpA complex formation in presence of in presence of 4 ng Pr2 DNA amplicon and an increasing amount 
of rCcpA (~ 1.5 - 5 uM as indicated). B. Competitive EMSA using increasing concentrations of non-fluorescent Pr2 as a specific 
competitor. C Competitive EMSA using increasing concentrations of non-fluorescent, non-specific competitor DNA lacking 0 M 1 
and OM2 binding motifs. D. Identification of specific binding sites for CcpA in POPM- AOM1 and AOM2 are synthetic DNA 
fragments of PapuA that lack the predicted binding sites. + rCcpA recombinant present - rCcpA recombinant absent. 
ApuA is co-regulated by carbon catabolite repression 
Given that OM2/cre specifically binds CcpA we hypothesized that apuA was co-regulated 
by carbon catabolite repression. To verify this finding we performed qPCR assays on apuR, 
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apuA, sgaT and ptsN. We first obtained growth curves where putative inducers were 
added to 5. suis growing in exponential phase (Fig. 4.8A and B). 
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Fig. 4.8. Growth curves of 5. suis S10 in CM containing lactose or glucose before and after addition of putative inducers. 5. suis 
bacteria were grown in CM plus 1% lactose (A) or 1% glucose (B) to which pullulan or one of three putative inducers (maltotriose, 
pullulan or glucose) were added (0.25% w/v) during exponential growth (arrow). The graphs show the means and standard 
deviations from two independent experiments. 
The growth curves for S. suis were very similar in lactose and glucose and were not 
influenced by addition of 0.25% (w/v) inducer. In medium containing lactose, both 
maltotriose and pullulan strongly induced expression of apuA (4.5 fold and 2.2 fold 
respectively; Fig. 4.9A and B). Transcription of sgaT and ptsN which lie downstream of 
apuA were not significantly modulated by addition of maltodextrin or pullulan. 
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30 60 
minutes 
apuR apuA sgaT ptsN 
Fig. 4.9. Relative expression of apu locus genes following addition of putative inducers. 5. suis was grown in CM with 1% of 
lactose and in the exponential phase, 0.25% (w/v) putative inducers of apuA expression were added as follows: A. Maltotriose, B. 
Pullulan and C. Glucose. Similarly D., E. and F. represent expression data of S. suis in CM containing 1% w/v glucose after addition 
of the putative inducers D. Maltotriose, E. Pullulan and F. glucose. At time zero (immediately prior to addition of the putative 
inducers) and after 10, 30, 60 and 90 minutes, the relative expression of opuR, apuA, sgaT and ptsN were measured by qPCR. The 
height of the bars shows the mean (n = 3) fold change in expression ± SEM from two independent experiments. Statistical 
significance was calculated using a two-way ANOVA test followed by Bonferroni's post hoc test (*, P<0.05; **, P< 0.01; •**, P < 
0.001). 
In medium containing glucose the addition of maltotriose (Fig. 4.9D) or pullulan (Fig. 4.9E) 
had no significant effect on the expression of apuA, apuR, sgaT, and ptsN; only a slight 
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increase (1.6 fold) of apuA expression was observed 30 min after addition of maltotriose 
(Fig. 4.9D). 
Furthermore, when bacteria exponentially growing in complex medium containing glucose 
or lactose were supplemented with additional glucose, the relative transcript levels of all 
the genes were lowered (Fig. 4.9C and F). 
Taken together these results suggest that apuA expression is repressed by growth in 
glucose. These results, together with the results shown in Fig. 4.3B and C, suggests that 
sgaTand ptsN are not co-transcribed with apuA. Supporting this is the finding that the 328 
nt intergenic region upstream of sgaTand ptsN does not contain the operator motifs OM1 
or OM2/cre. 
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binding motif for ApuR is also found in the predicted promoter for malQ but further work 
is needed to confirm the precise regulatory mechanisms for these opérons. 
On mucosal surfaces a-glucans may not always be abundant but other sugars apart from 
glucose could support growth. Under these conditions ApuA is presumably expressed at 
low levels but in sufficient amounts to initiate enzymatic degradation of a-glucans, 
thereby generating inducers of ApuR binding and activation. After invasion of the mucosal 
tissues and dissemination of S. suis via the bloodstream, our model predicts that 
expression of apuR (and potentially the mal Operon) would be repressed by blood glucose 
and the lack of maltotriose as an inducer (Fig. 4.10B). 
These complex intertwined mechanisms of regulation would allow fine tuning of ApuA 
production (energy-demanding because of its large size of 2094 amino acids, ca. 230 kDa), 
according to the availability of carbohydrates and sugars in order to optimize proliferation 
in the host. 
Here we demonstrate a link between virulence (adhesion to host epithelial cells) and 
carbohydrate metabolism whereby the degradation products of complex carbohydrates 
serve as environmental cues to regulate expression of proteins like ApuA which play a role 
in both virulence and carbohydrate catabolism. This concept is an emerging theme in the 
biology of opportunistic pathogens such as S. pyogenes and 5. pneumoniae [43]. The 
ability of a pathogen to efficiently utilize different carbohydrates and sugars during 
infection and to adapt rapidly to its environment is crucial to infectivity. In the future, it 
may be possible to devise strategies to combat pathogens by interfering with these 
regulatory mechanisms or pathways. 
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Fig. 4.10. Hypothetical model of a-glucan catabolism regulation in 5. suis. The proteins/genes indicated in this model are the 
most likely candidates for the predicted functions based on their homology and genome organization in related organisms. The 
extracellular surface anchored ApuA (5SU1849) is able to degrade a-glucans. MalX (SSU1914) is a maltodextrin binding protein 
anchored in the cell wall that is specialized in the binding and uptake of maltodextrins. MalP (SSU0357) is part of a PTS system 
specific for uptake of maltotriose and/or maltose. The presence of OMl and OM2/cre are indicated in the promoters of PcpM and 
the predicted promoters of PapM Pmcia and PmjK (Table 1). A. Regulation in the presence of relatively high amounts of a-glucans 
and low amounts of glucose. In the absence of CCR, the apuA gene will be expressed and the ApuA protein will degrade glucans 
leading to the generation of maltodextrin and maltose or maltotriose. The transport systems, maltose- and maltotriose-specific 
PTS (MalP) and the ABC permease system (MalX), are than expressed and import maltose and maltodextrins. The intracellular 
maltotriose is proposed to interact with ApuR to promote binding and transcriptional activation of P„p„a (continuous green line) 
and potentially P„oK (broken green line). 
B. Regulation in the presence of relatively low amounts of a-glucans and high amounts of glucose. The Hpr protein is activated by 
the phosphotransfer system for glucose. In its phosphorylated form, Hpr(Ser-P) acts as a cofactor for CcpA to increase the affinity 
of binding to ere operator motifs in P„M (continuous red line). CcpA is also predicted to bind to ere sites in P„p„« and the PM<,/ 
operon (broken red line). Binding of CcpA is predicted to repress transcription of expression of the apuR, apuA and mol opérons. 
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Materials and Methods 
Bacterial strains, plasmids and culture conditions 
In this study, the virulent S. suis strain S10 (virulent serotype 2 strain) [59] has been used. The 
genome of S. suis S10 is more than 99% identical to the genome of S. suis Pip, a sequenced 
reference strain of which the genome had been annotated previously (Chapter 1). S. suis was grown 
in Todd-Hewitt broth (THB) (Difco) or on Columbia agar plates with 6% sheep blood (Oxoid) at 37°C 
under 5% C02 for 18 hr. A complex medium (CM) comprising of 10 g I -1 proteose peptone, 5 g f 1 
trypticase peptone, 5 g I"1 yeast extract, 2.5 g f 1 KCl, 1 mM Urea, and 1 mM Arginine, pH 7.0 was 
used to assess growth on different carbon sources by supplementation with different carbohydrates 
at final concentrations of 1% (w/v) as previously described [44]. The carbohydrates were added 
separately and sterilized by autoclaving at 100°C for 10 min (pullulan) or filtration with 0.45 u.M pore 
size filter (glucose, lactose and maltotriose). We previously demonstrated that S. suis only grows to 
high density in CM when exogenous carbohydrates are added [18]. Growth in complex medium was 
determined by measurement of turbidity at OD60o using a SpectraMax M5 reader. 
Expression and purification of recombinant ApuR and CcpA 
To purify the recombinant His-ApuR and His-CcpA proteins we used a similar protocol as described 
below with some small modifications according the proteins. Briefly, the entire genomic regions 
encoding the mature regulators ApuR (amino acids 2 to 312) and CcpA (amino acids 2 to 333) were 
amplified by PCR from S. suis S10 genomic DNA using GoTaq (Promega) with primers ApuR_F/R and 
CcpA_F/R (Table 2). 
The purified PCR products were ligated to the pTrcHis TOP02 TA expression vector (Invitrogen) such 
that the expressed recombinant regulators would be fused in-frame to a C-terminal polypeptide 
containing six histidine residues for affinity purification. After transformation of E. coli TOPO 10, 
clones containing the recombinant apuR and ccpA were selected on LB agar containing 50 u.g mf 1 of 
ampicillin; several colonies were checked for the correct insertion of the apuR and ccpA gene 
fragments and verified by DNA sequencing. Expression of both regulators was induced by addition of 
1 mM isopropyl-ß-D-1-tiogalattopiranoside (IPTG, Invitrogen) to an exponentially growing culture 
(OD600 of 0.6) for 4 hrs at 18°C for ApuR and overnight at 18°C for CcpA under shaking (250 rpm). 
The cells were harvested by centrifugation (8 000 g x 10 min at 4°C) and the pellet was resuspended 
in lysis buffer (50 mM Tris-CI; 0.5 M NaCI, pH 7.4) containing a cocktail of protease inhibitors 
(Roche), and then disrupted using a high pressure cell disrupter (Constant Systems, U.K.). The 
soluble protein extract was recovered after high speed centrifugation (20 000 x g 40 min at 4°C) and 
loaded onto a HisTrap affinity chromatography column (Amersham Pharmacia Biotech, Freiburg, 
Germany). Proteins were eluted in a phosphate buffer containing 500 mM NaCI and increasing 
concentrations of imidazole (0-500 mM) and checked by SDS-PAGE gel electrophoresis. Fractions 
containing purified fusion proteins of the expected size (approx. 38 kDa for ApuR and 40 kDa for 
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CcpA) were collected and dialyzed against buffer (500 mM NaCI, 50 mM Tris-HCI pH 7.4) and stored 
at -80°C with 10% of glycerol. Protein concentrations were measured using a BCA Protein Assay 
(Thermo Scientific), according to the supplier's instructions. 
TABLE 2. Ol igonucleot ide pr imers used in th is study 
Primer Sequence3 ( 5 ' to 3') Purpose 
ApuR_F 
ApuR_R 
CcpA_F 
CcpAR 
PrlF 
PrlR 
Pr2F 
Pr2R 
Pr3F 
Pr3R 
A-CompF 
A-CompR 
AOM1 
AOM2/cre 
ASP1 
ASP2 
AAP 
proSl 
proS2 
apuRl 
apuR2 
apuAl 
apuA2 
sgaTl 
sgaT2 
ptsNl 
ptsN2 
ACGACATTAGCCGATGTGG 
CTGAGGTGTAGTCTCCCTTTCAA 
TTAAACACTGACGATACGGTAACG 
CTTAGTTGATTTACGTACTTTGATTCC 
AGGGAGACTACACCTCAGTA 
TTAACGGTAACAAGTTTTGA 
AAAGAAGGGGGAGCTATTTAT 
CTACCAGTATATACAATTCCAAGG 
CTTGTTACCGTTAACATTTAA 
TATTCTGAACGGATTTCTT 
GTTTATCAAGGTGACTTCAGA 
GTACCAATTCATCAAAGGA 
AAAGAAGGGGGAGCTATTTATTCTATTTTTGTTAGATAGTAGCTCAAAACT 
TGTTACCGTTAACATTTAAACTCCTTGGAATTGTATATACTGGTAG 
AAAGAAGGGGGAGCTATTTATTCTATTTTTGTTAGATAGTAGCTCAAAA 
TAAGAAAACGTTTGCAAAGACTCCTTGGAATTGTATATACTGGTAG 
CTCCCCAAGTCCAAA 
CTGTTACCGCTGTCGCTTCA 
GGCCACGCGTCGACTAGTACGGGIIGGGMGGGIIG 
TTACGTGCGGGCTATGT 
GCTGTAGCCGTCTTTCATG 
CTGAGGTGTAGTCTCCCTTTC 
GGGAGAGAAGAAGGCTACAA 
CACCACTTGTCGCTTGTC 
ACCTTTGACTGCAACAGTG 
GGGTTTATCAAAGCGACAG 
ACTGCCCAGTAGATACCACAG 
GCAGGAGGCTGTTCACA 
CTAGGTAAGGACTGTTTTTGG 
To produce rApuR 
To produce rCcpA 
EMSA fragment Prl 
EMSA fragment Pr2 
EMSA fragment Pr3 
Aspecific competitor 
Synthetic fragment 1 
with OM1 deletion 
Synthetic fragment 2 
with OM2 deletion 
5'-RACE cDNA 
5'-RACE nested PCR 
5'-RACE nested PCR 
qPCR proS reference gene 
qPCR apuR target gene 
qPCR apuA target gene 
qPCR sgoTtarget gene 
qPCRprs/V target gene 
5'-Rapid Amplification ofcDNA Ends (5'-RACEj 
The 5'-rapid amplification of cDNA ends (RACE) system (Invitrogen) was used to determine the 
transcription start site of the apuA gene. Briefly, the first strand cDNA was reversed transcribed 
from RNA from 1 u.g of total RNA 5. suis grown in CM plus pullulan using the specific primer ASP1 
(Table 2). The obtained cDNA was treated with RNase Mix and purified with a S.N.A.P. Column 
(Invitrogen). A homopolymeric tail was then added to the 3'-end of the cDNA using terminal 
deoxynucleotidyl transferase (TdT) and the deoxynucleotide dCTP. The tailed cDNA was amplified in 
nested-PCR with Abridged Anchor Primer (AAP) and a second apuA specific primer ASP2 primers 
upstream ASP1. The resulting 5'-RACE product of ~ 380 bp was sequenced and analyzed by Vector 
NTI software (Invitrogen). 
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DNA Binding Reactions and Electrophoretic Mobility Shift Assay 
Gel-shift assays were performed utilizing three pairs of fluorescent IRdye 800 labelled primer on the 
5' ends (Biolegio, the Netherlands). Primers used to PCR-amplify three DNA fragments (Prl-Pr3, 
~120 bp) containing overlapping regions to cover the full length of PapuA promoter from S. suis 
genomic DNA are listed in Table 2. The fluorescents PCR fragments were purified with QIAquick PCR 
Purification Kit (Qiagen) and used for the binding reaction at a concentration of around 4-6 ng. DNA 
binding reactions were performed in 20 u.1 of binding buffer containing 10 mM Tris-HCI pH 8.5, 
50mM NaCI, 10 mM EDTA, 0.5% Tween-20, 10 mM DTT, and 1 mg of poly(dl-dC); labelled PCR 
fragments at room temperature for 30 min. For the specific and aspecific competition assays, D(+)-
glucose 6-phosphate (30 mM) (Sigma) was added to the binding buffer in the EMSA as CcpA cofactor 
[60]. Purified ApuR and CcpA proteins (200-800 ng) were incubated, in separate experiments, with 
the fragment Pr2 and a non-specific competitor fragment that was obtained by PCR amplification of 
the gene (SSU0879) (4-14 ng). Two 95 bp oligonucleotides complementary to Pr2 fragment without 
the two predicted binding sites (AOM1 and AOM2/cre) were synthesized (Eurogentec, the 
Netherlands), PCR- amplified with labelled Pr2F/R primers and incubated with the proteins. Free and 
bound DNAs were separated on 5% Tris-Borate-EDTA (TBE) native gels for 30 min at 10 cm/v. The 
gels were visualized using a U-COR Odyssey Imager and scanned at 800 nm wavelengths. 
Bioinformatic tools 
In silico searches and comparisons of genomic regions containing apuR and homologous genes were 
conducted using the MicrobesOnline web server (http://microbesonline.org). 
The reference set of predicted régulons was present within the Streptococcus régulons collection, 
provided by the RegPrecise database (http://regprecise.lbl.gov) [35]. 
The MEME (http://meme.sdsc.edu/meme/meme.html) software suite (version 4.1.0) was used for 
the identification of motifs OM1 and OM2. MEME can be used to identify likely motifs within a given 
input set of aligned sequences [61]. It produces a consensus sequence and a position specific 
probability matrix, which has probabilities associated with each base at each position. A range of 
motif widths (15 nt in length) and zero or one motif per sequence were specified in our queries. 
We then applied the FIMO (Find Individual Motif Occurrences) module (part of the MEME suite), 
using the motif weight matrix from the MEME program, to search for the occurrence of operator 
motifs (OMs) in all S. suis opérons. Motif hits with a position-specific goodness-of-fit P value of less 
than 10"4 [62] were considered to identify putative ApuR-CcpA binding sites across the S. suis 
genome. 
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Growth of S. suis in CM media supplemented with different sugars and RNA extraction 
All growth experiments were performed at least in duplicate. S. suis S10 bacteria grown overnight in 
THB were harvested, washed in 0.1 M phosphate buffer and added to complex media supplemented 
with 1% of sugars to achieve a uniform starting OD6M of 0.05. 
To determine the activity of putative inducers, the growth curves for S. suis were carried out in CM 
plus 1% of glucose and CM plus 1% of lactose. During the exponential growth phase (~ OD600 0.24), a 
putative inducer 0.25% (w/v) was added to the media. Spectrophotometric density readings were 
then taken after 30 min until completion of the experiment. 
For analysis of gene expression under diverse growth conditions, S. suis S10 was grown to 
exponential-early stationary phase in the indicated media. Ten ml of culture was collected and 
centrifuged for each analyzed point. The pellet was immediately frozen in nitrogen and stored at 4°C 
overnight with 1.5 ml RNA/oter (Ambion). To isolate total RNA, 1.5 ml RLT lysis buffer (Qiagen) was 
added to the RNA/oter to dissolve the pellet and after incubation at 15 min at room temperature, 
centrifuged at high speed (13 000 g for 30 min). The cells were dissolved in 600 |il RA1 buffer 
(Macherey-Nagel) plus 6 u.1 ß-mercaptoethanol and destroyed using a FastPrep-24 (MP. Biomedicals, 
Solon, OH) for 20 sec at 6.0 m/sec. Total RNA was purified using NucleoSpin RNA II columns 
(Macherey-Nagel). Residual DNA was removed on a column with RNase-free DNasel (Ambion). The 
quality and the concentration of RNA samples were assessed with the Experion system (Bio-Rad) 
and by analysis of the A260/A280 ratio (Nanodrop). The absence of DNA from RNA samples was 
verified by PCR prior to reverse transcription, using prolyl-tRNA synthetase housekeeping gene 
(proS-SSU1753)-specific primers. 
cDNA synthesis and quantitative reverse transcription-PCR 
cDNA was synthesized from 1 u.g of total purified bacterial RNA and random oligonucleotide 
hexamers using SuperScript® VILO (Invitrogen) according to the manufacturer's recommendations. 
Primers were designed using Oligo Program version 6 (MedProbe, Oslo, Norway) to have melting 
temperatures above 83°C and an amplicon size of approximately 400 bp (Table 2). Quantitative PCR 
was performed with LightCycler 4.0 V and using LightCycler FastStart DNA Master SYBR Green I Kit 
(Roche). The identities of the resulting amplicons were checked by melting curve analysis using the 
LightCycler 4.1 software and 1.5% agarose gel electrophoresis. Reaction mixtures containing no 
template were included in each real-time PCR experiment to control for contamination. Constitutive 
gene expression in complex media was determined as a ratio of target gene vs reference gene proS 
and was calculated according to the following equation: ratio = (freference)Q referenc7(ftarget)a tarBe' 
where E is the amplification efficiency and Ct is the number of PCR cycles needed for the signal to 
exceed a predetermined threshold value. Expression following the addition of the possible inducer 
was determined relative to the expression at the non-induced time point according to the following 
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 [ ö ] > T h e ^ Q f ^ 
expression was constant at all the time points analysed (data not shown). Two replicates of all 
samples and primer pairs were included and the experiment was performed in triplicate. Non-
template controls were included for each gene in each run. Primers for targets and the internal 
control gene proS are listed in Table 2. 
Statistical analysis 
All qPCR experiments were reproduced at least two times in triplicates and, where indicated, 
representative experiments are shown. Two-way ANOVA tests were carried out using Bonferroni's 
post hoc test. Statistical analyses were performed using GraphPad Prism 5 software (La Jolla, CA, 
USA). Statistical significance was indicated as follows: * p < 0.05; ** p < 0.01; * * * p < 0.001. 
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Summary 
Streptococcus suis is a major pig pathogen as well as an emerging zoonotic pathogen. 
Previous work has demonstrated that the 5. suis extracellular amylopullulanase enzyme 
that degrades complex carbohydrates was also an important adhesin that increased 
bacterial binding to porcine epithelial cells. This finding suggested a link between 
carbohydrate metabolism and virulence. To explore this link, S. suis whole-genome gene 
expression microarrays were used to measure 5. suis transcriptome alterations when 
bacteria were grown in minimal media supplemented with glucose or pullulan as carbon 
sources. We found that the relative expression of seventeen virulence genes was 
increased during growth in presence of pullulan, compared to growth in glucose. To test 
the hypothesis that 5. suis grown in pullulan is more virulent, adhesion and invasion 
experiments were performed using porcine epithelial cells and bacteria grown in the two 
different media. We show that growth of S. suis using complex carbohydrates as carbon 
source significantly improves bacterial adhesion to host epithelia and significantly 
increased bacterial invasion of epithelia. 
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Introduction 
Streptococcus suis is a major swine pathogen and an emerging zoonotic pathogen of 
humans [1,2]. Young pigs typically acquire 5. suis by vertical or horizontal transmission, 
resulting in colonization of the tonsils and the nasal cavity (oropharynx). Some carrier 
piglets may develop invasive disease leading to bacteremia, meningitis, septicemia and 
arthritis, whereas other piglets also carrying S. suis may never develop disease [3,4]. 
Humans are thought to become infected via skin lesions or via the oral route upon contact 
with, or consumption of, contaminated pork [2,5]. 
There are only few studies on the interactions between S. suis and mucosal epithelial cells 
but according to these, the ability of S. suis to invade epithelial cells or pass the epithelial 
barrier remains somewhat controversial [6,7,8,9]. Some studies reported that only 
unencapsulated strains can invade epithelial cells [8] and it has been hypothesized that 
capsule production might be suppressed in response to environmental signals to promote 
adhesion and invasion, but this remains to be proven in vivo [7,8]. 
Passage of the epithelial barrier depends on several bacterial molecules, bacterial effector 
molecules or virulence factors, that interfere with host defense responses and promote 
disease. Suilysin (Sly) produced by some but not all S. suis isolates is an extracellular thiol-
activated haemolysin which belongs to the cholesterol-binding toxin family. Suilysin forms 
pores in host cells upon oligomerization [10] and has been shown to be cytotoxic for 
epithelial [7,11], endothelial [12,13,14] and immune cells in vitro [15,16]. Production of 
suilysin has been proposed to play a role in epithelial damage and translocation, enabling 
S. suis to invade the mucosal tissues and thereafter disseminate via the blood [11]. Suilysin 
may not be essential for host invasion since strains that do not produce suilysin have also 
been associated with invasive disease [14]. 
Host colonisation also depends on the efficiency by which bacteria can utilize host tissues 
as nutrient source. Starch ct-glucans (large polymers of glucose) are used as an energy 
storage by plants and are present in large amounts in the staple diet of food production 
animals [17]. Consequently starch cc-glucans are found in high concentrations in the saliva 
and oropharyngeal cavity of domestic animals including pigs [18,19,20,21]. Presence of 
high amounts of complex carbohydrates is of relevance to microbial ecology since the 
utilization of different carbohydrates by bacterial pathogens is known to influence their 
metabolism and as a consequence, pathogen virulence [22,23,24,25]. 
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Glucose, a common component of most diets, may also be present in the oral cavity but 
concentrations diminish rapidly (within 30 min) after ingestion [26] since glucose is readily 
metabolised by microbes. In human the concentration of available glucose in the human 
oropharynx is too low (0.02-0.4 mM) to support 5. suis growth, which means that other 
carbon sources are needed for bacterial proliferation [27]. Generally, host-associated 
bacteria do not synthesize degradative (catabolic) enzymes unless the substrates for these 
enzymes are present in their environment, and host-associated bacteria have evolved 
elaborate control mechanisms for selective uptake and utilization of the carbon source 
that allows fastest growth [28,29]. In the presence of glucose, a carbon catabolite control 
(CCC) mechanism controls (usually suppresses) the expression of genes encoding 
degradative enzymes, transporters and metabolic pathways for other sugars 
[30,31,32,33]. The catabolite control protein A (CcpA) is well-conserved among Firmicute 
species and can repress (the most common activity) or activate transcription by binding to 
c/s-acting catabolite response element (ere) sites that are present in promoter regions of 
genes controlled by CcpA [33]. Consensus ere sequences have been determined in several 
species [32]. Studies in Bacillus species have shown that the binding of CcpA to ere DNA 
sites is enhanced by interaction of CcpA with the histidine-containing phosphocarrier 
protein HPr-Ser-46-P [34,35]. The HPr phosphorylation status is determined by the action 
of HPr kinase/phosphorylase (HPrK/P), which, in turn, is affected by intracellular 
concentrations of fructose 1,6-bisphosphate (FBP) that is produced during glycolysis. 
Orthologues of Bacillus genes regulating CcpA-mediated carbon catabolite control are 
present in S. suis isolate Pl/7 (serotype 2), the pathogenic European reference strain of 
which a fully sequenced genome is available [36]. These genes comprise (i) the 
transcriptional regulator CcpA (SSU1202), (ii) prsG-IIBCAGIC (including enzyme l-HPr; 
SSU1309), (iii) the glycolytic enzyme fructose-bisphosphate aldolase (fba; SSU0312), (iv) 
the HPr kinase/phosphorylase {hprK; SSU1419). In addition to CcpA, other transcriptional 
repressors or activators play a role in the regulation of carbon metabolism in Gram-
positive bacteria [23,37] (Chapter 4). 
CcpA is important for virulence of streptococcal species, influencing growth, haemolysin 
production, biofilm formation and capsule expression [22,38,39,40]. In streptococci, 
several virulence factors are known to be controlled by CcpA, including genes that 
regulate and mediate capsule formation, the virulence M protein positive transcriptional 
regulator Mga, and several cytotoxins [38,40,41,42,43]. CcpA loss-of-function mutants in 
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Streptococcus pneumoniae were attenuated for virulence in mouse infection models 
[38,41] whereas CcpA depletion in Streptococcus pyogenes led to both hypervirulence and 
hypovirulence, again in experimental mouse infection models [22,43]. 
Recently, the role of CcpA was investigated by microarray analysis of wild-type 5. suis and 
an isogenic bccpA mutant grown in THB. Deletion of ccpA altered the expression of the 
surface-associated virulence factors arcB, sao and eno as well as ofs and cps2A in the 
capsule locus [44]. In electron micrographs of the AccpA mutant, the thickness of the 
capsule was shown to be markedly reduced. Reduced capsule was proposed to be the 
reason for enhanced binding of the deletion mutant to porcine plasma proteins and a 
reduced resistance of S. suis to killing by porcine neutrophils [44]. 
The recently obtained genome sequences of 13 S. suis strains [36,45] led to the 
identification of a large number of predicted surface proteins and secreted proteins that 
might play a role in virulence, including a number of putative complex carbohydrates 
degrading enzymes. Many streptococcal pathogens possess the ability to metabolize a-
glucans from the environment [46,47,48,49,50]. Here we took an experimental approach 
to study the role of 5. suis carbohydrate metabolism on global S. suis metabolism and 
virulence, by comparing the transcriptomes of S. suis Pl/7 grown in complex medium plus 
pullulan (an a-glucan) or glucose in both exponential and early stationary growth phases. 
Pullulan is a polymer of a-glucose linked by glycosidic bonds that is degraded by bacterial 
enzymes such as pullulanase or amylopullulanase into maltodextrins that can be 
metabolised further [9,48,51,52,53]. A metabolic pathway map was generated from the 
genome sequence of 5. suis Pl/7 and the transcriptome data. We also quantified 
production of suilysin and the expression of known virulence genes and performed 
adhesion and invasion assays of S. suis Pl/7 grown in pullulan or glucose, to study the 
effect of different carbon sources on in vitro virulence. The results provide new insights 
into carbohydrate metabolism in 5. suis and demonstrate links between carbohydrate 
metabolism and virulence gene expression concurrent with adhesion and invasion of 
epithelial cells. 
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Results 
The metabolic map ofS. suis 
The metabolic map of S. suis includes most of the metabolic pathways that have been 
found in other Streptococcus species; these include all standard metabolic pathways for 
fatty acid biosynthesis, nucleotide, amino acid and carbohydrate metabolism (Fig. 5.1). 
Streptococcus species do not encode all enzymes necessary for completion of the 
tricarboxylic acid (TCA) cycle, the series of chemical reactions whereby aerobic organisms 
generate energy through the oxidization of acetate derived from carbohydrates, possibly 
because streptococcal species tend to be facultative anaerobes. S. suis appears to produce 
energy (ATP) through homolactic and/or mixed-acid fermentation of carbohydrates. 
Under conditions of excess glucose and in presence of oxygen, glucose is oxidized via the 
glycolysis (or Embden-Meyerhof pathway) to pyruvate. In several streptococcal 
pathogens, the oxidative respiratory enzymes of the TCA cycle then metabolize pyruvate 
via an incomplete TCA cycle [54,55] (Fig. 5.1). Alternatively, under limited oxygen 
conditions, 5. suis can reduce pyruvate to lactic acid and products such as formate, 
ethanol and acetate. In addition, S. suis possesses the genes encoding proteins 
participating in the Leloir pathway, where UDP-glucose (UDP-GIc) and UDP-galactose 
(UDP-Gal) can be generated from glucose-1-phosphate or a-galactose. To date two ABC 
transporters and 17 phosphotransferase systems (PTSs) for the uptake of carbohydrates 
have been predicted for 5. suis in the KEGG database highlighting the potential for S. suis 
to ferment a variety of sugars and carbohydrates (Fig. 5.1). Indeed, metabolic pathways 
for metabolism of fructose, mannose, glucans, galactose and sucrose appear to be present 
in S. suis and the capacity to ferment ribose, L-arabinose, mannose, sorbitol, lactose, 
raffinose, maltotriose, and a-glucans such as glycogen and pullulan has been described for 
S. suis [9,56]. For the metabolism of a-glucans, the extracellular amylopullulanase (ApuA) 
is required to degrade a-D-glucose polymers into smaller units for transport across the 
cytoplasmic membrane [9]. ApuA is the only extracellular a-glucan catabolic enzyme 
found in the sequenced genomes of S. suis except in the pathogenic S. suis ST3 serotype 3 
[57] which possess an additional secreted amylase gene (SSUST3_0537). The broad 
fermentative capabilities of S. suis enables this organism to utilize dietary and host sources 
of carbohydrates for colonization of host mucosal tissues. 
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Fig. 5.1. Metabolic pathways chart, generated using iPath [58]. (Fragments of) pathways that include genes previously 
annotated in S. suis Pl/7 are indicated in red. 
119-
Chapter 5 
Fermentation ofpullulan has pleiotropic effects on gene expression 
To compare the effects of pullulan (Pul) and glucose (Glc) on bacterial growth and 
transcriptional activity, we performed a gene expression profiling experiment, hybridizing 
RNA prepared from bacteria in exponentially growth phase (e) and in early stationary 
phase (s) (Fig. 5.2) to whole-genome microarrays. 
0.8-1 
5 10 
hours 
-*- CM + pullulan CM+glucose 
Fig. 5.2. S. suis S10 growth curve at 37°C in presence of different carbon sources. OD600 measured in complex media (CM) 
supplemented with 1% (w/v) glucose or pullulan. 
At stationary phase, S. suis populations grown in CM + pullulan consistently yielded a 
higher biomass compared to 5. suis grown in CM + glucose. The numbers of genes 
differentially expressed during growth in pullulan versus glucose in exponential (e) or early 
stationary (s) phase were 1028 (52% of annotated genes) and 1015 (51% of annotated 
genes), respectively (Fig. 5.3). In total 738 (37% of annotated genes) genes were 
differentially regulated in pullulan compared to glucose, irrespective of the growth phase. 
In pullulan, 209 genes were differentially regulated between the exponential and early 
stationary phases of growth; in glucose, 432 genes were differentially regulated for the 
same comparison. 
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Fig. 5.3. Venn diagram of the genes differentially regulated growings, suis in pullulan (Pul) vs glucose (Glc) in exponential (e) or 
stationary (s) phase. This diagram was created using VENNY (http://bioinfogp.cnb.csic.es/tools/venny/index.html). For all 
intersections the numbers of differentially expressed genes are indicated. 
For all genes and proteins identified in the 5. suis Pl/7 genome, Gene Ontology (GO, 
http://www.geneontology.org) and KEGG pathway annotations were obtained using the 
BLAST2G0 software (www.blast2go.org) [59] including annotations based on terms 
obtained from EBI using the InterPROScan feature [60] that is part of BLAST2G0. The GO 
enrichment analysis feature of BLAST2G0 was used to identify the functional categories 
that were statically over- or underrepresented in the set of genes differentially expressed 
in pullulan vs glucose in exponential and early stationary phases of growth. GO 
enrichment was calculated using a Fisher's Exact Test and P value cut-offs of 0.05 and 
lower. We determined over- and under-represented GO categories of genes differentially 
regulated in pullulan versus glucose in early exponential and early stationary growth 
phases (Fig. 5.4A and 5.4B). Similar analyses were performed for a subset of differentials, 
namely all upregulated genes with the GO annotation "carbohydrate metabolism" (Fig. 
5.5Aand5.5B). 
The functional categorization of genes revealed that the highest number of genes 
differentially expressed in both growth phases participated in carbohydrate transport into 
the cell (11.7% of annotated sequences were annotated with this GO term). Related to 
carbohydrate transport, genes annotated with GO term "carbohydrate metabolism" 
(18.6%) (Fig 5.4A) and its sub-categories galactose metabolism (4.1%), starch-sucrose 
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metabolism (3.4%), pyruvate metabolism (7.1%) and fructose-mannose metabolism (6.0%) 
were also important components of the transcriptomes (Fig. 5.5A). The starch metabolic 
pathways comprise the genes encoding ApuA, transport systems for the 
maltose/maltodextrin breakdown products, and genes encoding enzymes that convert 
maltose and maltodextrin into GlclP or Glc6P for other metabolic pathways (see below). 
The category "galactose metabolism" was possibly over-represented due to increased 
expression of the Leloir pathway enzymes that convert galactose into GlclP (Fig. 5.5). 
Interestingly, genes in the GO category "energy reserve metabolism" (2.1%) were also 
enriched when bacteria were grown in pullulan versus glucose. Polysaccharide 
biosynthesis (4.1%) was over-represented in pullulan (Fig. 5.5), presumably due to the 
increased expression of the a-glucan branching enzymes (SSU0870, SSU0874 and 
SSU0873) that are required for the synthesis of glycogen from glucose-1-phosphate 
(GlclP) (Fig. 5.5). 
Another GO category that was enriched during growth in pullulan was lipid metabolism 
(11.7%) which is the metabolic pathway during which precursors of lipoteichoic acids and 
membrane phospholipids are generated. Linked to this GO category is glycolipid 
metabolism (2.7%), which includes glycosphingolipids and globosides (Fig. 5.5), molecules 
which are involved in membrane biosynthesis and biofilm formation [61]. Other enriched 
GO categories included amino acid metabolic pathways for arginine and proline, which in 
5. suis and other streptococcal pathogens are repressed in the presence of glucose by 
carbon catabolite repression (CCR) [44,62]. The under-represented categories in pullulan 
included ribosome biogenesis, trans-membrane ATPase activity, and regulation of gene 
expression by transcriptional regulatory proteins including two-component systems. 
Under-represented categories suggest possible cross-regulation (pathway repression) 
which could be due to activity of CcpA and other transcriptional regulatory systems. 
In early stationary phase (Fig. 5.4B), "rRNA binding" is the first over-represented category 
that includes genes encoding stress proteins binding to 5S RNA, possibly due to the 
depletion of the carbon sources that were metabolised to generate energy [63]. 
Carbohydrate transport systems were more enriched at early stationary than in early 
exponential phase (17.9%) while cellular carbohydrate metabolism was under-
represented (6.4%), possibly also due to the diminished availability of carbohydrate 
sources. 
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Fig. 5.4. GO term distribution of S. suis genes upregulated in pullulan vs glucose. A. early exponential (e) and B. early stationary 
phase (s) GO Enrichment analysis performed using BLAST2GO (P= 0.05, two-tailed Fisher's Exact test). 
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with their predicted function as a repressor and activator of the maltodextrin utilization 
system, respectively (Chapter 4). 
Glucose-1-P (GlclP), released upon pullulan degradation, can be metabolized in different 
pathways. Phosphoglucomutase (pgm-SSU0826), which is highly upregulated in pullulan 
compared to glucose, can isomerise GlclP to Glc6P which can enter the glycolytic 
pathway. However, the glycolytic pathway enzymes were either not modulated or slightly 
down-regulated in pullulan compared to glucose under all conditions (Fig. 5.6). In 
agreement with this, genes participating in the pentose-glucuronate pathway were 
upregulated in pullulan. The pentose-glucuronate pathway is an alternative to glycolysis 
for the metabolism forGlc6P. 
GlclP is a direct precursor substrate for synthesis of glycogen (glucose polymers) as an 
energy reserve. The three genes encoding the ADP glucose pyrophosphorylase, glycogen 
synthase, and branching enzyme (glgC-glgA-glgB; SSU0870 to SSU0874) were all strongly 
induced (Fig. 5.6). The glycogen utilization genes encoding glycogen Phosphorylase (glgP2-
SSU0354) and malQ2 (SSU0353), which convert glycogen or maltodextrins to GlclP, were 
not differentially regulated (Fig 5.6). Enzymes for maltodextrin utilization and glycogen 
synthesis are classified in starch-sucrose pathway (Kegg ssi00500). 
The genome of 5. suis encodes also predicted enzymes belong both starch-sucrose and 
galactose metabolism that participate to the interconversion of different sugars [69,70]; 
their activities have not been biochemically tested yet. These genes, sucrose 
Phosphorylase (gr//4-SSU1369), ß-fructofuranosidase/interconvertase [71] (invrtsC-
SSU1169) and raffinose galactohydrolase [72] (ra/gH-SSU0167) were strongly induced in 
pullulan compared to glucose (Fig 5.6) and may be associated with the downstream 
induction of genes associated with galactose metabolism (Fig. 5.6). 
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Fig. 5.6. Heatmap showing the effect of pullulan on the transcription of genes involved in key basic metabolic processes. 
Expression (ratios) of genes participating in 9 different metabolic processes (indicated at the right of the heatmap) are shown for 
6 different comparisons (indicated at the top of the heatmap). At the top of the figure, a color scale depicts the ratio of 
expression during growth in pullulan vs. glucose. Red colour indicate induction (upregulation of the respective genes) and blue 
indicates repression (downregulation of the respective genes) for each comparison. For each gene, the S. suis Pip locus tag and 
the gene name is given on the right. 
127-
Chapter 5 
Interestingly, the galT (galactose-1-phosphate uridylyltransferase) and galK 
(galactokinase) genes that participate in the Leloir pathway were strongly induced. The 
GalT enzyme (EC 2.7.7.9) interconverts galactose-1-phosphate (Gall-P) and UDP-Glucose 
(UDP-GIc) to UDP-galactose (UDP-Gal) and GlclP. Activated UDP-sugars are important 
intermediates in polysaccharide biosynthesis, e.g. as capsule components or 
exopolysaccharides. Expression ratios of capsule biosynthesis genes were slightly lower 
(cps2C-SSU0517, cps2D-SSU0518, cps2£-SSU0519, cpss_/p/-SSU1123) for bacteria grown in 
pullulan compared to glucose, suggesting capsule production would not be increased in 
pullulan. Indeed, similar levels of capsule production were observed in transmission 
electron micrographs of S. suis grown in pullulan or glucose (Fig. 5.7). 
Fig. 5.7. EM picture of S. suis grown in CM supplemented with A. pullulan or B. glucose. 
In lactic acid bacteria including streptococci, pyruvate, the end product of glycolysis, is 
converted to lactate during homolactic fermentation. Mixed-acid fermentation of 
pyruvate may also occur in lactic acid bacteria, resulting in end products such as 
acetate, ethanol, formate or lactate, the growth conditions. The fermentation of 
pullulan may result in the formation of formate and ethanol, predicted from the induction 
of genes encoding pyruvate formate lyase (p//0-SSUO191) and alcohol dehydrogenase 
(arJ/7f-SSU0260) (Fig. 5.6; Chapter 6). 
The prediction ofcre-sites in the genome ofS. suis 
The microarray analysis did show that carbohydrate metabolism is substantially altered 
when 5. suis bacteria are grown in presence of pullulan or glucose. The CcpA transcription 
factor that mediates carbon catabolite repression (CCR) or activation (CCA) is a major 
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Table 5.1: cre-site prediction in the genome of S. suis Pip. 
Sequence 
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P/GIc1 upregulated (U) or downrcgulated (D) expression when S. suis was grown in pullulan compared to glucose 
AccpA2 upregulated (U) or downregulated (D) expression in wild type S. suis 10 compared to its isogenic AccpA mutant (data from 
Willenborg et al. [44)) 
Pos3 tag locus located upstream of the start codon of predicted proteins (P) or in proximity of the gene transcription start (G) 
regulator of carbohydrate metabolism. Catabolite control, activated in presence of glucose, 
leads to high-affinity binding of CcpA to a catabolite responsive element (ere). Inactivation 
of ccpA in S. suis was reported to alter expression of 259 genes (13.2% of the genome) [44]. 
For this chapter, it was of interest to investigate if (part of) these genes were differentially 
expressed during growth in pullulan (compared to glucose) and thus, might be regulated by 
CcpA. Therefore, using MEME [73] and MAST-algorithms [74], the genome sequence of 5. 
suis strain Pl/7 was mined for presence of a cre-site motif (tGAAAACGTTTGCat); this motif is 
similar to a B. subtilis consensus cre-site (TGWAARCGYTWNCW) [75,76]. A total of 472 
putative cre-sites were identified within 71 sites in the tag locus located upstream of the 
start codon of predicted proteins (P) or in proximity of the gene transcription start (G) 
(Table 5.1). A total of 171 genes, including other genes within the same operon, were 
predicted to be under control of CcpA. In Table 5.1 we listed 38 ere sites and their 
downstream genes or opérons, and indicated if those genes were differentially expressed in 
pullulan compared to glucose (our study), and if genes were differentially expressed in a 
AccpA mutant [44]. 
In table 5.1, we observed that genes belonging to all main functional classes were 
represented in the ecp/\-regulon prediction, but with a relative enrichment of cre-sites in 
the upstream regions of genes predicted to encode carbohydrate PTS and ABC 
transporters (17%), genes (opérons) with regulatory functions (10%), and genes encoding 
enzymes involved in carbohydrate metabolism (25%) and, noteworthy, in virulence (8%). 
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A total of 171 genes, including other genes within the same operon, were predicted to be 
under control of CcpA. In Table 5.1 we listed 38 ere sites and their downstream genes or 
opérons, and indicated if those genes were differentially expressed in pullulan compared 
to glucose (our study), and if genes were differentially expressed in a AccpA mutant [44]. 
In table 5.1, we observed that genes belonging to all main functional classes were 
represented in the ccp/J-regulon prediction, but with a relative enrichment of cre-sites in 
the upstream regions of genes predicted to encode carbohydrate PTS and ABC 
transporters (17%), genes (opérons) with regulatory functions (10%), and genes encoding 
enzymes involved in carbohydrate metabolism (25%) and, noteworthy, in virulence (8%). 
Links between carbohydrate metabolism and virulence gene regulation 
To investigate if growth of 5. suis in cc-glucans could affect expression of known or 
predicted virulence genes, the expression of these genes were compared during bacterial 
growth in pullulan or glucose (Fig 5.8). 
Seven genes involved in the invasion of mucosal tissues or avoidance of host defenses by 
streptococcal pathogens were upregulated in pullulan compared to glucose. These genes 
included sly (suilysin-SSU1231) [11,77,78,79,80], hepll/lll (putative oligohyaluronate lyase-
SSU1048) [81], hyl (hyaluronidase precursor-SSU1050) [82], arcB (arginine deiminase-
SSU0580) [83,84], igaP (surface métallo serine protease-SSU1773) [85] dppIV (Xaa-Pro 
dipeptidyl peptidase-SSU0187) [86,87], and pepD (putative surface dipeptidase-SSU1215) 
[88]. 
Regarding the envelope structures which contribute to S. suis virulence, only two capsule 
biosynthesis genes (cpss_/p/-SSU1124 and cpss_ /p/2-SSU 1123) were slightly 
downregulated, but not the gene encoding the cps operon regulator. These transcriptional 
changes did not appear to have a visible effect on capsule production (Fig. 5.7). The 
neuACB operon, containing genes involved in sialylation of the capsule polysaccharides 
[89] was slightly induced. The only adhesin highly upregulated during bacterial growth in 
pullulan was ApuA. 
Remarkably, the genes with highest (sly, apuA, arcB, hyl-hepll/lll) or moderate (ssnA, 
cps2A) differential induction in pullulan all have a predicted ere element site in their gene 
or operon promoter region (Table 5.1) indicating they might be subject to CcpA-mediated 
repression when concentrations of glucose are high enough. However, these genes can be 
co-regulated by other transcriptional regulators, for instance suilysin may be co-regulated 
by the two-component system CovS/CovR (SSU1190-SSU1191)[90]. 
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Fig. 5.8. Gene expression ratio of putative and characterized virulence factors of 5. suis grown in pullulan or glucose in 
exponential (white bar) and early stationary (black bar) phases. The genes are grouped together according to their predicted or 
described function in S. suis pathogenesis. Envelope: cps2E*-SS0519 putative galactosyl transferase; wc/iF*-SSU0520 putative 
rhamnosyl transferase; cps2C-SSU0517 tyrosine-protein kinase; cpss_/p/-SSU1123 putative glycosyltransferase; cpss_lpi2-
SSU1124 putative rhamnosyl transferase pgd/4-SSU1448 peptidoglycan GlcNAc deacetylase, dVM-SSU0596 D-alanine-
poly(phosphoribitol) ligase subunit l ; Envelope/Adhesion neuB-SSU0535 putative N-acetylneuraminic acid synthase; neuC-
SSU0536 putative UDP-N acetylglucosamine 2-epimerase; neu4-SSU0538 N-acylneuraminate cytidylyltransferase; Adhesion: 
opu/4*-SSU1849 amylopullulanase; sadP-SSU0253 putative surface-anchored protein receptor; gnd-SSU1541 6-
phosphogluconate dehydrogenase; Adhesion/Invasion: srM-SSU0925 sortase; /bpS-SSU1311 fibronectin-fibrinogen binding 
protein; gapc/H-SSU0153 glyceraldehyde-3-phosphate dehydrogenase; eno-SSU1320 enolase; pepD-SSU1215 putative surface-
anchored dipeptidase; dpp /V-SSU0187 Xaa-Pro dipeptidyl-peptidase; Invasion: sly* SSU1231 suilysin (haemolysin); 
nep»/H/*-SSU1048 heparinase ll/lll-like protein; /)y/*-SSU1050 hyaluronidase precursor; ssnA*-SSU1760 surface-anchored DNA 
nuclease; orcS*-SSU0580 arginine deaminase; /goP-SSU1773 putative surface-anchored serine protease; ssp,4-SSU0757 cell 
envelope proteinase; o/s-SSU1474 serum opacity factor; /ux5-SSU0376 S-ribosyl homocysteinase; Marker: mrp-SSU0706 
muramidase-released protein precursor; e/-SSU0171 putative surface-anchored protein. * Indicates the presence of predicted 
cre-site in the promoter region of the gene virulence factor. 
Effect of carbohydrates on haemolytic activity ofS. suis 
According to our microarray analysis, the expression of suilysin, an important 5. suis 
virulence factor, was strongly induced in pullulan compared to glucose, both at 
exponential and stationary growth stages (+18.1/+17.9 ratio pullulan vs glucose). To test if 
secretion of suilysin was indeed increased during bacterial growth in pullulan, we 
measured erythrocyte haemolytic activity (HA) of culture supernatants of S. suis grown in 
glucose or pullulan. Haemolytic activity was higher in CM supplemented with pullulan than 
in CM plus glucose, over a wide range (ca. 0.5) of OD values (Fig 5.9). In early stationary 
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phase, HA for pullulan and glucose cultures was approx. 91% and 18%, respectively (Fig. 
5.9). We assume that suilysin (SSU1231) is the only active haemolysin that is produced by 
S. suis Pl/7. A haemolysin-like protein (SSU1464) has been annotated in the genome of S. 
suis, but this gene was not differentially expressed under these conditions. 
CM glucose CM pullulan 
Fig. 5.9. Hemolysis assay of S. suis growing in two different carbon sources. A. The hemolysis production was measured by 
analyzing the supernatant of 5 suis grown in CM plus 1% of glucose or pullulan in the lag, exponential and stationary phase (OD600 
values 0 to 0.56). B. Deep-well titer plate showing hemolytic activity of supernatants collected from 5. suis grown in CM 
supplemented with glucose or pullulan. 
Effect of carbohydrate source on S. suis adhesion and invasion 
From our microarray data, and the expression of (putative) virulence factors, we 
hypothesized that the adhesion and invasion capacity of S. suis might be enhanced upon 
growth in pullulan compared to glucose. Because of its porcine epithelial origin, the 
newborn pig tracheal cell line (NPTr) [9,91] was chosen to investigate the adhesion and 
invasion of S. suis S10 grown in pullulan or in glucose. Exponentially growings, suis grown 
in CM plus 1% of either carbohydrate were harvested and incubated for 2 h at a 
multiplicity of infection (MOI) of approximately 50 (number of bacteria per NPTr cell). To 
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maintain similar growth conditions, the cell culture medium was replaced with glucose-
free DMEM and supplemented with 1% glucose or pullulan during the incubation with 5. 
suis. In agreement with previous adhesion studies that used the NPTr cell line [9], we 
found that adherence of 5. suis bacteria grown in CM plus glucose was 19.4 ± 1.0 % of 
original inoculum (averaged over 3 independent replicates). 5. suis had a significantly 
higher adhesion capacity (24.9 ± 1.7 %; P <0.05; 3 replicates) after bacteria had been 
grown in CM plus 1% pullulan (Fig. 5.10A). In accordance with previous studies using a 
human Hep-2 cell line [8], 5. suis S10 showed low invasion capacity (0.05% of original 
inoculum) in glucose. Strikingly, invasiveness of 5. suis was nearly 9 times higher when 
grown in pullulan as a unique carbon source (0.43% ± 0.01) (*** P <0.01) (Fig. 5.10B). In 
conclusion, S. suis bacteria grown in pullulan showed a slightly but significantly increased 
adherence to, and a strongly increased invasiveness of NPTr cells, always compared to 
glucose. 
B 
CM+glucose CM+pullulan 
0.2 
0.0 
1 L* 
CM+glucose CM+pullulan Fig. 5.10. Comparison of NPTr adherence A. and invasion 8. of 5. suis after growth in CM+1% pullulan (black columns) vs. 
CM+1% glucose (white columns). 
NPTr confluent monolayers were co-cultivated for 2 h with S. suis SIO bacteria grown in CM medium complemented with 
pullulan or glucose. NPTr cells were washed and lysed and lysates plated on Columbia agar to determine number of adherent 
bacteria as calculated from CFU. To determine real invasion, antibiotics were added for 1 additional hours to kill extracellular 
bacteria before plating. Results were expressed as % adherence or % invasion (% recovered CFU of the inoculum) as described in 
Experimental procedures. Plotted values indicate means ± SD averaged across three independent experiments. 
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Discussion 
5. suis is an important pathogen of swine; some isolates have also shown to be able to 
infect humans. S. suis is among the more ubiquitous bacteria that colonise the oropharynx 
and oral cavity of asymptomatic carrier pigs [92,93]. It is unclear how, and under what 
external conditions S. suis bacteria can switch from an asymptomatic to a pathogenic 
association with their host. Host susceptibility to 5. suis infection may occur due to 
inadequate host immune responses but may also be due to reduced antagonism by 
commensal bacteria, concurrent infections or environmental factors such as the 
availability of nutrients. As shown in this study, carbohydrate availability may be an 
important environmental factor as carbohydrates can dramatically alter gene expression 
and may promote an increased production of toxins and other virulence factors. In the 
mammalian oropharynx and saliva, dietary a-glucans are present at high concentrations 
[18,19,27]. The importance of these substrates to the ecology of bacteria in this niche is 
evident from the high number of a-glucans degrading enzymes and starch metabolic 
pathway genes present in genome sequences of commensals [9,48,51,52,53]. 
Previously, we showed that the ability of S. suis to utilize a-glucans is dependent on a 
bifunctional a-glucan degrading enzyme (amylopullulanase, ApuA) that also mediates 
adhesion to porcine epithelial cells [9] (Chapter 3). Growth in pullulan led to an induction 
of S. suis starch metabolic pathway genes, including homologues of the maltodextrin ABC 
transport operon and a predicted PTS for maltose/maltotriose (prsG-SSU0357), as 
described in other Streptococcus species [94,95] (Fig. 5.11). PTS systems were important 
to utilize the two different carbon sources: one of the GO categories with the highest 
number of genes over-represented during exponential growth in pullulan was the 
phosphotransferase system (PTS) category (Fig. 5.4). 70% (12 out of 17) of the annotated 
PTS were upregulated in pullulan and 40% of the genes encoding these PTSs contained a 
ere binding site in the promoter region. As several PTS genes are transcribed at higher 
levels in pullulan, we cannot exclude the possibility that one of these is the major 5. suis 
transporter for maltose or maltotriose. 
Intracellular glgl and malQl are predicted to convert maltodextrins to GlclP which can be 
converted by phosphoglucomutase (pgm-SSU0856) to Glc6P, a substrate for glycolysis 
(Fig. 5.11). We observed that transcription of glycolytic pathway genes were not 
substantially altered by growth in pullulan compared to glucose, suggesting that this 
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pathway is similarly expressed under both conditions. Strikingly, the pentose and 
glucuronate interconversion pathway for metabolism of Glc6P were stronger induced 
during growth in pullulan compared to glucose, suggesting an accumulation of 
intracellular a-glucose. This suggestion is supported by the finding that glycogen 
biosynthesis genes including three a-glucan branching enzymes (SSU0870, SSU0874 and 
SSU0873) that synthesize glycogen from GlclP were stronger induced in pullulan than in 
glucose (Fig. 5.11). Thus growth in pullulan may promote glycogen energy storage. We 
noted that in early stationary phase, when glucose is depleted, the expression of glycogen 
biosynthesis genes was suppressed, whereas the expression of two genes encoding 
glycogen-degradation enzymes (glg2 and malQ2, SSU0353-SSU0354) was induced, 
presumably to enable the intracellular glycogen reserves to be converted to glucose for 
fermentation. This could explain why 5. suis bacteria grow to higher OD600 in pullulan than 
in glucose (Fig. 5.2). Glycogen concentrations can increase up to 50% of the cell dry weight 
without having detrimental effects on internal osmotic pressure in the bacterial cell 
[96,97]. S. suis appears to be able to metabolize pyruvate to different end-products 
including lactate, acetate, ethanol and formic acid (but not acetoin). This assumption is 
supported by the finding that the genes involved in metabolism of pyruvate to formate 
and ethanol were more strongly induced during growth in pullulan than in glucose. 
Expression of the two Leloir pathway genes galTK were highly upregulated in pullulan 
compared to glucose. The enzymes GalT and GalK catalyze the interconversion of UDP-
galactose (UDP-Gal) to UDP-glucose (UDP-GIc) [98,99] (Fig. 5.11). Although galactose was 
not a standard component of the bacterial growth medium, it can presumably be derived 
through enzymatic interconversion of other sugars. Activated sugars such as UDP-GIc and 
UDP-Gal are key components in the biosynthetic pathway of extracellular polysaccharides 
(EPS) [100,101]. Exopolysaccharides produced by Lactococcus and Streptococcus species 
have a range of functions including adhesion and biofilm formation [102]. In Streptococcus 
thermophilus, the overexpression of both phosphoglucomutase (PGM) and GalE increases 
EPS synthesis more than 2-fold; increased production of GalK, GalT, and GalU led to 
further increases of EPS production [103]. During our experiments, no difference in 
production of capsule was evident from comparing electron micrographs of S. suis grown 
in glucose or pullulan (Fig. 5.7). Recently, Willenborg et al. reported that the capsule of 5. 
suis S10 àccpA mutant strain was downregulated compared to the wild type. Moreover, 
the glycosyl transferases present in the capsule operon (cpssjpl and cpss_lpl2) and the 
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capsule operon regulator (cps2A/wzg) were slightly downregulated in exponential phase. 
S. suis cps and sialic acid transfer gene clusters have been proposed to be activated by 
CcpA [44]. However, in other Streptococcus species, production of capsule is influenced by 
carbon source but in a CcpA-independent manner [38,64] suggesting that the influence of 
CcpA control of capsule biosynthesis is not a straightforward consequence of glucose (or 
another monosaccharide) availability. 
Many of the transcriptional changes we observed could be attributed to carbon catabolite 
control (CCC). To predict which of the differentially expressed 5. suis genes could have 
been regulated by CcpA we searched for conserved catabolite-responsive elements (ere) 
motifs in the genome of S. suis Pl/7. 172 genes (or opérons) were predicted to be under 
control of CcpA (Table 5.1). Of these 172 genes, 145 (84%) were differentially regulated 
during growth in pullulan compared to glucose. The difference may be due to incorrect ere 
presence predictions, or to the fact that genes and opérons may have dual regulation 
involving not only CcpA but also other transcription factors (Chapter 4). 
The 145 genes that appeared to be controlled by CCC were also compared to a published 
microarray data set generated by comparison of a bccpA mutant with the corresponding 
wild-type strain [44]. In total, 99 genes comprising 38 opérons were differentially 
regulated in both datasets (Table 5.1), lending further support to the accuracy of ere site 
predictions for at least a subset (70%) of genes. 
The CCC-regulated gene set included genes encoding PTS and ABC carbohydrate 
transporters (17%), genes encoding proteins with regulatory functions (10%), and genes 
encoding enzymes involved in carbohydrate metabolism (25%) and in virulence (8%) 
(Table 5.1). These genes participate in metabolic pathways including Leloir pathway, 
pyruvate metabolism, starch metabolism, glycogen biosynthesis and pentose glucuronate 
interconversion pathway (Fig. 5.11). In S. pneumoniae, one of the genes activated by CcpA 
is lactate dehydrogenase (Idh). Under anaerobic conditions, CcpA CCR leads to increased 
production of lactate and repression of two mixed-acid fermentation genes, pfl and adhE 
[64]. A similar regulation mechanism may also occur in S. suis, where decreased 
expression of Idh (containing a predicted ere site) and induction of genes participating in 
mixed acid fermentation was observed during growth in pullulan compared to glucose. 
Most striking was the induction of nearly 30 genes encoding virulence factors associated 
with mucosal invasion and the avoidance of host defenses in pullulan compared to 
glucose. One of these was the gene encoding a secreted suilysin, a pore-forming toxin 
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which we showed to be highly induced during growth in pullulan, using a haemolytic in 
vitro assay (Fig. 5.9). Suilysin has been shown to play a role in damaging host epithelial 
[7,11], endothelial [12,14] and immune cells [16], suggesting that suilysin could faciltate 
the entry of 5. suis into tissues and avoidance of host defences [5,104]. In contrast to our 
own results, sly expression was not increased in a recent study which compared gene 
expression of a wild-type strain with a hccpA mutant grown to early exponential phase 
[44]. The reason for these different findings is unknown but may be related to the use of 
THB medium [44] instead of the supplemented CM medium. Also upregulated in pullulan 
(compared to glucose) was a gene encoding hyaluronidase, the enzyme which can 
breakdown hyaluronan, an anionic, non-sulphated glycosaminoglycan distributed widely 
throughout the extracellular matrix of eukaryote connective tissue cells. Its role in S. suis 
infection remains to be demonstrated but in Streptococcus intermedius, hyaluronidase 
may be important for detachment from a biofilm [105]. Additionally, two peptidyl 
peptidases (dppIV and pepD) were transcribed at higher levels when 5. suis was grown in 
pullulan. In 5. suis, the function of pepD is unknown but the 5. suis di-peptidyl peptidase IV 
(DppIV) has been shown to interact with human fibronectin, and a cfpp/\/-deficient mutant 
was greatly attenuated in a mouse infection model [86]. A putative heparinase ll/ll 
enzyme was also highly upregulated but its function and potential role in virulence is 
unknown. In our experiments, the sspA gene which encodes a secreted serine protease 
was also induced. This protease can degrade eukaryote pro-inflammatory interleukin-8 (IL-
8) molecules and, by degrading IL-8, SspA is predicted to inhibit Chemotaxis and infiltration 
of neutrophils and other leukocytes in vivo [106,107]. The ssnA gene, encoding a recently 
described DNase which is secreted by S. suis and is potentially involved in the breakdown 
of neutrophil entrapments (NETS) [108], was slightly upregulated in pullulan compared to 
glucose. 
Several adhesion factors, namely ApuA [9], FbpS [109], Eno [110], GAPDH [111,112], Gnd 
[113] and SadP [114]) have been characterized in S. suis. Transcription of apuA was 
strongly induced, whereas sadP and gapdH were only slightly induced during growth in 
pullulan compared to glucose. Adhesion and invasion of porcine epithelial cells was 
significantly increased when S. suis was grown in pullulan rather than glucose which may 
be due to increased expression of adhesins (apuA, sadP and gapdH) and possibly other 
genes including genes that modify the cell envelope by transfer of sialic acids (neu operon, 
capsule II; Figs. 5.6 and 5.8). In other streptococcal pathogens, it was shown that the 
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external part of the capsule was needed for binding alveolar cells by sialic acids contained 
in the envelope [115]. 
In blood, glucose levels are relatively high (6-9 mM) [116] compared to the oropharyngeal 
cavity where dietary sources of a-glucans will be the predominant carbon source that will 
be available for bacterial fermentation. Here we show that fermentation of a-glucans in 
the absence of extracellular glucose leads to differential expression of approximately 1000 
genes, of which about 145 contained predicted ere sites in their promoter regions. We 
propose that the altered expression of these 145 genes is most likely due to relief from 
CcpA-dependent carbon catabolite repression; most of the genes that we predicted to 
include a ere site in their promoter regions are predicted to participate in diverse 
metabolic pathways, including biosynthesis of glycogen (as energy reserves). In addition, 
nearly 30 genes encoding putative or confirmed virulence factors were transcribed at 
higher levels during growth in pullulan including the genes encoding the toxin suilysin and 
ApuA, an adhesion and extracellular enzyme required for growth on a-glucans. These 
findings demonstrate a clear link between carbohydrate utilisation and regulation of 
virulence, and suggests that fermentation of a-glucans favours colonisation and early 
stages of invasion at the mucosal epithelium. These findings are in agreement with studies 
in other streptococcal pathogens that have shown a role for CcpA and CCC in colonization 
and infectivity in animal models [22,42]. 
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Fig. 5.11. Schematic representation of S. suis metabolic pathways differentially regulated in pullulan vs glucose a-glucans (i.e. 
pullulan). a-glucans are degraded by extracellular amylopullulanase (ApuA) and the end degradation products, 
maltose/maltotriose and maltodextrins, are transported by PTS for maltose/maltotriose (malT) and maltodextrin ABC transport 
inside the bacteria (malx, malC and malD). Maltodextrins and maltose are presumably converted to glucose-1-phosphate (GlclP) 
or a-glucose by 4-a-glucanotransferase and maltodextrin Phosphorylase (mo/Ql and glgPl respectively). GlclP can be 
metabolized in different pathways: phosphoglucomutase (pgm) isomerize GlclP to glucose-6-phosphate (Glc6P) which may enter 
glycolysis (violet box) where it is consequently oxidated to pyruvate (pyr). Homolactic fermentation reduces pyruvate into 
lactate, whereas mixed-acid fermentation leads to other products, such as formate, acetate and ethanol (pyruvate metabolism, 
yellow box). The excess of GlclP that cannot enter in glycolysis may be used for synthesis of glycogen as an energy reserve (light 
blue box). The genome of 5. suis is predicted to encode the enzymes sucrose Phosphorylase gtfA, a-fructofuranosidase 
(interconvertase) invrtsC, and raffinose galactohydrolase, rafgH for the interconversion of sugars like raffinose. These enzymes 
participate in the starch and galactose-Leloir pathway. Part of Leloir pathway genes (e.g. galactose-1-phosphate 
uridylyltransferase galT and galactokinase galK) was induced more strongly in pullulan. GalT interconverts galactose-1-phosphate 
(Gall-P) and UDP-Glucose (UDP-GIc) to UDP-galactose (UDP-Gal) and GlclP. Alternatively, UDP-GIc may be converted into 
glucuronic acid (Glcur) by UDP-D-glucuronate (UDP-Glcur) to enter in an alternative (to glycolysis) pathway for pyruvate (pyr) 
production. Pathway predictions were reconstructed based on genome information 
(http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi), literature and database surveys (KEGG, MetaCyc). The following gene 
annotation was downloaded from NCBI: galM, aldose 1-epimerase; galK, galactokinase; galE, UDP-glucose 4-epimerase; galT, 
galactose 1-phosphate uridylyltransferase; pgm, phosphoglucomutase/phosphomannomutase; pfkA, 6- phosphofructokinase; 
fba, fructose bisphosphate aldolase; tpiA, triosephosphate isomerase; gap, glyceraldehyde-3-phosphate dehydrogenase; pgk, 
phosphoglycerate kinase; gpmA, phosphoglyceromutase; eno, phosphopyruvate hydratase; pyk, pyruvate kinase; Idh, L-lactate 
dehydrogenase; pyrox, pyruvate oxidase; ackA, acetate kinase; pfl, pyruvate formate-lyase; adIE acetaldehyde-CoA 
dehydrogenase; adhE alcohol dehydrogenase; g/gS, glgA glycogen synthase; glgC glucose-1-phosphate adenylyltransferase; glgP 
glycogen Phosphorylase 
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Materials and methods 
Bacterial strains, plasmids and culture conditions 
S. suis S10 strain was grown in Todd-Hewitt broth (THB) (Difco) or on Columbia agar plates with 6% 
sheep blood (Oxoid) at 37°C under 5% C02 for 18 h. An optical density (OD) of 1.2 at 600 nm with a 1 
cm path length corresponds to approximately 109 bacterial colony forming units per milliliter (c.f.u. 
ml-1). The genome of S. suis S10 is more than 99% identical to the genome of S. suis Pl /7, a 
sequenced reference strain of which the genome had been annotated previously (Chapter 1). 
A complex medium (CM) comprising of 10 g I"1 proteose peptone, 5 g I"1 trypticase peptone, 5 g I -1 
yeast extract, 2.5 g I"1 KCl, 1 mM urea, and 1 mM arginine, pH 7.0 was used to assess growth on 
different carbon sources (glucose-GIc, pullulan-Pul) by supplementation with different 
carbohydrates at a final concentration of 1% (w/v) as previously described [53]. Growth in complex 
medium was determined by measurement of turbidity at OD600 using a SpectraMax MS (Molecular 
Devices LLC) reader. 
RNA extraction 
For RNA extraction, S. suis S10 was grown to exponential and early stationary phase in indicated in 
Fig. 5.2. 10 ml of culture was collected and centrifuged for each analyzed point. The pellet was 
immediately frozen in liquid nitrogen and stored over night at 4°C in 1.5 ml RNAIater (Ambion). To 
isolate RNA, 1.5 ml RLT lysis buffer (Qiagen) was added to the pellet dissolved in RNAIater, incubated 
at 15 min at r.t. and centrifuged (13000 g for 30 min). The cells were dissolved in 600 u.1 RA1 reagent 
(Macherey-Nagel) plus ß-mercaptoethanol and lysed using a FastPrep-24 (MP. Biomedicals, Solon, 
OH) for 6.0 m/sec at 20 sec. Total RNA was purified using NucleoSpin RNA II (Macherey-Nagel). The 
quality and the concentration of RNA were assessed with an Experion™ System (Bio-Rad) and by 
analysis of the A26o/A28o ratio (NanoDrop 8000 UV-Vis Spectrophotometer). 
Transcriptome analysis, bioinformatics tools and data mining 
A two-color microarray-based gene expression analysis was performed on a custom-made 60-mer 
oligonucleotide array (Agilent Biotechnologies, submitted in GEO under platform GPL9359) to 
determine the global gene transcription levels of WCFS1 and the lp_2991 deletion mutant. Cy3- and 
Cy5-labeled cDNAs were prepared using a Cyscribe post labeling kit (GE Healthcare, United 
Kingdom). Slides were pre-hybridized for 45 min at 42°C in 20 ml prehybridization solution (1% 
bovine serum albumin, 56SSC, 0.1% sodium dodecyl sulfate; filtered), washed in filtered deionized 
water, and dried. Co-hybridization with Cy5-and Cy3-labeled cDNA probes was performed overnight 
at 42 °C for 16 h in Slidehybttl (Ambion, Austin, TX). The slides were then washed twice in 16SSC -
0.1% sodium dodecyl sulfate (16SSC is 0.15 NaCI plus 0.015 M sodium citrate) and twice in 16SSC 
before they were scanned. Slides were scanned with a ScanArray Express 4000 scanner (Perkin 
Elmer, Wellesley, MA), and image analysis and processing were performed using the ImaGene 
141-
Chapter 5 
Version 7.5 software (BioDiscovery Inc., Marina Del Rey, CA, USA). The microarrays were scanned at 
different intensities. For each of the individual microarrays the best scan was selected on the basis 
of signal distribution (combination of a low number of saturated spots and a low number of low 
signal spots). The data were normalized using lowess normalization as available in MicroPrep [117]. 
The data were corrected for inter-slide differences on the basis of total signal intensity per slide 
using Postprep [117]. The median intensity of the different probes per gene was selected as the 
gene expression intensity. CyberT was used to compare the different transcriptomes, taking into 
account the duplicates (dye swaps) of each of the conditions [118]. This analysis resulted in a gene 
expression ratio and false discovery rate (FDR) for each gene. Genes with FDR values under 0.05 and 
with expression ratios greater than 2 or lower than -2 were considered to be statistically significant 
and biologically relevant. All microarray data are MIAME compliant and are available in GEO. 
Venn diagrams 
Differential gene expression of S. suis bacteria grown in CM supplemented with pullulan (Pul) or 
glucose (Glc) and harvested at early exponential (E) or early stationary (S) phase was cross-
compared in different combinations (Pul_E vs Glc_E, Pul_S vs Glc_S, Pul_E vs Pul_S and Glc_E vs 
Glc_S). Overlapping and unique differentials were visualised using Venn diagrams generated by the 
on-line software program Venny, available at http://bioinfogp.cnb.csic.es/tools/vennv/index.html. 
Enrichment analysis using BLAST2G0 
BLAST2G0 was used to annotate all known S. suis genes and proteins according to standard Gene 
Ontology (www.geneontology.org) nomenclature. BLAST2G0 uses the integrated Gossip package 
[59] for statistical assessment of differences in GO term abundance between two sets of sequences. 
This package employs the Fisher's Exact Test and corrects for multiple testing. For our analysis we 
GO term enrichment using standard and more specific settings, employing similarity term filter 
settings ranging from P or FDR<0.05 to P or FDR<0.01. The similarity term takes into account the 
sequence similarity to the homologue sequence (max.sim), modulated by the individual evidence 
code (EC) of its corresponding annotations. 
Searching ere motifs in the S. suis genome using MEME 
The MEME (http://meme.sdsc.edu/meme/meme.html) software suite (version 4.1.0) was used for 
the identification of motifs 0 M 1 and 0M2. MEME represents motifs as position-dependent letter-
probability matrices which describe the probability of each possible letter at each position in the 
pattern and uses statistical modeling techniques to identify likely motifs within the input set of 
sequences [119]. After alignment of sequences that are thought to contain conserved motifs, MEME 
produces a consensus sequence and a position- specific probability matrix, which has probabilities 
associated with each base at each position. As input, we used the promoter sequences of the MdxE 
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and MalE genes, with well-characterised ere sites, from Bacillus and Listeria. A range of motif widths 
(15 nt in length) and zero or one motif per sequence were specified in our queries. 
We then applied the FIMO (Find Individual Motif Occurences) program, using the motif weight 
matrix from the MEME program, to search for the operator motifs (OMs) in the operon as well as for 
a random sequence model based on the letter composition of the target sequence. The algorithm in 
MAST calculates position scores for the motif at each possible position within a sequence [74]. Only 
the motif hits with a position-specific goodness-of-fit P value of less than 10 were considered to 
identify putative CcpA binding sites. In silico searches and comparisons of predicted ere sites within 
the 5. suis genome sequence and reconstruction of ere locations in the predicted opérons was 
conducted using the corresponding databases provided by the MicrobesOnline web server 
(http://microbesonline.org). As a further check for our predictions, we performed a cross-database 
comparison using predicted reference sets of cre-containing régulons that had been annotated for 
Streptococcus species and deposited within the RegPrecise database (http://regprecise.lbl.gov) 
[120]. 
Electron microscopy 
For morphological analysis of the capsule structure, samples of exponential phase (~ 0.5 OD600) 
bacteria were fixed according to the lysine-acetate-based formaldehyde/glutaraldehyde ruthenium 
red-osmium (LRR) fixation procedure, as described previously [8] and studied by JEOL JEM 2100 
transmission electron microscope at magnifications of 25.000 X. 
Titration of hemolytic activity 
The hemolytic activity was assayed as previously described [79]. Two different independent assays 
using triplicate were carried out. Briefly, S. suis bacteria were grown in CM+GIc and CM+Pul at three 
different growth stages: lag (OD600 0.1-0.2) exponential (OD600 0.2-0.5) and stationary (ODG00 0.5-
0.7). The supernatant was collected from 1 ml for each culture by centrifugation at max speed 
(12000g x l min). 
Serial twofold dilutions (150 u.1) of test samples were prepared in polystyrene deep-well titer plates 
(Beekman) with 10 mM Tris-buffered saline (PBS, pH 7.4). Subsequently, 150 ul of a 2% (washed) 
horse erythrocyte suspension in 10 mM Tris-buffered saline containing 0.5% BSA was added to each 
well. After the wells were sealed, the plates were incubated on a Coulter mixer for 2 h at 37°C. After 
unlysed erythrocytes were sedimented by centrifugation (1500 g for 10 min), 150 ni portions of the 
supernatant were transferred to a polystyrene flat-bottom microtiter plate and measured at 540 nm 
with a microELISA (enzyme-linked immunosorbent assay) reader (SpectraMax M5, Molecular 
Devices LLC). A 100% lysis reference sample was obtained by lysing bacteria with 1% Triton-X and 
background lysis was subtracted before calculation of hemolytic activity. 
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Cell line and culture conditions 
Newborn pig tracheal cells (NPTr) [91] were maintained in Dulbecco's Modified Eagle Medium / 
Ham's F-12 (1:1), 5 itiM glutamine (Gibco) supplemented with 10% fetal calf serum (Gibco), without 
antibiotics at 37°C and 5% C02. The cells were seeded into new flasks every 4-5 days by detachment 
of cells from flasks with 0.25% w/v trypsin, 1 mM Na-EDTA (trypsin-EDTA, Gibco-lnvitrogen) and 
replacement of the medium [121]. For the adherence assay, approximately 2.3 x 105 cells per well 
were seeded in antibiotic free complete medium on 12 well tissue culture plates (Costar) and 
incubated until they reached confluence. 
Adhesion and invasion assays using NPTr cell line 
For the adhesion assay, bacteria were pelleted by centrifugation, washed with PBS and resuspended 
at 10 c.f.u./ml in fresh cell culture medium without antibiotics. Bacterial suspensions (around 1.15 x 
10 c.f.u.) diluted in cell culture medium (glucose-free DMEM) were added to wells containing a 
monolayer (2.3 x 10 cell/well) of epithelial cells in 1 ml of medium (multiplicities of infection (m.o.i.) 
were approximately 50 bacteria per cell). Plates were incubated for 2 h at 37°C with 5% C02. The cell 
monolayers were washed three times with PBS and detached and lysed by scraping in 800 u.1 of ice-
cold Milli-Q water. To enumerate the viable bacteria, serial dilutions of each cell lysate were plated 
in triplicate on Columbia sheep blood agar plates and incubated at 37°C for 24 h. The number of 
bacteria recovered in this assay was expressed as a percentage of the original inoculum. For the 
invasion assay, the co-coture bacteria-cells (m.o.i 50) were incubated for 2 h at 37 °C with 5% C02, to 
allow cellular invasion by the bacteria. The monolayers were then washed three times with PBS, 1 
ml of cell culture medium containing 100 uJ/ml gentamicin and 5 u,g/ml penicillin G was added to 
each well, and the plates were incubated for 2 h at 37 °C, 5% C02 to kill extracellular and surface-
adherent bacteria. The monolayers were washed three times with PBS, and cells were disrupted by 
the addition of 800 u.1 of ice-cold Milli-Q water and repeated pipetting to liberate intracellular 
bacteria. To enumerate the viable bacteria, serial dilutions of each cell lysate were plated in 
triplicate on Columbia sheep blood agar plates and incubated at 37°C for 24 h. The rate of invasion 
was expressed as the total number of c.f.u. recovered per well. Assays were performed in triplicate 
and repeated two times. 
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1. Ecological niches of Streptococcus suis 
Infections caused by Streptococcus suis are considered a worldwide economical problem 
for the pig industry [1]. Moreover, S. suis is emerging as a zoonotic pathogen of humans 
due increased awareness of its association with meningitis and septicaemia [2,3]. 
Although 5. suis is considered a major swine pathogen, it has been isolated from a wide 
range of different hosts including domestic animals and birds [3] and has frequently been 
found to be a normal inhabitant of the intestine of a variety of ruminants [4,5]. These 
findings indicate that S. suis can colonize and proliferate in different hosts leading to a 
complex epidemiology [6,7,8,9]. 
S. suis can colonize the buccal gingiva, tonsils, nasal conchae [10], intestine and genitals of 
weaning pigs [11,12]. Disease occurs primarily in young pigs 2-3 weeks of age whereas 
asymptomatic carriage appears to be the norm in older pigs [13,14,15]. However, also in 
young pigs colonization by S. suis does not always lead to disease [5]. 
In the study of Baele et al. (2011) [10], S. suis was found to be the most abundant bacterial 
group isolated from the 40 study pigs; but none showed any symptoms of disease. In this 
study, twelve 5. suis serotypes were found; none of the S. suis strains was of serotype 2, 
and none of the strains expressed the virulence markers MRP or EF (Chapter 1). This does 
not contradict the notion that 5. suis serotype 2 is more strongly associated with disease. 
However, in an earlier study on 38 pigs S. suis serotype 2 strains were isolated from 
diseased as well as healthy pigs [16]. In this study 3 out of the 4 (11%) of the S. suis 
isolates came from healthy pigs and produced bacteriocin-like compounds that inhibited 
growth of other 5. suis strains, as well as several streptococcal pathogens and other few 
Gram+ and - bacteria often associated with microflora of pig tonsils and nasal cavities. 
Thus it is clear that S. suis can colonize pigs asymptomatically, and as such be a member of 
the pig nasal and oral commensal microbiota. 5. suis is among the most abundant bacteria 
in pigs, and it frequently co-occurs with Rothia sp. (/?. nasimurium) [10,17]. Rothia species 
have been associated with disease, at least in human [18,19]. 
In this respect 5. suis might be considered a "pathobiont" which is the term given to a 
symbiont that does not normally elicit any pathology in the host except under special 
circumstances (e.g. in susceptible hosts and environmental conditions including altered 
microbiota). We showed in Chapter 3 and 5 that a change in diet (a diet high in 
carbohydrates and low in glucose, or vice versa) alters virulence gene expression. Thus 
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changes in carbohydrate composition and availability could have a major influence on the 
ability of S. suis to cause disease. 
Changes in commensal microbiota may also influence 5. suis pathogenicity, e.g. via 
synergistic or competitive interactions. Cooperation between bacterial pathogens in order 
to optimize metabolism via quorum sensing [20] and iron uptake [21] has also been 
described. It is therefore of interest to consider that bacteria co-occurring with S. suis 
might complement its metabolism, such as has been shown for short carbohydrate 
conversions in populations of different bacteria co-occurring in the small intestine [22]. 
1.1 Transmission of 5. suis 
Young pigs typically acquire S. suis by vertical or horizontal transmission, resulting in 
colonization of the tonsils, nasal cavity (oropharynx) and occasionally, invasive disease 
leading to bacteremia, meningitis, septicemia and arthritis. Infections of humans have 
been considered for a long time to be sporadic and to have low prevalence and only affect 
people working with pigs or pig-derived products [12]. Two recent large outbreaks that 
occurred in China [23,24,25] changed that perception of the potential threat posed by 5. 
suis bacteria to human health. The current view is that humans become infected via skin 
lesions or via an oral route, due to contact with contaminated pork [3,26]. However, in 
some cases patients did not recall any contact with pigs or pork products [27,28,29,30] 
suggesting other potential routes of transmission. For instance, clinical case studies have 
reported the presence of S. suis in the nasopharynx of workers in the pig slaughter 
industry [31]. In one study, colonisation of the mucosal epithelia with S. suis was 
estimated to be around 5.3% of the case group [32], highlighting this as a potential route 
of invasion. 
Colonization of the nasopharyngeal cavity by 5. suis was shown to be an important risk 
factor for the infection of young pigs [33,34], and in vivo distributions of bacteria have 
pointed toward the pharyngeal and palatine tonsils as principal portals of entry [35]. Other 
circumstantial evidence for invasion via the tonsils comes from the finding that 5. suis 
serotype 2 bacteria were frequently identified in the lymph nodes draining the upper 
respiratory tract [35]. 
Adhesion of S. suis to mucosal epithelia of the nasal and oral cavities is likely to be 
important for colonization, as demonstrated for other opportunistic pathogens that 
colonize the oropharynx [36,37,38]. It is still unclear what triggers the switch from an 
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asymptomatic to pathogenic association of 5. suis with the host. Vulnerability to S. suis 
infection may occur due to weaknesses in host defences including reduced antagonism by 
commensals [10,15], concurrent or sequential infections by other pathogens, or 
environmental factors such as pH and the type of nutrients that are available. 
The purpose of this thesis research was to increase our knowledge of the 
interactions of S. suis with the host in the mucosal environment. The specific aims were 
investigate the following: 
1. The interaction of S. suis with human dendritic cells which are abundant in the mucosa. 
2. The functions of a surface amylopullulanase ApuA that was predicted to be involved in 
the catalytic breakdown of complex carbohydrates found in the oropharyngeal cavity and 
intestinal tract. 
3. The mechanisms regulating expression of ApuA. 
4. How carbohydrate sources alter global regulation of metabolism and importantly, 
expression of virulence factors involved in invasion and dissemination of bacteria. 
2. Alpha-glucans degrading enzymes are key factors for 
colonization of the host oropharynx 
To colonize host mucosal surfaces, bacteria typically must i) survive in critical niches with 
limited nutrient resources, ii) compete with other commensal microbes, iii) bind residues 
of host cell receptors, and iv) avoid or tolerate the host immune defences. Typically, such 
interactions are dynamic and multifactorial and are mediated by a diversity of bacterial 
proteins including surface-exposed, cell wall-anchored and secreted proteins and 
metabolites. 
In the mammalian oropharynx and saliva, different a-glucans (e.g. starch and dextrans) 
are present at high concentrations [39,40,41,42]. Apart from high abundance of starch in 
the animal diet [40,43], eukaryotic glycogen stores, released from damaged or lysed cells 
may be an important substrate for pathogen growth during the early stages of infection 
[44]. In contrast to a-glucans, glucose, the most readily metabolized polysaccharide, is 
present in too low an amount to support S. suis growth, highlighting the need for 
alternative carbon sources to support bacterial proliferation at the mucosal surface 
[45,46]. The importance of a-glucans as substrates to the ecology of bacteria in the oral 
and oro-/nasopharynx niche is evident from the high number of a-glucans-degrading 
152-
General discussion 
enzymes, maltodextrin transport systems, and the diversity of starch metabolic pathway 
genes that are typically present in genome sequences of commensals or pathogens of the 
host mucosal epithelia [47,48,49,50,51,52,53]. 
Genes encoding carbohydrate-degrading enzymes are common in the genomes of 
streptococcal pathogens and play key roles in nutrient acquisition for colonization of 
mucosal surfaces and proliferation. Transcriptome studies of Streptococcus pyogenes 
growing in saliva and in a mouse infection model [42,54,55,56] have identified genes that 
were highly expressed during the adaptive metabolic responses of bacteria that colonized, 
or dispersed into, different host organs. Among the highly expressed genes were genes 
involved in utilization of a-glucans. The metabolism of these complex carbohydrates 
requires the presence of specific transport systems and catabolic enzymes such as 
amylase, pullulanase or amylopullulanase that permit the utilization of sugars other than 
glucose in the host mucosal environment [52]. 
This led us to consider that 5. suis might be able to survive and proliferate in host mucosal 
epithelia via the degradation of a-glucans that are present in high amounts compared to 
glucose. In Chapter 3 we characterized a large 5. suis surface amylopullulanase (we 
designated as ApuA), which is the only extracellular a-glucan-degrading catabolic enzyme 
found in the sequenced genomes of S. suis, except for the pathogenic S. suis isolate ST3 
(serotype 3) [57] which possesses an additional gene (SSUST3_0537) that is predicted to 
encode a secreted amylase. ApuA was shown to possess both a-amylase and pullulanase 
catalytic activities that can breakdown a-glucans to maltodextrins. The evolution of this 
type of bifunctional enzyme could have resulted from recombination events (fusions) 
between genes encoding an a-amylase and type I pullulanase. Similar events are thought 
to be responsible for the origin of genes encoding bifunctional endo- and exoglucanase 
enzymes in Caldocellum saccharolyticum [58]. Indeed, as shown in Fig. 3.2 of Chapter 3, 
the presence of a bifunctional ApuA gene seems to be peculiarity of S. suis and is not 
found in the sequenced genomes of other streptococcal species. The fusion of both 
catalytic functions in one protein may have provided an evolutionary advantage for S. suis. 
We hypothesized that ApuA would play an important ecological role by allowing 5. suis to 
remain competitive in the environment of the host where environment where food 
sources change. As expected, our phenotypic characterization of apuA mutant 
demonstrated that ApuA was required for fermentative growth on food-derived starch 
and glycogen. Glycogen released from damaged host cells may also be degraded by ApuA 
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and used for fermentative growth. This agrees with the findings that both PulA from S. 
pyogenes and the related pneumococcal pullulanase SpuA bind with high affinity to 
alveolar type II cell glycogen in the mouse lung tissue [44]. 
Apart from its role in carbohydrate utilization, the extracellular pullulanase from S. 
pyogenes has been shown to bind to several carbohydrates including submaxillar mucin 
[49]. Furthermore, recombinant SAP, a type I pullulanase from Streptococcus agalactiae, 
was shown to bind human epithelial cells in vitro [59,60]. In Chapter 3 we investigated the 
possible role of S. suis ApuA in adhesion to a tracheal newborn pig cell line (NPTr) as in 
vitro model. In adhesion assays, our S. suis apuA mutant showed significantly less 
adherence to NPTr cells compared to the wild type S. suis. The host molecule or receptor 
bound by ApuA in vivo has not been identified so far. In S. pneumonia a library of 300 
(PhoA+) fusion mutants were screened against multiple eukaryotic sugar receptors [61]. A 
mutant pullulanase (PulA-PhoA+) was shown to have lost the capacity for adhesion to ß( l -
3)Gal glycoconjugate receptor [62]. Similar studies involving eukaryotic sugar receptors 
need to be performed with S. suis to identify which receptors they bind to in vivo in pigs 
and humans. ApuA is one of four adhesins identified in vitro for 5. suis, together with 
streptococcal adhesin P (SadP) [63], 6-phosphogluconate-dehydrogenase (6PGD-SSU1541) 
[64] and glutamine synthetase (GlnA-SSU0157) [65]. The latter 6PGD and GlnA are 
cytoplasmic glycolytic enzymes that are present on the surface of other pathogens and 
reported to be involved in adhesion to epithelia. 
3. Carbohydrate metabolism in 5. suis 
Before the completion of this thesis, there was little published information about 
carbohydrate metabolismin S. suis and its implications for colonization of host tissues, 
virulence factors production and tissue invasion. Given that we had established a role for 
ApuA in adhesion and as a potential virulence factor involved in mucosal colonization, we 
sought to gain a better understanding of its regulation with the aim of finding correlations 
between the regulation of carbon metabolism and virulence. 
We hypothesized that, in order to most efficiently use the entire spectrum of bacterial 
factors involved in adhesion and nutrient acquisition during the colonization of host 
mucosa, enzymes such as ApuA would need to be tightly regulated, depending on 
substrate availability. Genetic regulatory systems are fundamental to optimize (in terms of 
energy production) expression of adhesins and other colonization factors in response to 
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changes in the environment. The regulation of ApuA was studied using two different 
approaches, one involving transcriptome and qPCR transcript quantification of 5. suis 
grown in defined complex media (CM) containing different carbohydrates, and one 
focusing on transcription factor binding to the apuA promoter region. 
At the start of our study, little was known about the global metabolic potential of S. suis 
except for annotation of the genome and proteome sequence of S. suis Pl/7. The latter is 
a sequenced strain that is more than 99% identical to the often used S10 strain. We 
functionally annotated the Pl/7 strain using Gene Ontology (GO) terms and EBI protein 
domain annotations. We found that 1447 ORFs (73.5% of the total number of Pl/7 ORFs) 
matched known proteins [66] and we constructed a metabolic map, using the Cluster of 
Orthologous Group (COG) annotations of all known 5. suis proteins. The metabolic map of 
5. suis is described first time in this thesis and includes more than 80% of the metabolic 
maps known for other Streptococcus species (Chapter 5). The metabolic map indicated 
that like other lactic Streptococcus species, 5. suis is able to ferment a wide diversity of 
sugars, including mono- and di-saccharides but also a-glucans such as glycogen, starch and 
pullulan, to glucose [67]. To date, two ABC transporters and 17 phosphotransferase 
systems (PTSs) for the uptake of carbohydrates have been predicted for S. suis in the KEGG 
database, highlighting the potential for S. suis to ferment a variety of carbohydrates. Like 
other Streptococcus species, S. suis mainly produces energy through degradation of 
glucose via two different metabolic routes: homolactic or mixed-acid fermentation, 
depending on the environmental growth conditions. 
Comparative transcriptome analysis of S. suis grown in pullulan or glucose revealed that 
growth in pullulan induced expression of the maltodextrin utilization gene cluster that 
includes ApuA and the corresponding PTS and ABC transporters. Also induced were two 
intracellular phosphatase enzymes, glgl and malQl, predicted to convert maltodextrins to 
glucose-IP (GlclP). GlclP is then transformed, by intracellular phosphoglucomutase 
(pgm), into glucose-6P (Glc6P) that may enter glycolysis. However, expression of the 
glycolysis pathway genes did not change significantly during growth in pullulan compared 
to glucose, suggesting that activity of this pathway was not altered during growth in both 
carbon sources. Rather, it appeared that the excess of intracellular glucose was converted 
in glycogen as energy reserves or had entered into hexose-pentose carbohydrate 
pathways as an alternative to glycolysis. We noted that the genes that participate in the 
Leloir pathway were highly induced in pullulan compared to glucose. Leloir pathway 
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enzymes catalyze the interconversion of glucose or galactose to activated sugars (UDP-GIc 
and UDP-Gal) which are key components in the biosynthetic pathway of extracellular 
polysaccharides (EPS) production. S. suis, as other lactic acid bacteria, appears to be able 
to metabolize pyruvate, the end product of fermentation, to different end-products 
including lactate, acetate ethanol and formic acid. This pathway appeared to be 
upregulatedduring growth in pullulan, as the genes involved in pyruvate conversion to 
ethanol and lactate were transcribed at higher levels in pullulan compared to glucose. 5. 
suis has an incomplete tricarboxylic acid cycle (TCA cycle) (Fig. 6.1) as reported for other 
Streptococcus pathogens [68,69] and is unable to generate ATP from oxidative 
phosphorylation. 
Other metabolic pathways induced during growth in pullulan were lipid metabolism, 
important for generating lipoteichoic acid (LTA) precursors and membrane phospholipids 
important during adhesion/invasion [70,71], and metabolic pathways for arginine and 
proline, which in S. suis and other Firmicutes are used as reducing agents to maintain 
redox balance [72] during metabolism of pyruvate. 
In order to investigate the effects of a-glucans on global gene expression, we performed a 
transcriptome analysis of S. suis grown in defined complex media (CM) supplemented with 
an a-glucan (i.e. pullulan) or glucose. Fermentation of a-glucans enhanced the metabolic 
activity of S. suis, resulting in a higher biomass production (Fig. 5.1) and production of 
intracellular energy reserves (Fig. 6.1). 
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Aminoacid 
Fig. 6.1: Diagram depicting the major changes in metabolism of S. suis based on transcriptome analysis of bacteria grown in CM 
(see Methods, Chapter 5) supplemented with pullulan and compared to growth in CM with glucose. Continuous and dotting lines 
indicate induction and repression respectively. 
4. Transcriptional regulation of carbohydrate metabolism 
The expression of apuA was highly induced in presence of pullulan or maltotriose (which is 
the most abundant degradation product of pullulan) and repressed in presence of glucose. 
An analysis of the promoter region of ApuA revealed the presence of two transcription 
binding motifs (Chapter 4). Studies conducted on the molecular mechanisms of regulation 
of apuA (Chapter 4) showed that apuA expression was co-regulated by catabolite control 
protein A (CcpA) and a dedicated regulator (ApuR) that we suggest to be an activator that 
induces apuA transcription in the presence of (phosphorylated) maltotriose or maltose. 
Additionally, CcpA, in the presence of rapidly metabolized sugars such as glucose, 
mediates a repression of apuA transcription upon binding to catabolite response elements 
(ere) sites that we predicted to overlap with the apuA -35 promoter region. Similar binding 
sites for ApuR and CcpA were also found in the promoters of the maltodextrin-specific 
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ABC transporter operon and 4-a-glucanotransferase (malQl) (Chapter 5). We proposed 
that in vivo, dual regulation may ensure that apuA is expressed in the mucosa where 
glucose levels are low and when the substrates that can be degraded by ApuA are present 
(Fig. 5.10). 
Recently, the role of CcpA was investigated by microarray analysis of S. suis strain S10 and 
its isogenic hccpA mutant growth in standard THB culture media. Inactivation of ccpA in 5. 
suis altered expression of 259 genes (13.2% of the genome) including cell surface-
associated virulence factors and capsule genes [73]. In Chapter 5 we searched for ere 
motifs in 5. suis Pl/7 and predicted for 172 genes (8.7% of the genome; this number 
included genes belonging to the same operon) that these were under direct control of 
CcpA (Table 5.1). The number of genes is lower than that affected in the bccpA deletion 
mutant possibly due to the inaccuracy of informatics predictions or indirect effects in the 
mutant background. Genes belonging to all main functional classes were represented in 
the ccpA regulon prediction; a relative enrichment of cre-sites was found in the upstream 
regions of genes predicted to encode PTS and ABC carbohydrate transporters (17%), 
proteins with regulatory functions (10%), and enzymes involved in carbohydrate 
metabolism (25%) and in virulence (8%). 
5. Carbon catabolite control and virulence gene regulation in 5. 
suis 
As mentioned above, bacteria alter transcription of carbohydrate utilization genes and 
virulence factor production in response to changes in environmental conditions 
encountered during host colonization and infection [56,74,75,76]. Therefore, pathogenic 
bacteria have developed molecular strategies to directly link regulation of carbohydrate 
utilization and virulence factor production. CcpA has been shown to be important for 
virulence of several streptococcal species, influencing growth, haemolysin production, 
biofilm formation and capsule expression [56,77,78,79]; several virulence factors including 
capsule genes and cytotoxins are directly controlled by CcpA [77,79,80,81,82]. CcpA 
mutants in Streptococcus pneumoniae are often attenuated for virulence in mouse 
infection models [77,80]. However, in Streptococcus pyogenes, CcpA depletion did lead to 
both hypervirulence and hypovirulence, in the same set-up of experimental mouse 
infection [56,82]. 
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Table 6.1: S. suis virulence genes differentially expressed in pullulan (P) compared to glucose (Glc) 
Annotation 
Galactosyl / rhamnosyl transferase 
Tyrosine-protein kinase Wze 
N-acetylneuraminic acid synthase 
Peptidoglycan GIcNAc deacetylase 
D-alanine-poly(phosphoribitol) ligase 
Fibronectin-fibrinogen binding 
Enolase 
Glyceraldehyde-3-P-dehydrogenase 
Di-peptidyl peptidase IV 
6-phosphogluconate-dehydrogenase 
Amylopullulanase 
Glutamine synthetase 
Streptococcal adhesin P 
Arginine deaminase 
Anchored DNA nuclease 
Cell envelope proteinase 
Metallo-serine protease 
Suilysin 
Hyaluronate lyase 
Sortase A 
Serum opacity-like factor 
S-ribosyl homocysteinase 
Muramidase released protein 
Extracellular protein factor 
Protein 
CpsE/F 
Cps2C 
NeuB 
PgdA 
DltA 
FbpS 
eno 
GAPDH 
DpplV 
6-PGD 
ApuA 
GlnA 
SadP 
ArcB 
SsnA 
SspA 
IgAl 
Sly 
Hyl 
SrtA 
OFS 
LuxS 
MRP 
EF 
Function 
CPS biosynthesis 
CPS biosynthesis 
Sialic acid synthesis 
Peptidoglycan 
LTA D-alanylation 
Adhesion ECM 
Adhesion ECM 
Adhesion ECM 
Adhesion ECM 
Adhesion epithelium 
Adhesion epithelium 
Adhesion epithelium 
Adhesion epithelium 
Resistance to acidity 
Host DNA degradation 
Subtilisin-like protease 
IgAl protease 
Haemolysin 
Hyaluronan degradation 
Protein sorting 
Serum opacification 
Quorum sensing 
Unknown 
Unknown 
Virulence 
Attenuated-pi g 
Attenuated-pig 
Attenuated-pig 
Attenuated-pig 
Attenuated-pig 
Attenuated-pig 
no Mutant 
no Mutant 
Attenuated-mouse 
No Mutant 
Not tested 
Attenuated-mo use 
no Mutant 
Not tested 
Not tested 
Attenuated-mouse 
Attenuated-pig 
Unaffected-pig 
Not tested 
Attenuated-pig 
Attenuated-pig 
Attenuated zebrafish 
Unaffected-pig 
Unaffected-pig 
P/GIc 
U 
D 
U 
U 
U 
D 
U 
U 
u 
u 
u 
u 
u 
D 
D 
U 
U 
P/GIc upregulated (U) or downregulated (D) expression when S. suis was grown in pullulan (P) compared to glucose (Glc) 
These results could be explained by considering that CcpA may have a pleiotropic effect in 
host colonization and virulence since it can mediate the repression or activation of 
different virulence factors, depending on the location in the body where 5. suis is actually 
dispersed during the progression of the infection. 
Our transcriptome and ere site analyses predicted that CcpA regulated multiple virulence 
genes in S. suis and that carbohydrate utilization would play a key role in virulence 
regulation in vivo. In Chapter 4 and 5 we reported that the expression of 17 virulence 
genes associated with mucosal adhesion and invasion and avoidance of host defences 
were significantly differentially expressed when bacteria were grown in CM supplemented 
with pullulan (Table 6.1). 
One of these genes encodes a secreted suilysin, a pore-forming toxin which has been 
shown to play an important role in damaging host epithelial [83,84], endothelial [70,85] 
and immune cells [86]. Suilysin is cytotoxic to different cell and tissue types including 
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leukocytes [1,3] thereby facilitating bacterial tissue invasion. Increased expression of the 
suilysin gene by S. suis bacteria grown in pullulan (compared to glucose) was concomitant 
with a higher suilysin production in vitro and an increased hemolytic capacity of bacteria in 
vitro assays using horse red blood cells (Chapter 5). 
Additionally, a hyaluronidase (Hyl) gene, encoding an enzyme which is predicted to break 
down hyaluronan, a component from the extracellular matrix of eukaryote connective 
tissue cells, was highly induced in pullulan. Hyaluronidase, in combination with suilysin, 
could contribute to destruction of epithelial tissue, thereby promoting the release of 
glycogen from host cells. Glycogens can be degraded by amylopullulanase, and the 
degradation products (maltotriose/maltodextrin) can be imported by the invading 
bacteria via specific transport systems (MalT, part of the corresponding PTS and MalX part 
of a specific ABC transporter) and then metabolized to sustain bacterial proliferation in an 
infection site (Fig. 6.2). 
Bacterial-induced damage to host epithelia (e.g. brought about by suilysin) may expose 
ECM and may contribute to microbial colonization and infection. Some virulence genes 
could encode factors that contribute to bacterial binding to extracellular matrix (ECM) 
components such as collagen and fibronectin (Table 6.1). 5. suis encodes several additional 
secreted surface proteins that may bind ECM, two of which, GAPDH and peptidyl 
peptidase DppIV, were also induced in presence of a-glucans (Fig. 6.2). 
Bacteria that have translocated across epithelia and have invaded the connective tissue 
are very likely to be perceived by the mucosal immune system including dendritic cells 
(DCs). In Chapter 2, we investigated the fundamental role of capsule during interactions of 
5. suis bacteria with DCs. In addition to capsule production, S. suis may use additional 
virulence factors that modulate DC functions and escape immune surveillance, mainly by 
modulating cytokine release and avoiding phagocytosis. Invading 5. suis bacteria may also 
interact with neutrophils at infection sites. We observed that the ssnA gene that encodes 
a secreted DNase and is potentially involved in the breakdown of neutrophil entrapments 
(NETS) [87], was upregulated in bacteria grown in presence of pullulan (compared to 
glucose). Human and pig plasma cells in the lamina propria secrete large amounts of 
immunoglobulin A (slgA) which is transported to the lumen and secreted via epithelial 
cells into the lumen. Secretory IgA can effectively limits translocation of bacteria and 
several bacterial pathogens encode IgA proteases. In S. suis a metallo-serine protease with 
homology to IgA proteases was shown at hogh concentrations to cleave human IgA [88]. 
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In our experiments, the SspA gene which encodes a secreted serine protease was also 
induced in pullulan compared to glucose. This protease can degrade eukaryote pro-
inflammatory interleukin-8 (IL-8) molecules thereby inhibiting Chemotaxis and infiltration 
of neutrophils and other leukocytes to infection sites in vivo [89,90]. Note that these 
predicted or validated virulence genes were all induced when 5. suis bacteria were grown 
in CM supplemented with pullulan (compared to glucose) and that induction of these 
genes correlated with a significantly increased adherence and cell invasion of bacteria in 
vitro assays using a porcine tracheal epithelial cell line (Chapter 5). 
Defence 
> Proliferation 
Fig. 6.2 Virulence factors upregulated in pullulan and their (confirmed or proposed) role during adhesion to and invasion of 
host mucosal epithelia. 
Secreted suilysin promotes S. suis invasion, possibly by damaging host epithelial barriers exposing basolateral membrane 
receptors or extracellular matrix components (ECM) for interactions with S. suis. Surface-expressed proteins DppIV and GAPDH 
promote binding to ECM components, such as fibrinogen and fibronectin, and degradation of host cells and tissues once the 
epithelial barrier has been breached. Several 5. suis adhesins (ApuA and SadP) and LTA have been reported to contribute to 
cellular invasion [70]. The bacteria can proliferate upon degradation by ApuA of dietary a-glucans or eukaryotic glycogen coming 
from damaged cells in the infection site. Other secreted or cell wall-anchored proteins (IgAl, SsnA and SspA) protect the bacteria 
against the mucosal immune response. 
Abbreviations: ECM, extracellular matrix; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Sly, suilysin; Hyl, hyaluronidase; 
Dpp IV, peptidyl peptidases; ArcB, arginine deaminase; ApuA, amylopullulanase; SadP, streptococcal adhesin P; SspA, cell 
envelope proteinase; SsnA, (extracellular} DNA nuclease; Igal, metallo-serine protease; CPS, capsule; LTA, lipoteichoic acid. 
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6. The role of 5. suis capsule during infection 
In a previous study, higher levels of adhesion and invasion were obtained with 
unencapsulated mutants compared to wild type strains [91]. Unencapsulated S. suis 
strains, isolated from pigs that had developed endocarditis, also showed increased 
adherence to HEp-2 cell lines and porcine and human platelets compared to capsulated 
strains [91,92]. These findings suggest that the presence or composition of the capsule or 
its charge, may hinder the binding of surface adhesins to receptors on epithelial cells. A 
recent genetic analysis of the capsular polysaccharide synthesis locus of fifteen 5. suis 
serotypes predicted that capsules of serotypes 1, 2, and 14 may contain sialic acid [93]. In 
Streptococcus agalactiae, capsule sialic acid has been shown to increase the hydrophilic 
surface properties of the bacteria and to have an inhibitory effect on phagocytosis [94]. 
Based on these findings, it has been hypothesized that during infection, S. suis could down 
regulate capsule expression for increased adhesion to epithelial cells and, after passing 
the epithelial barrier, in response to external stimuli and after entering the bloodstream, 
up regulate capsule expression for protection against phagocytosis [1]. In a recent study, a 
àccpA deletion mutant of S. suis showed reduced transcription of the capsule gene cps2A 
and reduced thickness of the capsule in electron micrographs [73]. However, reduced 
capsule thickness was not observed in our study when S. suis was cultured in CM plus 
pullulan but no glucose (Chapter 4). The reason for these different findings is not clear but 
may be related to the use of a different serotype 2 strain or differences in the growth 
media (THB vs. CM supplemented by glucose or pullulan). Furthermore, reduced 
expression of the capsule during colonization remains to be proven in vivo. 
The capsule was previously shown to be essential for full virulence of S. suis in a porcine 
infection model [95]. However, not all capsulated isolates of S. suis (including serotype 2) 
are virulent, highlighting the (existence and) relevance of additional virulence factors in 
disease pathogenesis [1]. The capsular polysaccharide was shown to interfere with 
phagocytosis by porcine dendritic cells (DCs) and consequently, the level of DC maturation 
and cytokines production was reduced compared to an unencapsulated strain [96]. DCs 
are important sentinels in the host mucosa that play a key role in immune homeostasis 
and tolerance [97]. Phagocytosis of invading microbes typically results in DC activation and 
antigen presentation to T cells in the Peyer's patches or mesenteric lymph nodes. 
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Cytokines secreted by activated DCs have a major influence on T cell polarization, 
differentiation and clonal expansion [98]. 
Considering the emergence of 5. suis as a significant cause of meningitis in humans, we 
investigated the effect of different European serotypes that have been associated with 
human infections on the maturation and expression of cytokines in human monocyte-
derived DCs. As references, we also included the capsulated S. suis serotype 2 (SS2) and its 
own unencapsulated mutant (SS2J28) in these DC assays. Additionally, we compared the 
efficiency by which the different isolates were phagocytosed by DCs and studied the 
intracellular survival of internalized S. suis serotype 2 isolates. We measured a high 
variation in the induction of cytokine profiles and resistance to phagocytosis between the 
tested strains; the unencapsulated mutant SS2J28 was the most effective in stimulating 
and activating DCs. Interestingly, the capsulated SS2, which is the serotype most 
commonly associated with invasive disease in pigs and humans [99], was least effective in 
activating DCs. This might be due to presence of sialic acid in the capsule. Sialylated 
capsules and sialylated lipo-oligosaccharides are known to render bacteria more resistant 
to complement killing, and sialylation can affect bacterial interactions with neutrophils 
and epithelial cells [94]. 
The contribution of capsule to resistance to phagocytosis became clearly apparent when 
comparing the significantly higher phagocytosis of the unencapsulated SS2J28 with the 
much lower phagocytosis of SS2 capsule-bearing bacteria. It appears that the presence of 
capsule during colonization is needed to shield the bacteria from phagocytosis by DCs. To 
rule out the possibility that the quantified differences in phagocytosis of SS2 and the 
unencapsulated SS2J28 by DCs might be due to strain variation in intracellular survival, we 
measured kinetics survival over a period of 4 hours after phagocytosis. We found that 
once internalized, both the wild-type strain and its unencapsulated SS2J28 were killed at 
similar rates. 
Surprisingly, after 24 hours of incubation, we were still able to recover 103 CFU/ml from 
both strains. This has important consequences for pathogenesis because activated DCs 
eventually undergo apoptosis and may release viable 5. suis. As DCs traffic from the 
mucosa via the blood to lymphoid tissues [35], intracellular survival may enable 
phagocytosed S. suis to disseminate in the body and contribute to invasive disease 
(Chapter 2). 
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7. A revised model of 5. suis colonization and pathogenesis 
Based on the literature and novel results obtained in the course of this thesis we propose 
a revised model for colonization and pathogenesis taking into account the role of 
carbohydrate metabolism (this thesis; Fig. 6.3). 
S. suis bacteria, upon entering the host by a nasal or oral route, will colonize the mucosal 
epithelia. The composition of carbohydrates within this niche can be highly variable 
because of differences in parameters such as diet and resident microbiota. When the local 
carbohydrate composition is low in glucose and high in a-glucans, S. suis bacteria may 
behave as described in Chapter 3 and we propose that ApuA may contribute to adhesion 
of bacteria to host mucosa and acquisition of mucosal carbohydrates (Fig. 6.3 step A). 
During this colonization phase, the capsule may be thinner than when the bacteria are 
growing inside the body to promote adhesion of bacterial surface structures to host 
epithelia, possibly to specific epithelial receptors (Fig. 6.3 step A). 
Invasion of host mucosa may be a consequence of bacterial translocation across epithelia 
or after internalization and transport of bacteria by mucosal DCs (Chapter 2) (Fig. 6.3 step 
B). Eukaryotic glycogen, released by (suilysin) damaged host cells, can be used as substrate 
by ApuA and fermented during growth (Fig. 6.3 step C). Once bacteria have breached the 
epithelium and reach the loose connective tissues of the lamina propria, adhesins and 
proteases such as hyaluronidase are thought to bind and digest components of the ECM, 
promoting spreading of the infection (Fig. 6.3 step C). In the tissues and bloodstream, 
glucose concentrations are substantially higher compared to oral and nasal mucosa or 
saliva. The higher (around 5 mM) glucose concentrations will induce a change in metabolic 
gene expression in order to optimize bacterial metabolism and survival. In presence of 
high concentrations of glucose capsule genes will be induced and capsule thickness will 
increase to protect S. suis from phagocytosis by leukocytes recruited to the site of 
infection (Fig. 6.3 step D). 
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Fig. 6.3: S. su« colonization model of host mucosal epithelia. Sly, suilysin; Hyl, Hyaluronidase; CPS, capsular polysaccharides; DC 
dendritic cells, M o / M Monocytes/Macrophages, IL8-IL10-IL12-TNFa interleukins. The description of pathogenesis steps are 
found in the text. 
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8. The future of 5. suis research in the veterinary and medical 
field. 
S. suis continues to be an unresolved problem for the pig industry due to the lack of new 
preventive measures. New insights from our work suggest a few possible strategies to 
"combat" this important swine and human pathogen. 
1. Is ApuA a vaccine target? Possibly not since apuA may not be expressed in blood. 
However it could be useful to immunize sows with ApuA and test if anti-ApuA 
antibodies in the colostrum protect pigs against pathogenic colonization by S. suis. In 
order to do so, we should validate that ApuA (or other adhesins mentioned in this 
thesis) is (are) expresssed and immunogenic in vivo. Adhesins with demonstrated in 
vivo functionality could be combined in a single vaccine and tested. 
2. In pigs, S. suis is frequently present in the oral cavity. It may be worthwhile 
determining which members of the microbiota could influence 5. suis colonization 
and invasion of the host mucosa. 
3. What is the contribution of resident microbiota in suppression or induction of 
pathogenic factors in 5. suis? If S. suis could be suppressed by certain bacterial 
groups, this could indicate novel approaches for 5. suis control. 
4. In addition, could the diet be a major factor in promoting S. suis pathogenicity while 
at the same time, reducing competition by other bacteria? 5. suis infections of piglets 
are most common around weaning, when piglets no longer receive the sow's milk 
but instead, receive solid pig feed. Interestingly, starch is among the most abundant 
carbohydrate present in the feed of weaned piglets. Since the extracellular ApuA 
enzyme is a unique feature of S. suis, we propose that the unique (compared to other 
bacteria that do not possess extracellular ApuA) capacity of 5. suis to degrade starch 
provides it a major advantage over other resident bacteria. We propose that the 
starch from the piglet's feed provides a rich source of nutrients for S. suis but not for 
other bacteria that lack extracellular ApuA enzymes. Extracellular ApuA therefore 
provides S. suis a huge temporal competitive advantage. This could explain the 
frequent infections of weaned piglets, whereas infections of piglets receiving milk or 
of adult pigs occur far less often. We propose that it could be of interest to modify 
dietary composition to promote growth of competitive bacteria. 
166-
General discussion 
The last decade has clearly highlighted the clinical relevance of human infections by S. suis 
and the increasing numbers of cases of human infections reported in the literature. 
1. How does S. suis colonize the human mucosa cause and which route(s) is used to 
invade the host? Contaminated pork products have been demonstrated as a source 
for S. suis infections. A possible route of human entry leading to infection could be 
via colonization of the oral cavity, and then enter a bloodstream or other route to 
the brain. 
2. What determines differences in human or pig dendritic cell responses to 5. suis? it 
appears that sialic acid decorations could play a role here [100] although capsule 
sialic acids do not appear to function as virulence factor for serotype 2 isolates [101]. 
3. What (if any) are the correlations between 5. suis serotype and an isolate's capacity 
to disperse and cause disease? It is clear that especially serotype 2 is associated with 
human disease, and that distribution of highly virulent isolates in humans may 
change considerably within a decade [102,103]. 
There are many more research questions to be addressed, all relating to pathogenicity, 
ecology and infection of different hosts by S. suis. Based on the global distribution of 5. 
suis, and increased awareness of S. suis as a cause of human meningitis we anticipate that 
clinical relevance of S. suis as a human pathogen will increase during the coming years. 
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Summary 
Streptococcus suis (Firmicutes, Lactobacillales) is a major pathogen of swine and an 
emerging zoonotic pathogen that induces diverse serious diseases including septicaemia 
and meningitis. 5. suis bacteria show clear characteristics of pathobionts, which are 
symbionts that do not normally elicit any damage in the host except under specific 
circumstances (e.g. host hypersusceptibility or major changes environmental conditions 
including changes in microbiota composition and carbon sources). The purpose of this 
thesis research was to increase our knowledge of the interactions of 5. suis with the host 
mucosa and to investigate conditions that could alter virulence in 5. suis. 
The interaction of 5. suis with human dendritic cells was investigated by measuring 
phagocytosis and intracellular survival of different strain serotypes. Pathogen adhesins 
play a major role in colonization of the host which is typically a re-requisite to cause 
disease. Therefore, the role of an extracellular surface amylopullulanase (ApuA) in 
bacterial adhesion to porcine tracheal epithelial cells was investigated. ApuA indeed 
contributed significantly to bacterial adhesion to host cells and was also required for the 
utilization of a-glucans for fermentative growth. The expression of apuA gene was shown 
to be regulated by the presence of a-glucans (specifically pullulan) and maltotriose a 
breakdown product generated by the catalytic activity of ApuA. To understand the 
mechanisms regulating expression of apuA the roles of an upstream transcriptional 
regulator (ApuR) and the carbon catabolite control protein A (CcpA) were investigated. 
From these studies, it became clear that growth of bacteria in glucose or a-glucans greatly 
impacted on bacterial growth and possibly, on virulence. To determine whether 
carbohydrate sources could alter the global regulation of metabolism and the expression 
of virulence factors, 5. suis whole-genome gene expression microarray experiments were 
performed. Based on the recent literature and novel results obtained in the course of this 
thesis, a revised model for colonization and pathogenesis of 5. suis was proposed, taking 
into account the role of carbohydrate metabolism. According to the model, 5. suis 
bacteria, upon entering the host by a nasal or oral route, colonize mucosal epithelia. The 
composition of carbohydrates within this niche can be highly variable due to differences in 
parameters such as diet and resident microbiota. When the local carbohydrate 
composition is low in glucose but high in complex a-glucans, the expression of several 
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virulence factors is upregulated. This thesis exemplifies how carbon sources determine 
genetic regulation of S. suis metabolism and virulence. The results described in this thesis 
suggest how dietary carbohydrates could influence S. suis virulence and provide 
information that may contribute to the rational design of novel strategies to control this 
emerging zoonotic pathogen. 
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Streptococcus suis (Firmicutes, Lactobacillales) is een belangrijk pathogeen van varken en 
een opkomend zoonotisch pathogeen van de mens dat een aantal uiteenlopende ernstige 
ziektes kan veroorzaken inclusief septicemia en hersenvliesontsteking. 5. suis bacteria 
vertonen duidelijke kenmerken van pathobionten, oftewel symbionten die onder normale 
omstandigheden geen schade in de gastheer veroorzaken behalve onder specifieke 
omstandigheden (bv. hypervatbaarheid van de gastheer of drastische veranderingen in de 
omgeving waartoe veranderingen in microbiota samenstelling en koolstof bronnen 
behoren). Het doel van dit onderzoek was het vergroten van onze kennis omtrent de 
interacties van 5. suis met de gastheer mucosa en te onderzoeken welke omstandigheden 
de virulentie van S. suis zouden kunnen veranderen. 
De interactie van 5. suis met humane dendritische cellen werd onderzocht door 
fagocytose en intracellulaire overleving te meten van een aantal isolaten met 
verschillende serotypes. Pathogeen adhesines spelen een belangrijke rol in kolonisatie van 
de gastheer, een algemene voorwaarde om ziekte te veroorzaken. Om die reden werd de 
rol van een extracellulair oppervlakte amylopullulanase (ApuA) enzym in adhesie van 
bacteriën aan varkens trachéale epitheel cellen onderzocht. ApuA droeg inderdaad 
significant bij aan bacterie adhesie aan gastheercellen en was ook noodzakelijk om a-
glucanen voor fermentatieve groei te kunnen gebruiken. Het kon aangetoond worden dat 
de expressie van het apuA gen gereguleerd werd door de aanwezigheid van a-glucanen 
(vooral pullulan) en maltotriose, een afbraakprodukt dat gevormd werd door de 
katalytische activiteit van het ApuA enzym. Om de mechanismen te begrijpen welke 
bijdragen aan regulatie van apuA werden de functies van een upstream transcriptie 
regulator (ApuR) en het carbon catabolite control protein A (CcpA) onderzocht. Uit deze 
studies werd duidelijk dat groei van bacteriën in glucose of a-glucanen in belangrijke mate 
van invloed was op bacteriegroei en mogelijk ook op virulentie. Om vast te stellen of 
carbohydrate bronnen de globale regulatie van metabolisme en expressie van 
virulentiefactoren konden veranderen werden S. suis compleet-genomische genexpressie 
microarray experimenten uitgevoerd. Uitgaande van de recente vakliteratuur en de 
nieuwe resultaten verkregen tijdens de uitvoering van dit promotie onderzoek wordt hier 
een aangepast model voor kolonisatie en Pathogenese van S. suis voorgesteld, met 
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inachtneming van de rol van het carbohydraat metabolisme. Volgens dit model 
koloniseren S. suis bacteriën het mucosale epitheel na binnendringen van de gastheer via 
de neus of mondholte. De samenstelling van de carbohydraten in deze niche kan erg 
verschillend zijn vanwege verschillen in de samenstelling van de lokale microbiota. 
Wanneer de plaatselijke carbohydraat samenstelling van glucose laag is maar a-glucanen 
algemeen zijn neemt de expressie van een aantal 5. suis virulentie genen toe, waaronder 
expressie van suilysin, een bekend cytotoxine. 
In dit proefschrift wordt aangetoond hoe koolstofbronnen de genetische regulatie van 5. 
suis metabolisme en virulentie bepalen. De resultaten die in dit proefschrift beschreven 
worden stellen voor hoe carbohydraten, onderdeel van het dieet, virulentie van S. suis 
zouden kunnen beïnvloeden, en verschaffen informatie die kan bijdragen tot het rationeel 
ontwikkelen van nieuwe strategieën om dit belangrijke, opkomende zoönotische 
pathogeen. 
182 
Acknowledgements 
185 
Acknowledgements 
186 
Acknowledgements 
Acknowledgements 
This PhD has been a big journey and without the help of some key people who have been 
next to me, it would not have been possible for me to complete it. First of all I would like 
to express a deep gratitude to my boss Jerry. 
Dearest Jerry I learned a lot from you, we enjoyed having our nice discussions, either 
scientific, with the typical headache of brain-storming, and philosophic, where we 
expressed our opinion about life. I often used to remind you about Italian life-style and 
my motto "You just live once" ... 
I started with you from the beginning of our adventure in Wageningen. Day by day I have 
seen you building the nice group that now you lead. Sometimes the path has been 
difficult, but you achieved your dream, our dream to establish a good research quality. I 
always consider you as a pioneer, a real source of inspirations, ideas and creativity! You 
are for me an example to follow to be a good scientist! Thank you again for having given 
me the possibility to finally express my potential in this work that we both love. 
I am glad to see as your HMI group is growing with new strength and good scientists like 
Michiel Kleerebezem, Annick Mercenier, Jan Dekker, Mari Smits. You will fly high guys: 
union makes strength! 
In particular I would like to acknowledge Michiel Kleerebezem for the nice and useful 
discussions on bacterial metabolism. 
"Beste" Peter, you are another fundamental reference point in my "Dutch life". We know 
what we built in these four years... You are a great scientist and friend. You helped me 
many times to find the light when I was lost in the darkness. You gave me always a big 
psychological and scientific support. Thank you for all the discussions, corrections and 
ideas. I'm so happy that you shared with me the best moments of these past years. 
Moreover I found a new friend who loves the sun and the sea almost as I do (like Poetto or 
Mondello). 
You are special to me and I would like it if you can still be part of my funny adventurous 
life... 
Thanks also to my co-supervisor Hilde who supported the PhD and provided all the 
materials to start this new research line in Wageningen at the HMI group. 
187 
Acknowledgements 
It is a pleasure for me to mention also Astrid who has been so close and helpful in these 
four years. Hilde and Astrid thank you for your tips and advices and for sharing important 
information with me. 
I want also to express my deep gratitude to Germano Orrù from University of Cagliari who 
supported me throughout roughly ten years of my career, and encouraged me to embark 
in the hard but rewarding PhD journey! Dear Germano it has been a big pleasure to host 
you in our group, and your visit gave us a strong contribution. You left very nice memories 
among all of us! 
Rosaria, thank you for your excellent help for microarray experiment that you performed 
under the supervision of the great NIZO colleagues (Michel Wels and Roger Bongers). Dear 
Rosaria I wish you all the best in your new life and group at WUR. 
And now I would like to spend a lovely thought to my nice HMI colleagues. A special thank 
you to my two paranymphs: Oriana and Edoardo. Ori, you conquered me with your smart 
humour and deep sensibility, I am happy that you stayed the same lovely girl I met years 
ago in the green Ede station... (Remember?). Edo I consider you a little brother, I really 
hope we can also enjoy working in the lab together with the same fun and enthusiasm 
that we are used to have!!! (Mondelllllo beach the revenge....) 
My dearest HMI girls Linda, Ellen, Marjolein, I would like to thank you for the nice time 
spent together during coffee, trips and warm dinners. What I found special is that we have 
tried to support each other during the difficult PhD life. Lindy, I wish you to finish in the 
great way as you absolutely deserve it, and if you are bit tired... just ride your white horse. 
Elly (the tallest mamma ever), you brought a bit of fresh air and I really enjoyed doing 
cloning work with you. Mayo, it has been nice to work with the big expert of FACS and I 
am so glad for you that your career at WUR is going so well. Success girls for all that you 
desire. 
A special thank you to Jürgen, alias the king of the cells. I really appreciate your passion for 
the fluorescent colours in all the assays that you set up! 
I also want to acknowledge dearest Nico and Anja. Nico (alas "Chocolate-man"), in the end 
we have had the same pleasure purifying proteins using the ÄKTA system together, and 
maybe you also discovered to have those famous genes of hyper-enthusiasm (see Laura) 
188-
Acknowledgements 
;-) Anja (alas "THE artist"), as you see from the thesis I have made good use of the EM 
photos that we shot together. 
Trudy and Loes, the special HMI secretaries who are always present to help, listen and 
support us! You are an example of wonderful women to all of us. 
A special thought to Susana Fuentes, who has been my daily supervisor in my first year 
and introduced me to the magic molecular cloning work! 
Gracias Susanita ;) 
Thank you also to Irene and Sylvia, who helped to set up the group in the first years. 
A big thank you to all my students Laura M., Géraldine, and Steffie. To be a supervisor was 
a challenge for me, but I learnt back also from you, it has been a pleasure to work 
together with you. 
Thank you to all the nice people who recently joined HMI, Agnieszka, Rogier, and also the 
other groups that I met during these years, Annelies, Rogier L, Nathalie, Valentina P., 
Valentina R., Danilo, Carla, DuDu, Dulantha, Malgosia, Marcela, Maria and Marijke. 
E adesso finalmente in Italiano. Ringrazio tutti i miei cari amici vicini e lontani (Gianlu, 
Wenny, John, Alessandro, Fabio, Luca, Maria, Wim, Ceci, Matteo, Irma, Pirn, Igor, Ines, 
Laura, John, Linda, Bruno, Giovy ,Maurizio, Claudia, Manu, Gaetano, Rita, Nicola, Ruth, 
Francesca, etc etc), zii, cugini, etc, che hanno creduto in me!! E un grazie di cuore a 
mamma, papa, Giampiero, e il mio gattino Occhietto! So benissimo che siete super 
orgogliosi che la vostra "picciuna" si fa onore in terra straniera. Un ringraziamento 
speciale al mio Tesoro, Michèle, che quando parlo troppo di concetti di microbiologia 
molecolare mi riporta alla realtà mandandomi a fare la lavatrice! Grazie Miki senza di te 
tutto ciô non sarebbe stato possibile, grazie per assecondare il mio amore per la scienza e 
il mio lavoro!! Continueremo in questa grande avventura che è la vita. 
Vi voglio bene! Un abbraccio forte a tutt i ! 
J, aura 
189 
Acknowledgements 
Ave well 
4fe ;éaugk often 
y Ä>ve much 
190 
Personalia 
If the doors of perception were cleansed 
everything would appear to man as it is: Infinite. 
W. Blake 
191 
Personalia 
192 
Personalia 
Curriculum vitae 
M. Laura Ferrando was born in Cagliari (Italy) on 10th 
September 1972. In 1992, after graduating at Classic 
Gymnasium "Siotto Pintor", she started her bachelor and 
masters in Biological Sciences education at the University 
of Cagliari. She had been working for almost eight years 
as team-researcher in several Italian research institutes 
(University of Parma - Division of Genetics and 
Environmental Biotechnologies; Istituto zooprofilattico di Brescia - Centro substrati 
celluari; Université di Cagliari- Public Health Institute) mainly focussing on molecular 
diagnostics of animal and human pathogens. During these years, she acquired good work 
experience in the development of molecular methods for detection of pathogens in food, 
veterinary and environmental research areas. 
In the meantime, she also obtained the title of "Clinical microbiology and virology 
specialist" after successful completion of a 4-year specialization course at the Faculty of 
Medicine and Surgery of University of Cagliari. She completed this course with a thesis 
titled "Role of the Two-Component Systems (TCS) of Streptococcus pneumoniae in 
virulence", performed during a long-term fellowship at Swammerdam Institute (SILS) in 
Amsterdam under the supervision of Prof. J. M. Wells. After this, the author started as 
PhD student on the project entitled "Role of cell envelope proteins in virulence and 
pathogenicity of Streptococcus suis infections in pigs" funded by "Programma binnen KB-
thema 8 Diergezondheid", I.POP and CVI "kennisbasis". The project was carried out at the 
Host-Microbe Interactomics group, under the supervision of Prof. Dr, J. M. Wells, Dr Hilde 
E. Smith and Dr Ir Peter van Baarlen. 
Currently the author is employed as PostDoc at the Medical Microbiology Department 
of the Academic Medical Center of Amsterdam in the group of Dr Constance Schultsz. 
193-
Personalia 
List of publications 
Meijerink M., Ferrando M.L, Lammers G., Taverne N., H.E. Smith, Wells J.M. (2012). 
"Immunomodulatory effects of Streptococcus suis type 2 capsule on human dendritic cell 
responses and intracellular survival". PLoS ONE, in press. 
Ferrando M.L, S. Fuentes, de Greeff A., Smith H. E. &. Wells J. M. (2010). ApuA, a 
multifunctional alpha-glucan-degrading enzyme of Streptococcus suis, mediates adhesion 
to porcine epithelium and mucus. Microbiology 156: 2818-2828. 
Orru G., Ferrando M. L, Meloni M., Liciardi M., Savini G. & De Santis P. (2006). Rapid 
detection and quantitation of Bluetongue virus (BTV) using a Molecular Beacon 
fluorescent probe assay. J Virol Methods 137: 34-42. 
Losio M. N., Ferrando M. L, P. Daminelli & Chegdani F. (2004). Setting up a PCR based 
method to trace animal species in processed meat products. Vet Res Commun 28 Suppl 1: 
253-255 
Bertasi B., Bignotti E., Ferrando L, D'Abrosca F., Scaratti L & Pomati F. (2003). The 
standardization of a molecular biology method to verify the presence of Microcystis 
aeruginosa. Vet Res Commun 27 Suppl 1: 277-279. 
194 
Personalia 
Training and Supervision Plan 
The Basic Package Year 
WIAS Introduction Course, Wageningen, The Netherlands 2008 
Course on Ethics and Philosophy in Life Sciences, Wageningen, The Netherlands 2009 
Subtotal Basic Package 3.0 credits 
Scientific Exposure 
International conference 
CSHL, Microbial Pathogenesis & Host Response, New York, USA 2009 
Scientific Spring Meeting NVMM&NVvM Papendal, The Netherlands 2010 
Scientific Spring Meeting NVMM&NVvM Papendal, The Netherlands 2011 
XVIII Lancefield International Symposium, Palermo, Italy 2011 
Seminars and workshops 
WIAS Science day, Wageningen, The Netherlands 2008 
HMI Workshop, Cagliari, Italy 2008 
WIAS Science day, Wageningen, The Netherlands 2011 
Presentations 
"Surface virulence determinants of 5. suis" WIAS Science day (Poster) 2008 
"Surface virulence factors of S. suis" (Italy) HMI Workshop (Oral) 2008 
"Role of a multifunctional carbohydrate utilization gene apuA, in the virulence of S. suis" CSHL (Poster) 2009 
"ApuA a multifunctional a-glucan-degrading enzyme of S. suis mediates adhesion to porcine epithelium" 
NVMM&NVvM (poster) 2010 
"A transcriptional control mechanism linking carbohydrate metabolism and virulence in Streptococcus suis" 
WIAS Science day (Oral) 2011 
"Catabolite regulation of a afunctional adhesin and a-glucan utilization enzyme in Streptococcus suis" 
NVMM&NVvM (Poster) 2011 
"Transcriptional control mechanisms linking carbohydrate metabolism, colonization and virulence in S. suis." 
XVIII Lancefield (Oral) 2011 
Subtotal Scientific Exposure 11.8 credits 
In-Depth Studies 
Disciplinary and interdisciplinary courses 
Workshop on phylogeny & genetics in microbiology and virology, Rotterdam, The Netherlands 2008 
2nd Workshops molecular microbiology of Infectious diseases, Rotterdam, The Netherlands (Oral presentation) 2008 
WIAS Adavnced statistics course design of experiment, Wageningen, The Netherlands 2009 
Advance in genomics 2010, Ghent, Belgium 2010 
Stars network and training event Siena, Italy (Oral presentation) 2011 
Advanced visualisation, integration and biological interpretation of -omics data, Wageningen, The Netherlands 2011 
Statistics for the Life Sciences, Wageningen, The Netherlands 2011 
Subtotal In-Depth Studies 6.8 credits 
Statutory Courses 
International course on laboratory animal science, Utrecht, The Netherlands 2011 
Subtotal Statutory Courses 3 credits 
Professional Skills Support Courses 
Techniques for writing and presenting a scientific paper 2011 
Carrier and sperpective 2011 
Effective behavour surround 2010 
Subtotal Professional Skills Support Courses 3.5 credits 
Research Skills Training 
Preparing own PhD research proposal 2008 
Subtotal Research Skills Training 6.0 credits 
Didactic Skills Training 
Supervising practical and excursions 
HMI practical course 2008 
HMI practical course 2009 
HMI practical course 2010 
HMI practical course 2010 
Supervising theses 
Supervising 1 MSc minor 
Tutorship 
Tutor of 1 WIAS student 2008 
195 
Personalia 
Tutor of 1 MBO student 2009 
Preparing course material 
HMI practical course 2009 2009 
Subtotal Didactic Skills Training 6.5 credits 
Management Skills Training 
Organization of seminars and courses 
Host Microbe Interactomics Workshop at University of Cagliari (Italy) on September 2008 2008 
Subtotal Management Skills Training 1.0 credits 
196 
Cover design: M.L. Ferrando and M. Olla 
Layout: M.L. Ferrando 
Printed by GVO drukkers & vormgevers B.V. 
The research described in this thesis was financially supported by KennisBasis-middelen, 
KB-thema 8, Programma binnen KB-thema: "Diergezondheid" 
Financial support from Wageningen University for printing this thesis is gratefully 
acknowledged 
198 
